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Abstract
Seizures are one of the most common neurological disorders encountered in the canine patient. 
The susceptibility of the brain to a wide spectrum of structural and metabolic disorders means 
that the occurrence of seizures is indicative of an underlying condition of cerebrocortical 
dysfunction, not of a specific aetiology. However, all the pathological processes resulting in 
seizures may also occur without being accompanied by seizure activity. In addition, seizure 
activity in humans with brain tumours most commonly originates from cortical tissue that is 
distant from the tumour.
This dissertation focuses on seizures as a sign of intracranial dysfunction and through the 
presentation of selected canine clinical cases highlights the reasons and times at which 
seizures may be a clinical feature of intracranial neoplasia.
The majority of brain tumours associated with seizures affeet the rostrotentorial structures, 
especially the frontal, olfactory, and parietal lobes. Of the sixteen cases presented here, ten 
had seizures as admitting complaint. Of these, two were diagnosed with idiopathic epilepsy, 
one with hydrocephalus and intracranial arachnoid cyst, and seven with brain tumours. All but 
one of these seven dogs had tumours located in the rostral fossa. Unexpectedly, one dog had a 
caudal fossa tumour. In this case, post mortem examination revealed the presence of 
metastasis within the forebrain.
At the time of presentation to a veterinarian, seizures may be the only clinical manifestation of 
an intracranial tumour. However, in most instances interictal neurological abnormalities are 
present."" Conversely, animals affected with idiopathic epilepsy typically do not manifest 
interictal neurological deficits. In the case material here reported, two of the seven dogs 
presented for evaluation of seizure disorders and diagnosed with brain tumour did not exhibit 
interietal neurological abnormalities. These findings emphasise that a normal interictal 
neurological examination does not exclude the possibility that a structural brain abnormality is 
the cause of the observed seizure activity.
Overall, changes in mental status, behavioural derangement and ataxia are the neurological 
abnormalities most frequently observed in patients with intracranial neoplasia. Signs of 
vestibular dysfunction are a common manifestation of tumours affecting the caudal fossa
structures. In the series here reported, two of the three dogs diagnosed with hindbrain 
neoplasia exhibited signs of vestibular dysfunction at the time of presentation.
Combining the results of this study with a broad review of the literature pertaining to seizure 
disorders in dogs, this dissertation emphasises the non-speeificity of seizures as a sign of 
intracranial disease / dysfunction and the need for a logical and systematic diagnostic 
evaluation.
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Introduction
Definitions
Seizure
A seizure is the clinical manifestation of excessive and / or hypersynchronous discharge 
activity of populations of neurons in the cerebral cortex. This abnormal electrical activity 
produces characteristic paroxysmal discharges (epileptiform activity) on 
electroencephalographic (EEG) recordings. Each seizure is a discrete clinical event consisting 
in transient, self-limiting, stereotyped and involuntary changes in behaviour or neurological 
status. Seizures can manifest as anything from a subtle alteration in alertness to a generalised, 
tonic-clonic event (March 1998; Thomas 2000).
The definition of seizure given above implies a specific neuronal origin. In this dissertation 
the teim “seizure” will be always used to refer to paroxysmal events of neuronal origin, 
whereas the term “seizure-like event/s” will be used to refer to paroxysmal events, which do 
not have a neuronal origin.
The clinical features of seizures can be separated into three components: the preictal stage or 
aura, the ictus and the postictal period. Preceding the seizure a prodromal period may occur.
Prodrome
The prodrome is a long-term indication of a forthcoming seizure manifested in man by 
disturbances of mood or behaviour, less frequently of subjective symptoms such as headache, 
nervousness, and anxiety. These manifestations occur hours to days before a seizure. 
Similarly, occasionally owners report that they know that their pet is going to seizure days in 
advance by changes in the animal’s behaviour such as anxiety, restlessness, and uncontrolled 
barking. The pathophysiology of prodromes is not understood, but in contrast to auras, 
prodromes are long lasting (hours to days), not associated with electroencephalographic 
activity, and not part of the seizure. Prodrome is therefore a clinical definition. Prodromes are 
thought to reflect a preictal increase in excitability of an epileptogenic focus or of the entire 
brain (Podell 1996; Berendt & Gram 1999; Thomas 2000). However, this increased 
excitability does not result in EEG changes because the number of neurons firing in synchrony 
is probably not sufficient to generate electrical activity detectable at the scalp surface (Berendt 
& Gram 1999).
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Aura
In human epileptology the aura is defined as the initial sensation / manifestation of a seizure 
before there are observable signs; it is caused by the initial abnormal electric activity of a 
single group of neurons, and therefore it represents the onset of a seizure. During this period, 
which can last seconds to minutes, human patients describe various sensations including 
dizziness, tingling, and anxiety. Because auras are usually subjective, they are difficult to 
characterise in animals. Nevertheless animals can exhibit stereotypic sensory or motor 
behaviour (pacing, licking), autonomic patterns (salivating, urinating, vomiting), or even 
unusual behaviour (hiding, excessive barking, increased or decreased attention seeking). 
During the aura, consciousness is unimpaired (Podell 1996; Berendt & Gram 1999; Thomas 
2000). An. aura is commonly seen prior to a generalised seizure, rarely prior to a partial one 
(Dodman et al 1992; Podell et al 1995).
Ictus
The ictus is the actual seizure event manifested by involuntary movements and / or abnormal 
sensations or behaviour, usually lasting from' seconds to minutes (30 to 90 seconds in most 
cases). The ictus may be accompanied by disturbances of the autonomic nervous system, 
resulting in salivation, urination, defecation, pupillary dilation and piloerection.
Postictal period
After the ictal event comes the postictal period, which can last from minutes to days. Postictal 
signs are the clinical manifestation of transient abnormalities in brain function caused by the 
ictus. They may consist in unusual behaviour, disorientation, inappropriate bladder / bowel 
control activity, excessive or depressed thirst and appetite, fatigue, deep sleep, and actual 
neurologic deficits of weakness, blindness, or sensory and motor disturbances. The latter 
problems if asymmetric are known as Todd’s paralysis and, are an indicator of a focal, 
contralateral cortical seizure focus. Often owners only observe the postictal period as 
evidence that their pet has had a seizure. Thus, careful questioning is needed by the clinician 
to decide if an animal did have a seizure. No correlation exists between the type, intensity, or 
duration of seizures and the duration of the postictal phase (Podell 1996; March 1998; Thomas 
2000).
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Interictal period
The interictal period is the time between resolution of any postictal signs and the beginning of 
the next ictus (Thomas 2000).
Status epilepticus
Status epilepticus has been defined as, a seizure lasting 20 to 30 minutes, which is an 
estimation of the duration necessary to cause brain damage (Shell 1999; Podell 2000). 
However, loss of brain homeostasis occurs within 1 to 2 minutes of seizure onset (Shell 1999). 
On the basis of this consideration, and the fact that isolated seizures rarely last more than a few 
minutes the following practical definition of status epilepticus has been proposed: “status 
epilepticus is a continuous seizure lasting at least 5 minutes, or two or more discrete seizures 
without full recovery of consciousness between seizures, even if the duration of each seizures 
is less than 5 minutes” (Shell 1999; Thomas 2000), The aim of this definition is to enhance 
the clinicians’ ability to address the metabolic and physiologic changes, which follow status 
epilepticus more quickly (Shell 1999).
Cluster seizures
Cluster seizures (serial seizures, acute repetitive seizures) are two or more seizures occurring 
over a brief period (minutes to hours) but with the patient regaining consciousness between the 
seizures (Thomas 2000).
Epilepsy
The term “epilepsy” defines a chronic condition characterised by recuiTent seizures.
Some authors refer to seizures, which are neuronal in origin, as to epileptic seizure cf. 
nonepileptic seizures (Podell 1996). The latter are paroxysmal events associated with transient 
alteration in neurologic function, but not accompanied by abnormal electrical discharges from 
the brain (Podell 1996; Knowles 1998). The term epileptic seizure is incorrect, because 
although seizures are always abnormal events, not all seizures are the result of a condition of 
chronic cerebrocortical dysfunction. A seizure can in fact be the natural reaction of a normal 
brain to a transient systemic insult or physiologic stress (extracranial metabolic or toxic insult, 
head injury). Seizures that occur at the time of a systemic disorder or brain insult are defined 
as provoked seizures or reactive seizures (RS). If the seizures stop when the underlying
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condition resolves, the patient does not have epilepsy, as the seizures are not recurrent and an 
underlying chronic brain disorder is not present (Podell et al 1995; Podell 1996). In this 
dissertation paroxysmal events, which do not have a neuronal origin are referred to as 
“seizure-like event/s” because the term seizure always implies a neuronal origin.
Chronic recurrent seizures may be due to a wide spectrum of causes. Therefore, the term 
epilepsies is more appropriate than epilepsy. Epilepsies may be categorised as being 
symptomatic or idiopathic (Wolf 1997; Thomas 2000).
Symptomatic or secondary epilepsies (SE) are those in which seizures are the consequence of a 
structural brain lesion. Brain trauma, hydrocephalus, encephalitis, and neoplasia are examples 
of potential inducers of structural damage. Metabolic and toxic insults may also alter 
permanently the brain structure, hence causing SE (March 1998; Berendt & Gram 1999; 
Thomas 2000).
The designation of idiopathic or primary epilepsies (IE / PE) implies recurrent, unprovoked 
seizures in which no underlying brain abnormality exists or can be detected. Idiopathic 
epilepsy also implies that there are no interictal neurologic deficits (Knowles 1998). A 
functional defect probably underlies most forms of IE. A pre-existing (ion channel defects) or 
early development defect (persistent overabundance of excitatory circuits) affecting the 
cerebral cortex diffusely is considered the most likely causes of PE (Mischel & Vinters 1997; 
March 1998). This form of epilepsy is presumed to have a genetic component but definitive 
evidence for this in certain breeds is often difficult to find. The term inherited or genetic 
epilepsy should be used only when there is a known genetic cause for the epilepsy (Podell 
1996; Thomas 2000).
The term cryptogenic epilepsy has been used, when recurrent seizures are presumed 
symptomatic, although diagnostic tests have failed to demonstrate an underlying cause 
(Berendt & Gram 1999; Thomas 2000). The definition of cryptogenic epilepsy is a clinical 
one and refers to patients with chronic recurrent seizure activity, which for history and 
physical/neurological examination findings would indicate symptomatic epilepsy, but the 
results of diagnostic tests are unremarkable. In these circumstances the term cryptogenic 
epilepsy is more appropriate than idiopathic epilepsy (Berendt & Gram 1999; Thomas 2000).
Introduction
Types of seizures
Seizures may be classified by their clinical appearance as partial and generalised seizures 
(Wolf 1997; March 1998; Thomas 2000).
Partial seizures
Partial or focal seizures begin in a discrete cerebrocortical area and may or may not generalise. 
The appearance of the seizure reflects the location of the seizure focus. Partial seizures are 
defined as simple partial (SP) seizures when consciousness is not impaired and as complex 
partial (CP) seizures when consciousness is impaired (March 1998; Thomas 2000).
SP seizures are characterised by asymmetrical clinical manifestations, which reflect 
asymmetrical electrical activity in the brain (Selcer & Selcer 1990; Shell 1993a). There are 
many types of SP seizures depending on the cortical area affected. SP seizures are 
characterised by unilateral focal motor activity, involving isolated groups of muscles (for 
example, rhythmic contractions of facial or masticatory muscles). SP seizures are in fact also 
called “focal motor” seizures (March 1998). SP seizures may develop into CP seizures, and 
both types of partial seizures may secondarily generalise and develop into convulsions 
(secondary generalised seizures) (Podell 1996; Berendt & Gram 1999; Thomas 2000). The 
motor area of the cerebral cortex of domestic animals is small, allowing seizure activity to 
generalise rapidly (Oliver et al 1993b). The development of SP seizures into CP seizures is 
usually not identified because of obvious problems with the evaluation of subtle and/or rapid 
changes in consciousness (March 1998; Berendt & Gram 1999).
CP seizures, also called psychomotor seizures, are characterised by bizarre behavioural 
abnormalities accompanied by complex motor activity. Unprovoked aggression, extreme 
irrational fear (rage), jaw snapping, fly-biting, star-gazing, tail chasing, running, hiding, and 
senseless vocalisation have been described (Selcer & Selcer 1990; Dodman et al 1992; 
Sorjonen 1992; Shell 1993a; March 1998). Involuntary automatic motor behaviour such as 
swallowing movements, lip smacking or chewing, may occur at the time that consciousness is 
impaired. Episodic gastrointestinal disturbances, thought to be caused by abnormal limbic 
system function, have also been reported in dogs (Breitschwerdt et al 1979). CP seizures have 
a temporal or frontotemporal origin and epileptiform discharges are frequently bilateral 
(Dodman et al 1992; Sorjonen 1992; Dodman et al 1996; March 1998).
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Partial seizures may also represent abortive forms of generalised, tonic-clonic seizures in 
animals receiving anticonvulsant medication (Knowles 1998).
Generalised seizures
Generalised seizures imply a diffuse disturbance of brain function from onset to termination 
(Podell 1996; Zifkin & Dravet 1997; March 1998). Clinical signs are symmetric in character 
and are usually associated with loss of consciousness (Shell 1993a; March 1998). With close 
observation, including videotaped review of seizures, it has become apparent that many 
patients suffer focal seizures with secondary generalisation (secondary generalised seizures) 
(Berendt & Gram 1999). Generalised seizures in which the first clinical signs indicate initial 
involvement of both cerebral hemispheres are referred to as primary generalised seizures 
(Shell 1993a; Berendt & Gram 1999).
Generalised seizures are subdivided into convulsive and nonconvulsive. The most common 
type of generalised convulsive seizure in dogs is a generalised, tonic-clonic seizure (Podell 
1996; Thomas 2000). The first part of the seizure is the tonic phase, during which there is 
sustained contraction of all muscles. The anitnal loses consciousness and falls to its side in 
opisthotonus with the limbs extended. Respiration is often irregular or absent, and cyanosis is 
common. Autonomic release is also common. The tonic phase gives way to the clonic one, 
during which there is rhythmic contraction of muscles that manifests as paddling or jerking of 
the limbs and chewing movements. Occasionally tonic-clonic seizures occur in which 
consciousness is maintained (Chrisman 1991, Shell 1993a; Reynold et al 1997; Jaggy & 
Bemardini 1998; Thomas 2000). Very occasionally purely tonic or clonic seizures may be 
obseiwed (Heynold et al 1997; Jaggy & Bemardini 1998). Atonic jgzzures and myoclonic 
seizures are also uncommon in domestic animals (Podell 1996). There are other causes of 
myoclonic jerks in animals, that is, not all myoclonic jerks are seizures (de Lahunta 2000b; 
Thomas 2000).
Generalised nonconvulsive seizures are also called absence seizures due to the transient loss of 
consciousness and lack of motor activity. Tme absence seizures have not been substantiated 
in either dogs or cats (Thomas 2000).
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Epidemiological Issues
Seizures are one of the most common neurological disorders in the canine patient; for example 
2 to 3% of one refenal hospital’s canine admissions were for evaluation and management of 
seizures (Podell et al 1995). Estimates of seizure incidence during an individual lifetime vary 
from 0.5% to 5.7% (LeCouteur 1995)
The relative frequency of structural symptomatic and idiopathic epilepsy varies between 
species. Idiopathic epilepsy is more common than structural symptomatic epilepsy in dogs, 
whereas the reverse is true in cats (Podell 1996; March 1998).
The true prevalence of idiopathic epilepsy is difficult to establish because of problems with the 
diagnosis and confident exclusion of other causes (Knowles 1998; Thomas 2000). Seizures in 
which an underlying cause is present but cannot be demonstrated by routine neurodiagnostic 
testing (so called cryptogenic epilepsy) are probably more common than is described in the 
veterinary literature (Thomas 2000). Refining neuroimaging and histological examination 
techniques in humans has resulted in an increase in epilepsies classified as symptomatic and a 
concomitant decrease in the proportion of cryptogenic and idiopathic epilepsies (Berendt & 
Gram 1999).
The textbook description of canine idiopathic epilepsy is that of bilaterally symmetrical 
generalised, tonic-clonic seizures, lasting approximately 1 to 3 minutes, initiating when the 
dog is 1 or 2 to 5 years old, common to certain breeds (de Lahunta 1983b; Oliver et al 1993b). 
More recent studies report that although most dogs with idiopathic epilepsy experience their 
first seizure between 6 months and 5 years of age, seizures occasionally start before 6 months 
or as late as 10 years of age (Heynold et al 1997; Jaggy & Bemardini 1998; Knowles 1998; 
Berendt & Gram 1999; Thomas 2000).
Breed-related inherited epilepsy in dogs has been documented in Beagles, Belgian Tervurens, 
Keeshounds, Dachshunds, and British Alsations German Shepherd dogs (Cunningham & 
Farnbach 1988; Shell 1993b; Hall & Wallace 1996; Famula et al 1997; Thomas 2000) and in a 
number of other breeds this is strongly suspected (Srenk & Jaggy 1996; Jaggy et al 1998; 
Knowles 1998). However, any breed may be affected. The mode of inheritance is still 
unknown (Schwardtz-Porsche 1994; Knowles 1998). As in most studies male dogs slightly
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outnumber female dogs (Podell 1996; Thomas 2000) a sex linkage limitation, or modification 
cannot be excluded.
Causes of seizures
Causes of seizures are routinely ascribed as extra- or intracranial in origin.
Extracranial causes
Extracranial causes of seizures disrupt normal brain function; they are in turn divided into 
those that originate outside the body (e.g., toxins) and those that arise within the body but 
outside the nervous system (metabolic disorders) (LeCouteur 1995) (Table 1, page 11). 
Seizures in response to extracranial disease are called reactive seizures (Podell 1996).
There have been many articles published which review the extracranial causes of seizures with 
emphasis on the mechanism by which they generate seizures, and discussion of some general 
aspects of their diagnosis and therapeutic management. These aspects will not be addressed in 
this dissertation (Cuddon 1996; O’Brien 1998; Schwartz-Porsche 1999).
Intracranial causes of seizures
Intracranial causes of seizure disorders may be divided into functional and structural causes. 
Despite the absence of epidemiological studies aimed to establish the incidence of seizures 
specifically due to intracranial causes, the overall impression is that intracranial causes are by 
far the most common causes of seizures in dogs (LeCouteur 1995).
Functional and structural causes o f seizures
Functional causes of seizures include primary epilepsy (LeCouteur 1995). Structural causes of 
seizures can represent any process that disrupts / changes the normal character of the brain 
tissue or vasculature, such as neoplasia, inflammation, vascular lesion and trauma (Table 3, 
page 13; Tab 4 page 14). Structural causes of seizures may also be described as progressive or 
non-progressive. Storage diseases and neoplasia are the most common types of progressive 
brain diseases (Shell 1993b; Jolly et al 1994; Podell et al 1995). Non-progressive brain 
diseases are those brain disorders that, although previously active, have become inactive but 
have left the brain in a “seizure-prone” state (hypoxic event, vascular accident, head trauma); 
morphological brain lesions may have occurred long before the first seizure occurs (LeCouteur
1995). Clinically it is important to distinguish between progressive and non-progressive brain
9
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diseases because this influences both treatment options and prognosis (Schwartz-Porsche 
1999).
In the canine species, symptomatic epilepsy is thought to be less common than idiopathic 
epilepsy. Intracranial causes of seizures have been widely reviewed elsewhere (Shell 1993b; 
LeCouteur 1995; Bagley 1997; Thomas 1998; Schwartz-Porsche 1999; Thomas 2000). A 
section of this dissertation is specifically designed to discuss brain tumours in dogs; 
conversely only brief notes of the other intracranial disorders, which may result in seizures, 
will be given in the context of the diagnostic approach to seizures.
Pathophysiology of seizure disorders
The specific pathophysiological mechanisms of seizures generation are complex and still not 
completely understood. In this dissertation only a brief description of the general mechanisms 
thought to underlay seizure activity will be given. Detailed considerations may be found in 
Engel & Pedley (1997), March (1998) and Westbrook (2000).
The potential for the generation and spread of paroxysmal neuronal discharges as found in 
seizure activity reflects features of the anatomical and functional organisation of the brain. 
Significant amongst these are: inherent neuronal properties such as burst firing (March 1998; 
Galarreta & Hestrin 1999); failure of local and regional inhibition of activity (March 1998; 
Westbrook 2000); features of inter-neuronal connectivity (Shell 1993a; Coulter 1997; Proctor 
& Gale 1997; March 1998).
After insult or as the consequence of disease, a spectrum of changes may occur that enhance 
the likelihood of a seizure developing. These include: changes in receptor density and / or 
sensitivity on neurons (McNamara & Wada 1997); changes in the performance of cellular ion 
pumps (Dichter & Wilcox 1997); loss of inhibitory circuits (March 1998); the development of 
kindling and mirror foci (Au Louis et al 1997; McNamara & Wada 1997); increased extra­
cellular potassium levels (McNamara 1994; McNamara & Wada 1997).
10
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Table 1. Extracranial causes of seizures
Metabolic disorders
Hypoxia
Congenital and acquired cardiac disease 
Respiratory disturbances 
Polycythemia
Hypoglycaemia 
Table 2, page 12
Hepatoencephalopathy
Portosystemic shunt 
Severe liver diseases
Hypocalcaemia
Peripaiturition
Hypoparathyroidism
Immune-mediated lymphocytic parathyroiditis
Hypercalcaemia
Primary hyperparathyroidism 
Functional adenoma 
Pseudohyperparathyroidism
Lymphosarcoma, anal sac adenocarcinoma 
Osteolysis secondary to neoplasia 
Acute and chronic renal failure 
Hypoadrenocorticism
Electrolyte and acid-base status imbalances
Hyper- and hyponatremia 
Nonketotic hyperosmolar diabetes
Hyperlipidemia
Fat emboli in Miniature Schauzers 
Hypothyroidism
Renal encephalopathy 
Uremia
acid-base, fluid and electrolytes abnormalities 
hypertension
Pancreatic encephalopathy
Thiamin deficiency 
(terminal stages)
Intoxication
Organophosphates, carbamates 
Chlorinated hydrocarbons 
Rodenticides, herbicides 
Heavy metals (especially lead)
Drug related (e.g. ivermectin)
Plant toxins and mycotoxins
Animal toxins (e.g. bee and wasp venom)
 ________________ (Cuddon 1996; Podell 1996; O’Brien 1998; Schwartz-Porsche 1999; Thomas 2000)
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Table 2. Causes of hypoglycaemia in dogs
Increased glucose consumption 
Excess o f  insulin
Insulin-secreting tumours (insulinoma)
Therapeutic overdose
Extrapancreatic neoplasia (insulinlike substances)
Hunting dog hypoglycaemia
Insufficient glucose supply 
Inadequate blood supply 
Inadequate glucose production 
Hepatic diseases
Neonatal and transient juvenile hypoglycaemia 
Substrate deficiencies (starvation, malabsorption)
Enzyme deficiencies
Glycogen storage disease
Glucose-6-phospatase deficiency (Von Gierke’s disease) 
Acid a-glucosidase deficiency (Pompe’s disease)
Am ylo-1-6 glucosidase deficiency (Cori’s disease)
Sepsis
(Cuddon 1996)
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Table 3, Intracranial structural causes of seizures
Degenerative
Storage diseases
GM2 gangliosidosis, metachromatic leukodystrophy,
Glycoproteinosis, glycogenosis, ceroid lipofuscinosis
Anomalous
Hydrocephalus
Acquired, congenital 
Malformations
Lissencephaly
Neoplastic
Primary brain tumour 
Metastatic brain tumour
Infectious-Inflammatory
(meningitis and/or encephalitis)
Viral
Canine distemper, rabies 
Bacterial
Various types (e.g., Spirochaetes)
Fungal
Cryptococcosis
Protozoal
Toxoplasmosis 
Neosporosis 
Rickettsia rickettsii and Ehrlichia canis 
Parasitic
Aberrant migration (e.g., Cuterebra species larvae)
Granulomatous meningoencephalitis /-encephalomyelitis (Table 4, page 14)
Necrotizing encephalitis 
Unknown causes
Traumatic (head trauma)
acute -»  haemorrhages /  hypoxia 
delayed scars
Vascular
Intracranial haemorrhage 
Brain infarction
embolism from underlying cardiac disease (e.g., bacterial endocarditis) 
hypertension
cerebral artery atherosclerosis secondary to hypothyroidism  
Hypertensive encephalopathy 
Essential hypertension 
Secondary hypertension
acute and chronic renal failure
glomerulonephritis
hyperadrenocorticism
(Shell 1993a; Jolly et al 1994; Podell 1996; Bagley & Gavin 1998;Thomas 1998; Schwartz-Porsche 1999; Thomas 2000)
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Intracranial neoplasia in dogs 
Epidemiology and classification
Epidemiology
Intracranial tumours occur relatively frequently in dogs. The incidence of intracranial 
neoplasia occurring in veterinary patients has not recently been evaluated; previously reported 
incidence of primary brain tumours in the canine species is 14.5 a year per 100,000 dogs at 
risk (Vandevelde 1984). Metastatic disease appears to be less common (Moore et al 1996). 
However, the actual incidence of intracranial neoplasia is probably unknown because: a) the 
access to advanced imaging modalities, which allow ante-mortem diagnosis of intracranial 
space-occupying lesions (computed tomography and magnetic resonance imaging), has limited 
availability and represents a significant cost to the owner; b) the cranial vault is uncommonly 
evaluated as a site of metastatic disease at routine post-mortem examination (Bagley & Gavin
1998). In addition, improved therapy for neoplasia has resulted in longer survival and change 
in metastatic behaviour for some cancers, leading to increased incidence of intracranial 
metastasis. This has been shown to be particularly true for lymphoreticular neoplasia because 
lymphocytes can cross the blood-brain barrier (EBB) (Couto et al 1984; Moore et al 1996),
Although, brain tumours occur in dogs of all breeds, both genders and any age, the incidence 
increases over five years of age, and the relative risk increases in certain breeds. The median 
age for dogs for being diagnosed with a brain tumour is 9 years (Kraus & McDonnell 1996; 
Moore et al 1996; Bagley 1999; LeCouteur 1999). Interestingly, brain tumours are over­
represented in immature dogs (<6 months): intracranial tumours are second only to tumours of 
the haematopoietic system in dogs of this age group (Keller & Madewell 1992; Spugnini et al
1995). Brain tumours that can occur in dogs younger than 5 years of age include 
medulloblastoma, ventricular tumours (e.g., ependymoma, choroid plexus papilloma), and 
tumours of congenital maldevelopment such as epidermoid / dermoid cysts, 
craniopharyngiomas and teratomas (LeCouteur 1990; Moore et al 1996). Teratomas may be 
associated with the onset of clinical signs late in life (Targett et al 1998). Gliomas and 
meningiomas have also been reported (Cox et al 1990; Keller & Madewell 1992; Trioio et al 
1994).
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Breeds such as Golden Retriever, mixed breed, Labrador Retriever, Boxer, Collie, Doberman 
Pinscher, Schnauzer, Scottish Terrier, and Old English Sheepdog have been reported to 
develop intracranial tumours more commonly than other breeds (Heidner et al 1991; Kraus & 
McDonnell 1996; Moore et al 1996; Bagley 1999; LeCouteur 1999).
Breed predisposition for certain tumours types has been reported: glial cell tumours 
(astrocytomas, oligodendrogliomas) and pituitary tumours have a predilection for 
brachycephalic breeds. Conversely, meningiomas have a similar incidence in all breeds of 
dogs, although marginally higher in the dolicocephalic ones (Moore et al 1996; Dewey et al 
2000).
Overall, meningiomas and astrocytomas are the most common types of intracranial neoplasia 
in dogs (Moore et al 1996; LeCouteur 1999; Dewey et al 2000). Some reports indicate 
meningioma (Heidner et al 1991) as the most common tumour type, whereas in others 
astrocytoma is (Zaki 1977). These differences may reflect a change in the incidence of 
tumours, changing in breed popularity, geographic differences or other unknown reasons. 
Similar consideration has to be made regarding the incidence of astrocytoma and 
oligodendroglioma. Astrocytoma is reported to be the most common glial cell tumour of dogs 
in the United States of America, whereas in some European countries oligodendroglioma 
appears to be the most common (Moore et al 1996).
Gender predisposition is not well established. Some studies report a higher incidence of brain 
tumours in males (Zaki & Nafe 1980; Moore et al 1996) although a higher proportion of 
females appear to develop meningiomas, perhaps as a consequence of oestrogen receptors 
identified in this tumour type in both dogs and humans (Spéciale et al 1990; Spugnini et al 
1995; Moore et al 1996).
Classification
Classification of brain tumours is generally based on histological and cytological criteria 
capable of determining the cell type of tumour origin, the growth characteristic of the tumour 
and the degree of differentiation within the tumour. Such determinations provide the 
clinicians with a basis for making a prognosis and determining therapeutic options (LeCouteur 
1999).
16
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Primary and secondary brain tumours
Intracranial neoplasms may be classified as either primary or secondary, depending on their 
cell of origin. Primary brain tumours arise from the brain parenchymal tissue (glial cells, 
neurons), cells comprising the outer and inner lining of the brain (meninges and ependyma, 
respectively), vascular elements (choroid plexus) and lymphoid tissues (LeCouteur 1990; 
Dewey et al 2000). Secondary tumours include all metastatic tumours. These may reach the 
brain by haematogenous metastasis from a primary tumour located outside the nervous system 
or by local invasion (or extension) from adjacent non-neuronal tissue (e.g., nasal and frontal 
sinuses tumours, middle ear and calvarial tumours) (LeCouteur 1999). As the central nervous 
system (CNS) lacks a lymphatic system, CNS métastasés most likely occur by haematogenous 
routes; this partially explains the high incidence of infarction and / or haemorrhage observed 
with CNS métastasés (Fenner 1990). The cortical grey / white matter junction is a common 
area of métastasés due to increased vascularity; brain stem and cerebellar métastasés are less 
frequently seen (Bagley & Gavin 1998; Moore & Taylor 1988).
Local extension from nasal adenocarcinoma or métastasés from mammary, prostatic or 
pulmonary adenocarcinoma, lymphosarcoma and haemangiosarcoma are the most frequently 
encountered secondary tumours in dogs (Moore & Taylor 1988; Sackman et al 1989; Nafe 
1990; Mori et al 1991; Bagley & Gavin 1998). Tumours that readily metastasise to the lungs 
are more likely to metastasise to the brain (Bagley & Gavin 1998), because 15% of cardiac 
blood flow returning from the lungs goes to the brain (Johnson 1990). Calvarial tumours that 
may affect the brain by means of local extension include osteosarcoma and multilobular 
osteochondrosarcoma (Straw et al 1989).
Pituitary gland neoplasms (adenomas and carcinomas) and tumours arising from cranial nerves 
(e.g., nerve sheath tumour of the IIF^ or VIF^ cranial nerves) are considered secondary brain 
tumours, as they affect the brain by means of local extension (LeCouteur 1999). Some authors 
refer to tumours that affect the brain but which are not strictly derived from the nervous 
system to as CNS-associated tumours, and include in this category: pituitary tumours, germ 
cells tumours % craniopharyngiomas, chordomas and osteochondrosarcomas. Of these.
‘ These are also referred to as suprasellar germ cells tumours because most com monly located in the pineal and 
suprasellar region.
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pituitary tumours and osteochondrosarcomas occur relatively frequently in dogs (Moore et al
1996).
In general, lymphoma is classified as a secondary brain tumour, because it almost always 
occurs simultaneously with the development of, or late in the course of therapy for, 
multicentric lymphoid neoplasia originating from a primary focus outside the CNS (Britt et al 
1984; Couto et al 1984; Johnson 1990; LeCouteur 1990). Occasionally, however, lymphoma 
involves the CNS in absence of systemic disease, in which case it is classified as primary CNS 
lymphoma (Johnson 1990).
Cytological and biological malignancy
In assessing the malignant potential of a brain tumour, the difference between cytological and 
biological malignancy has to be emphasised. Cytological malignancy is a morphological 
assessment of anaplasia, whereas biological malignancy is related to the life-threatening 
potential of the mass in itself (LeCouteur 1999). Most cytologically malignant brain tumours 
are also biologically malignant, despite the treatments presently available. Cytologically 
benign brain tumours may be biologically malignant because of various secondary effects e.g. 
increased intracranial pressure (ICP).
The capability of a brain tumour to: locally infiltrating normal brain parenchyma, spreading 
along the surface of the brain to local sites, or spreading by cerebrospinal fluid (CSF) to other 
sites within the cranial vault and / or the spinal cord, influences its biological malignancy. 
Multiple space-occupying lesions usually carry a worse prognosis than single masses (Le 
Couteur 1999). Most primary brain tumours of dogs are solitary. However, multiple CSF 
métastasés of medulloblastoma (LeCouteur 1990) and choroid plexus papilloma (LeCouteur et 
al 1981) have been reported. Multiple tumours of different histologic type are rare (e.g., 
pituitary carcinoma, meningioma) (Patnaik et al 1986; Johnson 1990; Schulman et al 1992). 
Primary brain métastasés to non-CNS sites can occur but are uncommon (Schulman et al 
1992; Moore et al 1996; Furushima et al 1989).
Tumour types
This dissertation concentrates on meningiomas and glial cell tumours these being the tumour 
types more frequently encountered in dogs. Table 11 (page 28-30) summarises the
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classification of primary brain tumours in human patients according to the World Health 
Organisation (WHO, 1993); not all these tumour types have been described in dogs.
M en in g iom as
H i s t i o g e n e s i s
Meningiomas arise from the mesenchymal arachnoid layer of the meninges; they develop from 
the periphery of the brain parenchyma and expand inward. However, despite the striking 
ultrastructural similarities between arachnoid cells and meningiomas cells, the ultimate 
histogenesis of meningiomas remains to be established (Lantos et al 1997).
B e h a v io u r
Canine intracranial meningiomas are most often at the convexities of the cerebral hemispheres, 
in the midline attached to the falx cerebri or to the tentorium cerebelli, or at the lateral / ventral 
surface of the brain at the rostral and middle fossa (Braund 1984; Braund & Ribas 1986). 
Meningioma may also arise intraventricularly from the tela choroidea, mimicking a choroid 
plexus tumour (Bagley & Gavin 1998). Retrobulbar, paranasal and frontal sinus localisation 
are uncommon, but have been described (Patnaik et al 1986, Patnaik 1989; Moore et al 1996).
Growth is usually slow and within meningeal layers; lesions are usually discrete and may be 
delineated by a thin investing capsule (Kraft 1990). Meningiomas may compress or extend 
into adjacent brain tissue causing pressure atrophy and a mass effect. Meningiomas are often 
adherent to the dura mater. Attachment to the dura can be broad-based (narrow), sessile 
(peduneulated) or complete (meningioma en plaque). Meningiomas may be spheroidal, or 
lobate, with a regular or a nodular surface (Kraft 1990).
Hyperostosis, a proliferative bony response that is a hallmark of human meningiomas, is a 
common finding in dogs (Braund & Ribas 1986; Kraft 1990). Currently hyperostosis is 
believed to result from high activity of the enzyme alkaline phosphatase (AP) in the neoplastic 
cells and/or a change in local blood supply (Lantos et al 1997). Alternatively, meningiomas 
may produce bone erosion as a result of pressure atrophy of the calvarium (Bagley 1996b).
In dogs, meningiomas tend to be more infiltrative into surrounding cortical parenchyma than 
in cats where meningiomas are often multiple and always well encapsulated (LeCouteur
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1999). Predominantly cystic meningiomas, most commonly involving the olfactory area, have 
been described (Bagley et al 1996; Bagley 1999).
H is t o l o g ic a l  f e a t u r e s
The major histological features of the three subtypes most commonly encountered are 
summarised in Table 5, page 20. Two or more subtypes are often present within the same 
tumour mass (Kraft 1990). Méningothélial and transitional subtypes are most common in 
dogs (Johnson 1990). In most cases a single H&E-stained section secures the diagnosis, and 
immunostaining is performed only to further confirm it (Johnson 1990). Sarcomas of the 
meninges have been described in dogs. They may occur as discrete masses or as a diffuse 
sarcomatosis of the meninges (Moore et al 1996).
Table 5. Histology and Immunocytochemlstry of meningiomas
Histology Immunohistochemistry
Méningothélial
Fibroblastic
Transitional
Nests, lobules of méningothélial cells with 
round to oval nuclei and abundant 
cytoplasm. Cell membrane is not well 
defined and the overall imprèssion is that of 
a syncytium (also called syncytial
meningiomas)
Bundles of elongated fibroblastic-like cells
Islands of méningothélial cells alternate with 
interlacing bundle of spindle-shaped cells. 
They have a striking tendency for whorl 
formation. They may contain psammoma 
bodies
positive vimentin and 
EM A* reactivity
* Epithelial Membrane Antigen 
proved for humans, not for 
canine meningiomas
( J o h n s o n  1 9 9 0 ;  Kraft 1 9 9 0 ;  S u m m e r s  e t  al 1 9 9 5 ;  M o o r e  e t  al 1 9 9 6 )
GRADiNG AND PROGNOSIS
Although, typically solitary and benign (WHO Grade I), histologically malignant 
meningiomas are described (Moore et al 1996). In human meningiomas, the histological 
pattern in itself appears to be of little prognostic importance, with the exception of the 
aggressive papillary variant (WHO Grade II or III). This variant has also been reported in 
dogs (Schulman et al 1992). In contrast, the presence of necrosis, mitotic figures and 
infiltration of brain parenchyma, are considered indicators of poor prognosis. These features
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cannot be taken as prognostic indicators in dogs: areas of focal necrosis with pools of 
neutrophils, and invasion along the Virchow-Robin spaces, are all common findings in canine 
meningiomas (Johnson 1990; Summers et al 1995; Moore et al 1996).
Gliomas
Gliomas arise from neuroglial cells of the parenchyma, which include astrocytes, 
oligodendrocytes, ependymal cells, and choroid plexus cells (McLendon et al 1998).
A s t r o c y t o m a s
Histogenesis
Astrocytomas are tumours of neuroepithelial origin, which arise from neoplastic 
transformation of astrocytes in different stages of maturity (Frenier et al 1990).
Behaviour
Astrocytomas are diffusely infiltrating neoplasms, preferentially located in the cerebral 
hemispheres (especially the ffonto-temporal region and the piriform lobe) and diencephalon 
(Johnson 1990; Moore et al 1996). However, brainstem localisation has also been reported 
(Johnson 1990; Kraft & Gavin 1999).
Histological features
Astrocytomas are characterised by a wide range of histopathological features and biological 
behaviour (Moore et al 1996). These are summarised in Table 6, page 22.
Grading and prognosis
The two grading systems, both of which have prognostic significance (Lantos et al 1997), used 
in man are summarised in Table 7, page 22. Increasing grade is consistent with the degree of 
aggression of the tumour. However, astrocytomas show a consistent tendency to diffuse 
infiltration of adjacent and distant brain structures largely irrespective of histological grade, in 
addition to an inherent tendency for progression to a more malignant phenotype (Lantos et al
1997). Whether this anaplastic progression also occurs in dogs is not known (Moore et al
1996). In addition, other glial neoplasms, mainly oligodendrogliomas, may also become 
highly anaplastic and morphologically indistinguishable from glioblastomas (Moore et al
1996).
Glioblastoma multiforme appears to be less common in dogs than in humans and it has been 
reported in brachycephalic breeds (Moore et al 1996). In addition, the extremes of nuclear 
pleomorphism with exuberant multinucleated giant cells seen in human glioblastomas are
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much less common; the canine variant often qualifies as a small cell glioblastoma (Summers et 
al 1995).
Table 6. Classification, histology and immunohistochemistry
of astrocytic tumours
Histology Immunohistochemistry
Low grade 
Astrocytomas
Slight hypercellularlty and pleomorphism with 
no mitosis though atypical nuclei may be
o bserved^ 'S .
Fibrillary, protoplasmic and gemlstocytic 
tumours are found in man and the dog'^ -^ >®. 
Fibrillary tumours are the commonest in the 
dog2.5.
GFAP
(Glial fibrillary acidic protein)
In man expression directly 
correlates with the degree of 
differentiation and this may be 
true of canine tumoursf^'^'^*® 
(Table 10, page 26)
SA  00
Expressed in human tumours 
but not of diagnostic relevance®
Anaplastic
astrocytomas
Focal moderate hypercellularlty with 
pleomorphism and mitotic figures"*^ -^ '®.
Glioblastoma
V a n t j e v e l d e  e t  al 
®Lantos e t  al 1 9 9 7
Hypercellular, pleomorphic with obvious 
mitosis. A hallmark finding Is vascular 
proliferation and necrosis; the latter may 
account up to 80% of the tumour mass^>®.
1985;  ^F ren ier  e t  al 1 9 9 0 ;  ^ J o h n s o n  1 9 9 0 ;  ^ S u m m e r s at al 1 9 9 5 ;  ®Moore e t  al 1 9 9 6 ;
Table 7. Grading of astrocytic tumours
Low-grade astrocytomas Grade IP WHO Grade I and II
Anaplastic astrocytomas Grade III WHO Grade II and III
Glioblastoma Grade IV WHO Grade III and IV
(Frenier et al 1990; Summers et al 1995; Moore et al 1996; Lantos et al 1997)
*Grade I astrocytomas is used to designate human juvenile pilocytic astrocytomas and subependymal giant ceils astrocytoma. The pilocytic 
variant has also been reported in the dog (Moore et al 1996) (Table 11, page 28)
O l i g o d e n d r o g l i o m a s
Histogenesis
Oligodendrogliomas are tumours of neuroepithelial origin arising from oligodendrocytes 
(Moore et al 1996).
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Behaviour
These tumours can occur anywhere in the white matter but are more commonly found in the 
diencephalon and cerebral hemispheres, with the frontal and pyriform lobes (especially the 
frontal lobe) being more frequently affected (Moore et al 1996).
Growth occurs by infiltration and encroachment of surrounding tissues (Moore et al 1996). 
Despite a capacity for infiltrative spread that is shared with astrocytoma, oligodendrogliomas 
tend to have relatively well delineated macroscopic borders, especially in the deep white 
matter (Johnson 1990; Summers et al 1995).
Histological features
The most striking feature of smear preparations of oligodendrogliomas is the cytological 
uniformity (Lantos et al 1997). The histological features are summarised in Table 8, page 23. 
The histopathological diagnosis of oligodendroglioma relies primarily on the recognition of 
the few typical morphological features described (Table 8). These are complemented by 
immunohistochemical features, which alone, however, are not specific for this group of 
tumours.
Table 8. Histological and Immunohistochemical characteristics of
Oligodendrogliomas
Histology Immunohistochemistry
Well-differentiated
oligodendrogliomas
Typical honeycomb or fried eggs  
appearance: dense packing of 
isomorphic cells demarcated by a 
delicate fibrovascular strroma. Cells 
have small, round chromatin-rich 
nuclei, empty-looking cytoplasm and 
sharp cellular boundaries. Microcysts 
of mucinous matrix are frequent within 
the m ass‘d’2.
M S P  {myelin basic protein)
and GPyAP n e g a t i v e k 2 . 3 , 4
v a r ia b le  MAG* an d  L e u -7 ^  
a n t i g e n  im m u n o rea c t iv i ty  in d o g s  
a n d  h u m a n s  but not  o f  
d ia g n o s t i c  relevance''-'^
Retlcuiin staining used to 
em phases the typical “chicken 
wire" pattern of blood vessels^
Anaplastic
oligodendrogliomas
D o h n s o n  1 9 9 0 ;  ^ S u m m e r s
Frequent mitosis and moderate nuclear 
pleomorphism, with ovoid to fusiform 
vesicular nuclei -^®.
Sometimes features similar to 
glioblastoma multiforme^»®.
e t  al 1 9 9 5 ;  ®Moore e t  al 1 9 9 6 ;  ^ L a n to s  e t  al 1
MBP negative2>4; 
variable GFAP** 
immunoreactivity^^
*myel in-associated 
glycoprotein 
**proved in humans
9 9 7
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C h o r o i d  p l e x u s  t u m o u r s  
Histogenesis
They are neuroepithelial in origin, and arise from the cells of the choroid plexus (Summers et 
al 1995; Moore et al 1996).
Behaviour
Choroid plexus tumours are relatively common in dogs (Moore et al 1996). They arise most 
commonly in the fourth ventricle but can occur in the lateral and third ventricles (Zaki & Nafe 
1980; Johnson 1990; Moore et al 1996). They are usually well-defined, expansive masses that 
grow slowly into the ventricular system and cause compression of adjacent brain tissue. They 
may cause hydrocephalus both due to obstruction (Moore et al 1996) and increased CSF 
production (Johnson 1990). Haemorrhages are frequent (Moore et al 1996).
Histological features
Histological features are summarised in Table 9, page 25. In most instances recognition of the 
features described allows a confident diagnosis of choroid plexus tumour. However, choroid 
plexus carcinomas may be particularly difficult to distinguish from secondary carcinomas 
(Johnson 1990); many immunohistochemical markers may be necessary to secure the 
diagnosis (Lantos et al 1997).
E p e n d y m a l  t u m o u r s  
Histogenesis
They are neuroepithelial in origin, and arise from the ependymal cells lining the ventricular 
system (Dewey et al 2000).
Behaviour
Ependymal tumours are uncommon in dogs (Moore et al 1996). They can occur anywhere 
along the ventricular system (Moore et al 1996), but most often they develop in the lateral 
ventricles (Johnson 1990; Nafe 1990). Conversely, in human beings, they most often develop 
in the caudal fossa in the fourth ventricle. The ratio between infratentorial and supratentorial 
(lateral ventricles) ependymomas in people is about 60:40 (Lantos et al 1997).
They are usually poorly defined, highly infiltrative and destroy surrounding neuronal tissue. 
They are capable of intracranial métastasés via CSF pathways: portions readily break off the 
primary mass because of the absence of extensive supporting stroma (Moore et al 1996). They 
frequently cause internal obstructive hydrocephalus (Johnson 1990; Moore et al 1996).
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Histological features
The histological features of ependymal tumours are summarised in Table 9, page 25. In most 
cases a single H&E-stained section secures the diagnosis. Immunocytochemically, human 
ependymomas express vimentin and GFAP, but infrequently cytokeratin (Johnson 1990; 
Moore et al 1996; Lantos et al 1997). In this respect they show transition toward glial cells in 
contrast to the epithelial nature of the plexus papilloma, which is keratin-positive and less 
frequently GFAP-positive (Summers et al 1995; Lantos et al 1997) (Table 9).
Table 9. Histological and Immunohistochemical characteristics of 
ependymomas and choroid plexus tumours
Histology Immunohistochemistry
Ependymomas
Anaplastic
ependymomas
Highly cellular, well-vascularised tumours. Cells 
with ovoid, deeply chromatic, fairly uniform, polar 
nuclei and Indistinct eosinophilic cytoplasm. 
Growth occurs as solid sheets. Characteristic is 
the presence of perivascular pseudo-rosettes 
and true rosettes. The cells that compose the 
rosettes may have surface cilia and / or basal 
bodies®-^. Mucinous change and cyst formation 
may be seen" .^
Moderate nuclear pleomorphism and necrosis"^»®. 
They may merge into glioblastoma multiforme^.
immunohistochemical 
properties proved in 
humans but not well 
established 
in dogs'''®'®:
Vimentin and GFAP 
positive®' '^®
Cytokeratin negative®-^
Choroid plexus 
papilloma
Choroid plexus 
carcinoma
Typical stereotyped branching papillary 
structures formed by cuboidal to columnar 
epithelium with regular, ovoid nuclei supported 
by a richly vascular stroma. Mitoses are 
absent®'^.
Focal kératinisation of cells may occur^. 
Haemorrhages, calcification and cysts are 
frequent®'"^ '®.
Loss of papillary architecture with features of 
anaplasia, necrosis and frank local 
invasiveness®-®.
GFAP* and S-100 
negative'*-2’®
Cytokeratin and 
carcinoembryonic antigen 
positive^-®
‘ occasionally positive 
In humans®»®
W andevelde et al 1985; ^Ribas et al 1989; ^Johnson 1990; ‘^ Summers et al 1995; ^Moore et al 1996; ®Lantos et 
al 1997
M ix e d  g l io m a s
Many canine glial cells tumours are composed of mixed cell types including astrocytic, 
oligodendroglial and / or ependymal cells, thus justifying similarly to the human counterpart a 
diagnosis of mixed glioma (Johnson 1990; Summers et al 1995; Moore et al 1996).
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Other primary brain tumours
Primary brain tumours derived from other cell types are rarely described in the dog. They 
include neuronal cell tumours (e.g., gangliocytomas); (Moore et al 1996); haemangioblastoma 
(LeCouteur 1999); primary lymphoma (Dewey et al 2000, Long et al 2000) and embryonal 
tumours (LeCouteur 1990; Moore et al 1996), as well as pathologic entities of still 
controversial classification such as microgliomatosis and gliomatosis cerebri (Vandevelde et al 
1981; Cuddon & Smith-Maxie 1984; Summers et al 1995; Moore et al 1996; Lantos et al
1997).
One case of primary intracranial malignant plasma cell tumour (Sheppard et al 1997) and one 
case of primary malignant hystiocytosis (Chandra & Ginn 1999) has also been reported.
Pituitary tumours
Most pituitary tumours arise from the pars distalis and less frequently from the pars 
intermedia. They can be classified as adenomas or adenocarcinomas, with most being 
adenomas. Many are functional tumours derived from chromophobe cells that produce 
adrenocorticotropic hormone resulting in hyperadrenocorticism (Moore et al 1996). Pituitary 
macroadenomas / carcinomas may also result in signs primarily related to CNS dysfunction 
because of dorsal enlargement with encroachment on diencephalic structures and 
hypothalamic dysfunction (Sarfaty et al 1988).
Immunocytochemical studies reveal staining for ACTH, (3-lipoprotein and p-endorphin in both 
pars distalis and intermedia adenomas of the dog. Strong a-melanin stimulating hormone 
immunoreactivity occurs in pars intermedia tumours (Summers et al 1995).
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Table 10. Immunohistochemistry characteristic of primary brain tumours in
dogs and human beings
v im entin G F A P S -1 0 0 M B P cytokeratin
Meningiomas ?  (D) /  o (H) ♦  ( D ) / .  (H) ♦  ( D ) / .  (H)
Low grade 
astrocytomas
♦  ( D ) / o (H) ?  (D) /  o (H) 
Strong and uniform
" ( H )
Anapiastic
astrocytomas
o ( H )
variable
? ( D ) / o ( H )
but less consistent 
than low grade 
astrocytomas
Gliobiastoma
muitiforme
o ( H )
variable
o (H)
Highly variable degree 
and extent of posltivity
Weli-differentiated
oligodendrogiiomas
♦  ( □ ) / •  (H) ♦  ( D ) / . ( H ) ♦  (D) /  .  (H)
Anaplastic
oiigodendrogliomas
o ( H )
variable
o ( H )
variable
♦  (D) /  .  (H)
Ependymomas ? ( D ) / o ( H ) " (H )
(♦  in dogs?)
• ( H )  
occasional » (H)
Choroid plexus 
tumours
♦  ( D ) / .  (H) 
occasional " (H)
♦  (D) /  .  (H) ♦  (D) /  0 (H)
Immunoreactivity: {o) 
unknown or uncertain
positive in the dog; {») positive in humans; (♦ ) negative in the dog; (♦) negative in humans; (?)
(Vandevelde et al 1985; Johnson 1990; Summers et al 1995; Lantos et al 1997)
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Table 11. WHO (1993) Classification of the CNS tumours (Lantos et al 1997)
Tumours of neuroepithelial origin
Astrocytic tumours
Diffuse astrocytoma
Low grade astrocytoma (Grade II)
3 subtypes: fibrillary, gemlstocytic, protoplasmic 
Anaplastic astrocytoma (Grade III)
Glioblastoma (Grade IV)
Variants: giant cell glioblastoma, gliosarcoma 
pylocltic astrocytoma (Grade I) 
subependymal giantcell astrocytoma (Grade i) 
pleomorphic xanthoastrocytoma (Grade II)
Oligodendroglial tumours
Oligodendroglioma (Grade ii)
Anaplastic (malignant) oligodendroglioma (Grade IV)
Mixed gliomas
Oligoastrocytoma (Grade ll)
Anaplastic oligoastrocytoma (Grade III)
Ependymoastrocytoma (Grade ll)
Oligoependymomas (Grade li)
Ependymal tumours
Ependymoma (Grade ll)
3 subtypes: cellular, papillary and clear cell 
Anaplastic (malignant) ependymoma (Grade III)
Myxopapillary ependymoma (Grade i)
Subependymoma (Grade I)
Choroid plexus tumours
Choroid plexus papillomas (Grade i)
Choroid plexus carcinoma
Neuroepithelial tumours of uncertain origin 
Astroblastoma 
Polar spongioblastoma 
Gliomatosi cerebri (Grade III or IV)
Neuronal cell tumours
Gangliocytoma
Dyspiastic gangliocytomas of the cerebellum
Central neurocytoma
Variant: atypical central neurocytoma
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Table 11 (cont). WHO (1993) Classification of the CNS tumours (Lantos et al 1997)
Mixed neuronal-glial tumours
Gangliogliomas
Variant: anaplastic (malignant) gangliogliomas 
Ganglioneuromas
Desmoplastic infantile gangliogliomas 
Dysembryoplastic neuroepithelial tumours
Tumours of the pineal region
Pineal parenchyma tumours
Pineocytomas (Grade II)
Pineoblastoma (Grade IV)
Mixed pineocytoma and pineoblastoma 
Craniopharyngioma 
Germ ceil tumours 
Glial tumours
Primary and secondary astrocytomas 
Mesenchymal tumours
Primary and secondary meningiomas, angiomas 
Ependymomas and Choroid plexus tumours 
Primary (rare) and secondary 
Ganglionic tumours
Gangliocytoma, gangliogliomas 
Non-neopiastic masses 
Pineal cysts
Embryonal tumours (Gradeiv)
Medulioepitheiiomas 
Ependymoblastoma 
Central neurobiastic tumours
central neuroblastoma 
olfactory neuroblastomas 
Primitive neuroectodermal tumours (PNET)
Medulloblastomas
Variants: desmoplastic m., melanotic m., lipomatous m., 
medullomyoblastomas 
Extracerebellar primitive neuroectodermal tumours
Tumours of the meninges
Tumours of méningothélial cells
Meningiomas (benign meningiomas) (Grade I)
11 subtypes: méningothélial, fibrous (fibroblastic), transitional, 
psammomatous, angiomatous, microcystic, secretory, clear cell, 
chordoid, lymphoplasmacyte-rich, metaplastic 
atypical meningiomas (Grade ii) 
papillary meningiomas (Grade ll) 
anaplastic (malignant) meningiomas (Grade ill)
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Table 11 (cont). WHO (1993) Classification of the CNS tumours (Lantos et al 1997)
Mesenchymal, non- méningothélial tumours (MN-M)
benign MN-M tumours
chondromas, osteochondromas, osteomas, lipomas, fibrous 
histiocytomas 
malignant MN-M tumours
haemangiopericytomas, fibrosarcomas, chondrosarcomas, 
rhabdomysarcomas, meningeal sarcomatosis, malignant fibrous 
histiocytomas
Tumours of uncertain histogenesis
Haemangiobiastomas
Germ cell tumours
Germinoma 
Embryonal carcinoma 
Endodermal sinus tumour 
Choriocarcinoma 
Teratoma
Lymphomas
Primary malignant lymphomas
Primary B cell lymphomas 
Primary T cell lymphomas 
Secondary lymphomas
Lymphomatous leptomeningitis 
Durai involvement
Intravascular malignant lymphomatosis 
Lymphomatoid granulomatosis 
Plasma cell tumours
Solitary plasmacytomas 
Multiple myelomatosis
Chordomas
Variant: chondroid chordomas
Cysts and tumour-like conditions
Epidermoid cysts 
Dermoid cysts 
Colloid cysts 
Enterogeneous cyst 
Neuroglial cysts 
Glial cysts of the pineal gland 
Cysts of the choroid plexus 
Arachnoidal cysts 
Plasma cell granuloma
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Pathologie effects, historical and clinical features of brain tumours
Brain tumour-induced pathology
Brain tumours cause cerebral dysfunction through primary and secondary pathologic effects; 
these are summarised in Table 12 (page 31).
Primary brain tumours are often slow growing, allowing intracranial structures to initially 
adapt successfully to the increasing pressure (North & Reilly 1990; Bagley 1996b; LeCouteur 
1999). Exhaustion of the compensatory mechanisms may result in sudden onset of severe 
neurological dysfunction in absence of premonitory signs, or in rapid deterioration of 
previously vague clinical signs (e.g., subtle behavioural changes). Acute onset of neurologic 
deficits may also occur following tumour-associated acute haemorrhage, infarction, or 
obstructive hydrocephalus. Rapidly growing tumours do not permit the same degree of 
compensation and in such cases a sudden onset of severe neurological dysfunction is 
frequently observed (LeCouteur 1999, Dewey et al 2000).
Table 12. Pathologic effects of Intracranial neoplasia
Primary effects Secondary effects
• Infiltration of normal nervous tissue • Vasogenic cerebral oedema
• Compression/encroachment of adjacent • Inflammation
anatomic structures • Haemorrhages
• Disruption of cerebral blood circulation • Disturbance of CSF flow dynamics
Local ischemic necrosis obstructive Hydrocephalus
• Elevated ICP
• Brain herniation
caudal transtentorial herniation
foramen magnum herniation
Carrillo et at 1986; Johnson 1990; North & Reilly 1990; Bagley 1996b; Kraus & McDonnell 1996; LeCouteur 1999;
Dewey et al 2000; Webb & Muir 2000
Historical features of brain tumours
Historical and presenting clinical signs of patients with intracranial neoplasia are variable and 
reflect the location, size and associated pathologic effects of the tumour (LeCouteur 1999; 
Nafe 1990). In dogs with brain tumours, the most common presenting clinical sign of 
dysfunction is seizure activity (LeCouteur 1999; Dewey et al 2000).
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With the exception of seizure activity, the onset of neurological dysfunction is often insidious 
over weeks to months, especially with meningiomas (Nafe 1990). Many dogs have a long 
history of ‘vague’, intermittent signs, such as: disorientation, hiding during the day, lethargy, 
change in appetite and water consumption, unsteadiness, stumbling, getting stuck in comers, 
bumping into objects (Kraus & McDonnell 1996). It is very likely that both owner and 
veterinarian do not recognise these non-specific early signs, which are often initially attributed 
to “old age” (Mandigers et al 1994; LeCouteur 1999). However, even with a slowly growing 
tumour subacute or acute development of neurologic dysfunction may occur, following 
exhaustion of brain compensatory mechanism. Other potential explanations include tumour- 
associated acute haemorrhage, infarction or obstructive hydrocephalus (LeCouteur 1999).
Location and effective size influence the clinical presentation of a brain tumour independently 
from the inherent growth characteristics of the tumour itself (Foster et al 1988; Nafe 1990; 
LeCouteur 1999).
Localising the lesion
Although definitive localisation of the tumour is achieved by imaging, a clinically developed 
localisation of the lesion is helpful in early prognostication and counselling of the client and in 
planning further investigation. A clinical appreciation is developed from a consideration of 
the history and clinical findings (see Lesion localisation, page 132). However, dogs with 
symptoms of intracranial neoplasia are often presented at later stage of illness when the 
secondary effects make exact anatomical localisation of the lesion difficult (Mandigers et al
1994).
Brain tumours cause clinical signs that localise to forebrain, brainstem and cerebellum; clinical 
signs are referred to as multifocal when indicative of the involvement of several areas of the 
CNS (Moore et al 1996). Intracranial CNS structures, as well as clinical signs arising from 
their dysfunction, are also often referred to as rostrotentorial or rostral fossa and caudotentorial 
or caudal fossa structures. Although the classification of these portions may be arbitrary and 
overlapping, it is often useful.
The strict location of the diencephalon (forebrain Vs brainstem) remains controversial in 
veterinary anatomy (Jenkins 1978). For the purpose of this dissertation, I consider the 
forebrain to comprise of the telencephalon (cerebral hemispheres) and the diencephalon
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(thalamus, epithalamus, metathalamus, subthalamus, and hypothalamus) because of the strict 
functional and anatomical correlation existing between these two portions in the adult brain. 
The forebrain structures are also referred to as rostral fossa or rostrotentorial structures. 
Located caudally to the diencephalon are the mesencephalon (or midbrain; middle fossa) and 
the caudal fossa structures, the latter including the metencephalon (ventral pons and dorsal 
cerebellum) and the myelencephalon (medulla oblongata). The brainstem encompasses the 
myelencephalon, the ventral portion of the metencephalon (pons) and the mesencephalon, thus 
including both caudal fossa (except for the cerebellum) and middle fossa structures. Some 
authors locate the diencephalon in the brainstem (Jenkins 1978; de Lahunta 1983a; Hogg 
1987).
Overview of the management of primary brain tumours
Treatment for brain tumours in dogs depend upon tumour type, tumour location, natural 
history of the tumour, associated morbidity / mortality of the treatment modality, and cost 
(Bagley 1999), Treatment modalities can be divided into supportive and definitive therapy. 
For the purposes of this dissertation, supportive therapy refers to treatments aimed at the 
alleviation of secondary effects of the tumour, whereas definitive therapy is directed toward 
diminishing tumour volume or eliminating the tumour (Dewey et al 2000). The ultimate goal 
of both strategies is to provide the patient with a good quality of life for as long as possible.
Supportive therapy
Supportive therapy is usually recommended regardless of whether the client elects to pursue 
definitive therapy. Clinicians must emphasise the limitations of supportive therapy (Dewey et 
al 2000). Waning of the palliative effects of supportive therapy and exhaustion of 
compensatory brain mechanisms results in recurrence of clinical signs, usually within several 
weeks to several months. Recurrence of clinical signs is often sudden and dramatic (Moore et 
al 1996; LeCouteur 1999; Dewey et al 2000).
Corticosteroid medication
Supportive therapy consists initially of an anti-inflammatory regimen of oral corticosteroids, 
more commonly prednisolone (0.5 mg/kg every 12 hours), which can be increased or 
decreased depending on patient response (Dewey et al 2000). Other authors advise an initial 
dose of prednisolone varying between 2 to 4 mg/kg/day, which is then tapered during 1 to 2
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weeks to the lowest effective dose to alleviate clinical signs (Kraus & McDonnell 1996). 
However, at this dose side effects of corticosteroids medication such as polyuria, polydipsia, 
polyphagia and panting are more severe than at anti-inflammatory doses and serious side 
effects such as haemorrhagic gastroenteritis are more likely to occur. Corticosteroids 
medication should be discontinued if haemorrhagic gastroenteritis ensues (Kraus & 
McDonnell 1996). Prednisolone therapy is believed to exert its beneficial therapeutic effects 
by decreasing ICP tlirough reducing tumour-associated vasogenic oedema and decreasing CSF 
production. Via reducing vasogenic oedema prednisolone therapy also reduces the effective 
mass of the tumour (Bagley 1996b; Dewey et al 2000).
Anticonvulsant therapy
If seizure activity is part of the patient’s clinical signs, anticonvulsant medication should be 
prescribed (Dewey et al 2000). For the control of seizure activity in patients with brain 
tumours, established treatment protocols for idiopathic epilepsy are commonly used (Lane & 
Bunch 1990, Podell 1996). The anticonvulsant drug most commonly used as adjunctive 
therapy for brain tumour is phenobarbitone; the recommended dose varies between 2 to 5 
mg/kg every 12 hours orally. Phenobarbitone has shown to be effective in lessening seizure 
frequency and duration in patients with brain tumours, however some animals may require 
combination of phenobarbitone and potassium bromide (KBr) (Boothe 1998). Some authors 
report to have been successful in controlling seizure activity in dogs with brain tumours using 
KBr as a sole anticonvulsant agent, but no indication is given regarding tumour’s 
characteristics and type, duration and frequency of seizures (Dewey et al 2000). However, 
seizures in dogs with brain tumours are more likely to be difficult to control or refractory to 
standard antiepileptic drugs (Bagley & Gavin 1998).
Other factors that need to be considered in dogs with brain tumours on antiepileptic 
medication include the effects of concuiTently administered drugs on the antiepileptic drug 
metabolism and elimination. It is not uncommon for dogs with brain tumours to receive 
combination of antiepileptic drugs, corticosteroids, antinuclear medications, diuretics, and 
antibiotics. Increasing the number of drug therapies, increases the potential for drug 
interactions, and may significantly alter antiepileptic concentration (Bagley & Gavin 1998).
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Most animals, prior to specific diagnosis of a brain tumour are placed on anticonvulsant 
medication for treatment of seizure activity. If definitive therapy is undertaken, these 
anticonvulsants are continued throughout the therapy. If an animal is not receiving 
anticonvulsants at the time of surgical therapy, anticonvulsant therapy is initiated prior to 
surgery, with the aim to decrease postsurgical seizure activity. Ideally, steady state serum 
levels of anticonvulsant should be achieved prior to surgery (Bagley & Gavin 1998). 
Guidelines for the management of seizures in the postoperative period have been reported 
elsewhere (Spugnini et al 1995; Bagley & Gavin 1998).
Definitive therapy
Definitive therapy is directed at long-term control or cure by eliminating neoplastic tissue and 
inhibiting further tumour growth. Modes of definitive therapy include surgery, radiation 
therapy, and chemotherapy. Surgical removal / debulking and / or megavoltage radiation 
therapy are the most common definitive therapies for canine brain tumours. Modalities 
described are summarised in Tab 13, page 37.
Surgery
Dogs with superficially located tumours of the cerebral hemispheres and cerebellum are the 
best candidates for surgical intervention (Dewey et al 2000). If the tumour is located in areas 
of the brain where access and exposure is limited, the risk of surgical morbidity increases 
remarkably (caudal fossa, brain stem) (LeCouteur 1999). Poor surgical access often leads to 
increased surgical mortality. If the tumour is within the parenchyma or within a ventricle, it is 
impossible to access these lesions without damage to the surrounding and / or overlying brain 
tissue (LeCouteur 1999; Dewey et al 2000). Many intracranial tumours have multiple vessels 
supplying blood flow lending to the risk of haemorrhages during resection. Possibly fi-om 
these factors and others, dogs have historically had less than encouraging results with surgical 
treatment of brain tumours (Bagley & Gavin 1998, Heidner et al 1991, Niebauer et al 1991). 
However, with advances in surgical techniques and equipment, as well as improved 
monitoring, surgical removal of brain tumours in dogs is an increasingly viable treatment 
option (Bagley & Gavin 1998).
When location of the mass makes surgical intervention possible, this should always be 
performed regardless of tumour type and degree of aggression. Removal of all grossly visible
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neoplasia provides some therapeutic benefit to the patients by decreasing ICP (decompression 
effect of craniectomy / durotomy). In addition it may render the patient a better candidate for 
other therapy (e.g. radiation therapy) (LeCouteur 1999; Dewey et al 2000).
Radiation therapy
Experience in veterinary radiation oncology indicates that many patients with brain tumours 
benefit from radiation treatment, both when it is used as an adjunctive therapy to surgery, or as 
the sole definitive therapy for mass lesions that are difficult to access surgically, such as 
brainstem, pituitary tumours and both rostral and caudal fossa tumours located on the floor of 
the calvarium (Gavin et al 1995, Kraus & McDonnell 1996; Burk & Giel 1997; LeCouteur 
1999; Dewey et al 2000).
Radiation therapy is most effective at controlling tumour growth and only rarely will eradicate 
the tumour completely (Bagley & Gavin 1998); brain tumours are defined as “moderately 
radiosensitive” meaning that treatment by radiation therapy alone is most often palliative 
(Thrall 1997; Blackwood & Dobson 1998; Smith et al 2000). However, as CNS tumours 
generally have a low metastatic potential, lodal control offers potential benefits (Gavin et al
1995).
External beam, megavoltage irradiation is currently recommended for the therapy of brain 
tumours in dogs (LeCouteur 1999; Dewey et al 2000). Other modalities of delivering 
radiation therapies have been described including brachytherapy (Heidener et al 1991; Evans 
et al 1993; Gavin et al 1995); Boron Neutron Capture Therapy (BNCT) (Gavin et al 1994; 
Bagley et al 1999b; Coderre & Morris 1999); X-ray phototherapy (XPT) (Iwamoto et al 1990; 
Norman et al 1991; Iwamoto et al 1992; Norman et al 1997).
Chemotherapy
Cytotoxic drugs have had a limited role in the treatment of intracranial neoplasia in dogs 
mainly because of their poor ability to cross the blood-brain barrier, even when its 
permeability is increased by the presence of a tumour.
In some tumours, primarily those of glial origin, some control has been achieved with the use 
of nitrosourea compounds (lomustine and carmustine), but the survival time was not 
significantly increased in comparison to animals receiving only supportive therapy. However
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the data reported is incomplete and does not allow objective evaluation of efficacy of these 
drugs (Cook 1990, Dimski & Cook 1990; Fulton & Steinberg 1990).
Table 13. Treatment modalities for brain tumour in dogs
Supportive therapy 
Corticosteroids I"*
Anticonvulsants
Phenobarbitone and Potassium Bromide®
Definitive therapy 
Surgery
a) Meningiomas
Usually benign and poorly invasive^®’
b) Gliomas
Usually malignant and invasive^®’^^
c) Pituitary tumours
potentially accessible to a skilled surgeon®’ 1®> 1®
d) O sseous tumours of the skull
potentially excisable even If malignant provided localized^®
e) Metastatic and multicentric tumours in the brain
Usually not surgical but removal of a solitary metastatic lesion might be considered^®
f) Nasal and orbital tumours
once In the brain usually hopeless^®
g) Dermoid/epidermoid cysts
Slow growing and excisable if accessible^ ®
h) Intracranial granulomas
Slow growing and excisable if accessible^®’
Radiation therapy
a) Focused radiation
Orthovoltage (X-rays)f®-^ and Megavoltage (X-rays orY-rays)'*2.l®.i4 nnear 
accelerator 
Cobalt 60 teletherapy units®’®
Boron neutron capture'*''
b) Whole brain radiation
(only for GME'*®)
c) Hypoxic cell sensitizers (with radiation therapy)®
Chemotherapy
a) carmustine (BCNU)®
*Turrel et al 1984; ®Fulton & Steinberg 1990; ®Heidner et al 1991; ^Evans et al 1993; ^Moore et al 1996; ^Burk & Giel 1997; ^Bagley & 
Gavin 1998; ®Boothe 1998; ®Lantz et al 1988; *®Munana & Luttgen 1998; * * Bagley 1999; *®Brearley et al 1999; *®LeCouteur 1999; 
*"*Dewey et al 2000; *^Meij 2000b; *^Meij 2000a
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Aims of dissertation
The goal of this dissertation is to examine seizures as a manifestation of intracranial disease in 
the dog and in particular to consider how the presenting features of a patient reported to have 
seizures may alert a clinician to the possibility of intracranial neoplasia. Such patients benefit 
from intracranial imaging in their assessment but because of the relatively limited availability 
of the relevant technologies and their associated costs the decision to seek such investigation 
may require some justification for an owner.
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Case selection
The sixteen canine clinical cases presented in this dissertation were selected from those 
referred to the Neurology Service of the Small Animal Hospital at the University of Glasgow 
Veterinary School (UGVS). Accessions included were seen during the period October 1999 to 
September 2000 and are patients referred for investigation of seizure disorders and / or 
neurological abnormalities other than seizure activity suggestive of intracranial disease.
Investigation of cases 
Clinical assessment
The signalment was obtained in all cases. The historical details described include information 
from the referring veterinary surgeon and the owner. All cases underwent a full physical 
examination. A neurological examination was performed, as detailed by Oliver et al (1993a), 
including a fundic examination. For both physical and neurological examination only 
significant abnormal findings are described, though unremarkable findings were recorded.
History and physical examination
History taking and physical examination followed the standardised form in use in the Small 
Animal Hospital at UGVS (see Figure 1 (history), page 41; Figure 2, page 42).
Further questions were asked of the owner(s) as appropriate. Specifically, owners of dogs 
presented for evaluation of seizures were questioned about: any similar episodes; any 
traumatic incidents; exposure to toxins; behavioural changes; the nature of the seizures, 
including events that might have occurred before or after the seizure(s), changes in 
consciousness, pattern of muscle activity, urination / defecation, and duration. Seizure pattern 
was defined by questioning the owner about seizure frequency; particular note was made of 
any perceived change in the pattern of seizures. The owners where also asked if they had 
noticed any correlation between seizures and time of the day and/or activity (feeding, sleeping, 
exercise, etc).
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MEDICAL HISTORY
1. CHIEF COMPLAINT
2. PRESENT ILLNESS
O n se t/d u ra tio n
F irst s ig n s /p ro g re s s io n
T re a tm e n t
3. PAST HISTORY
O w n e rs tiip  
P a s t  Illn e sse s  
S u rg e ry /tra u m a  
V a ccin a tio n  s /d a t e s
4. DIET & ENVIRONMENT
F o o d /ty p e  a m o u n t 
H o u s in g /e x e rc ise  
G e n era l en v iro n m e n t 
O th e r  an im als
5. SYSTEM REVIEW
A G e n era l 
B IrU egum an t 
C  E yas, e a r s ,  n o s e ,  Itiroa t 
0  M u sc u lo sk e le ta l 
E C a rd io v a sc u la r  
F R e sp ira to ry  
G G a s tro in te s tin a l 
H G e n lto -u rin a ry
Figure 1. UGVS Small Animal Hospital standardised history form
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PHYSICAL EXAMINATION
G eneral A ppearance
Weight Temp P u Ie b R esp
H ydration
1. M u c o u s  M e m b ra n e s  
Ü  N orm al 
□  A b n o rm a l
8. C ircu lato ry  
U  N orm al 
LI A bnorm al
2 . E ars
□  N orm al
□  A b n o rm a l
9. R esp ira to ry  
Ü  N orm al 
□  A bnorm al
3. S k in  M am m  G la n d s  
LI N orm al 
□  A b n o rm al
1 0 . D igestive  
□  N orm ai 
U  A bnorm al
4 . Lym ph N o d e s
□  N orm al
□  A bnorm al
11 . A bdom inal P a lp a tio n  
Ü  N orm al 
U  A bnorm al
5 . M u sc u lo sk e le ta l 
Q  N orm al 
□  A bnorm al
12. G enita l 
■_i N orm al 
U  A b n o rm al
G, N eural
□  N orm al
□  A b n o rm al
13. U rinary 
U N orm al 
U A b norm al
7. E y e s  
□  N orm al 
_ l  A b n o rm a l
14. R ec ta l 
U  N orm al 
Ü  A bnorm al
COMMENTS ---
Figure 2. UGVS Small Animal Hospital physical examination form
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If, at the time of presentation, the animal was on anti-epileptic medication dose regimen and 
time of administration were recorded; this information providing an early indication regarding 
adequacy of dose and management from both the point of design and implementation.
All clients with a dog presented for evaluation of neurological abnormalities other than 
seizures, or whose animal manifested other neurological signs in addition to seizures, were 
questioned about period of time for which such signs had been present and the progression of 
signs during this time. In addition, response to any medication started at the referring 
veterinary practice was noted, with particular regard to systemic steroid medication.
Neurological examination
A full neurological examination was performed and results recorded in a standardised form in 
use at UGVS (see pages 44-45).
In the consulting room while the history was taken, the animals were allowed to interact 
unimpeded with the environment to evaluate mentation, posture, gait, response to visual, 
auditory and tactile stimuli, and the presence of behavioural abnormalities such as circling, 
pacing, and head pressing. The gait was evaluated for lameness, co-ordination and weakness.
The proprioceptive, strength and reflex tests outlined on the neurological examination form 
(page 44) were undertaken to further characterise any deficits or abnormalities in gait and 
posture. The specific goal was to characterise any abnormalities as to whether they involved 
spinal cord / neuromuscular disease or were of likely intracranial origin. Sti'ong indicators of 
intracranial disease were thought to be conscious proprioceptive abnormalities with otherwise 
normal gait and proprioceptive deficits in association with specific cranial nerve abnormalities.
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University of Glasgow Veterinary Hospital 
Neurological Examination
Attach Label Here
D a t e ___
S t u d e n t .
1) SUBJECTIVE
ijoBJBCTIvis
Observation
Mental
Posture
Galt
Limbs affected 
Other (e.g. fits)
m^mm
Key: 4 =0xaggerated. clonus; 3=increased; 2=ncnY,A;' 1 «decreased; O=none; ME«not evaluated
Weakness
Hopping 
Wheelbarrow 
Ext. postural thrust 
Hemistand/walk
Proprioception
Paw Position 
Reflex Step 
Hip Sway 
Placing-tactile 
Pladng-viaual
UMN or LMN
Muscle Bulk 
Muscle Tone 
Ext. Carpi Rad. 
Patellar 
Pedal
Pannlculus and Sacral Segm en ts
L é f t .:E p ïë v ..  .
Pannlculus 
Anal reflex 
Tail
Bladder
Pain
./Left- ■ Right
• VblùlitatŸïmovehïerit
cdwtfci'' \ ,slà.ddéTsIü:ô/ 1 |'.E #e#e#fess#/1
Hyperaestiiesta -C e r v W :Th#Clp:-:
Superficial Pain
Deep Pain L-pôre' ■ ■ RvFore-- - -
Figure 3. Neurological examination form from UGVS -  general observation and cord 
tests.
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3ranial Nerves
Vision 2 
Menace 2,7 
PMR-stIm L2,3 
PMR - stim R 2,3 
Pupil size 2,3,Symp. 
Fundlc Exam 
Vest, eye move. 
Strabismus 8,3,4,6 
Nystagmus 8,3,4,6
J B Facial Sens, max 
mandibular 
ophthalmic 6 
Mast, muscle S 
Facial muscle 7 
Palpebral 5,7 
Gag 9,10 
Tongue 12 
Sympathetic
Summary of Neurological Exam:
\) ASSESSMENT
.ocatlon:
Peripheral NS 
Neuromuscular 
Spinal Cord 01 to 05  
C6toT2 
T3 to L3 
L4 to SI 
SI to S3 
Brain Forebrafn 
Brain Stem 
Vestibular 
Cerebellar
Normal
uatificatfon for localisation:
location; |
-
}PLAN
lifferential Diagnoses; Tests: 
1.........
2.........
 3........
 4..........
6.........
Figure 4. Neurological examination form from UGVS -  cranial nerves and 
localisation.
45
Case Assessment Protocols
The cranial nerve examination outlined on the neurological examination form (page 45) was 
undertaken to further characterise any deficits or abnormalities in the function of structures of 
the head, head position and posture. The pattern of abnormalities was further used as evidence 
for intracranial localisation to the two major anatomical divisions of the brain (rostral and 
caudal fossa). Strong indicators of forebrain disease were abnormalities of visual pathways 
thought not to be of retinal origin. Strong indicators of brainstem dysfunction were specific 
deficits of cranial nerves III-XII, thought not to be peripheral in nature. A full fundic 
examination was provided by the Ophthalmology Service if required.
Based on these findings the pathologic process was ascribed as affecting the forebrain, the 
brainstem or the cerebellum; alternatively, the author referred the neuroanatomical localisation 
as to the forebrain, midbrain or hindbrain. In some cases the lesion was characterised as 
multifocal or diffuse.
Lesion localisation, history and signalment were used to logically establish a list of differential 
diagnoses and plan further diagnostic work-up accordingly.
Ancillary Investigations
Further diagnostic procedures were performed in all cases in order to rule out other potential 
causes of the clinical signs (with particular regard to extracranial causes of seizures and/or 
primary extracranial neoplasia) and to evaluate general health prior to anaesthesia. The full 
details of the diagnostic evaluation of each case is summarised in Table 18 (page 122).
Clinical pathology
Haematology, biochemistry, and urinalysis panels
Routine haematological and biochemical evaluation was performed in all cases. Results of 
pre-referral investigations were used if this was recent and appropriate. Urinalysis was 
performed as indicated. Parameters analysed, results of all tests and reference ranges quoted 
by the UGVS laboratories and specialist laboratories used by them are reported in Table 20 
(page 126).
Serology
Serology was undertaken on serum and CSF samples.
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Distemper antibodies were measured by a standardised neutralisation technique^. Toxoplasma 
antibodies titres were determined using a dye test .^ Neospora caninum antibodies were 
detected using an indirect fluorescent antibody test (IFAT) and the titres determined using a 
standardised neutralisation technique" .^
Evaluation ofpituitary and thyroid function
Investigations varied with individual cases.
An ACTff stimulation test was used in the assessment of rostral lobe pituitary function. 
Serum cortisol concentration was determined before, and at 30 minutes after intravenous 
administration of 0.25 mg of tetracosactrin (Synacthen, Alliance Pharmaceuticals Ltd) 
(Herrtage 1998a)
Basal serum insulin-like growth factor (IGF-I) concentration^ was measured as an indirect 
measure of growth hormone (GH) and as an indicator of increased rostral pituitary lobe 
function (Feldman & Nelson 1996, HeiTtage 1998a).
Plasma thyroxine (T4) and thyroid stimulating hormone (TSH) were measured in conjunction 
as a technique for assessing for hypothyrodism (Herrtage 1998a).
Anticonvulsants
Serum phenobarbitone level was determined where indicated. In some cases, monitoring of 
the serum phenobarbitone level was also performed at the referring veterinary practice.
CSF analysis
See CSF analysis, page 49.
Diagnostic imaging
Conventional radiographic investigation
These were undertaken using an SMR Galaxy 15HF unit (SMR Medical Imaging, Blackpool, 
UK). The cassette systems were all rare earth (Quanata Fast Detail and Sterling Ultra Vision
 ^Canine Infectious Disease Research Unit, UGVS
 ^Scottish Toxoplasma Reference Laboratory, Raigmore Hospital NHS Trust, Inverness 
Liverpool School o f  Tropical Medicine, Pembroke Place, Liverpool L3 5QA  
® Cambridge Specialist Laboratory Services, Stapleford, Cambridge CB2 5XY  
® Cambridge Specialist Laboratory Services, Stapleford, Cambridge CB2 5XY
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Rapid, Cronex) and an optimised radiographic film (Cronex Medical Xray film) was used. 
Films were developed using an automatic processor (Cronex CX-130).
In cases with suspected extracranial neoplasia and / or when considered indicated on the basis 
of the physical examination findings, conventional radiographic studies were undertaken. 
These included survey radiographs of chest, abdomen, vertebral column, nasal cavity, skull 
and distal limbs. Specifically, in cases with suspected extracranial neoplasia, left and right 
inflated views of the thorax were obtained to evaluate the lung field for metastatic disease.
Computed Tomography
All cases underwent computed tomographic (CT) studies of the brain and skull, using a third 
generation transverse slice CT unit (Excel 2400 Elite®, Elscint Ltd, Haifa, Israel). Dogs were 
positioned in sternal recumbency with the forelimbs pulled alongside the chest (so that the 
paws were outside of the imaging field of view) and the head extended and supported on a 
radiolucent headrest.
Scanning was undertaken at 120 KV, 300 mAs, with a 240 mm diameter scan field size, 
256x256 image matrix, standard resolution and soft tissue reconstruction filter. A bed 
increment of 5mm and a 5mm slice width were selected to maximise the imaging of the brain 
parenchyma. If considered necessary areas of interest were rescanned using a bed increment 
and a slice width less then 5mm. The scanning area extended from the occipital protuberance 
to the cribriform plate, but in some dogs it was extended rostrally and / or caudally. Images 
were acquired using a scan angle of 360° and a scan time of 2 seconds.
Post-contrast scans were taken following intravenous administration of 2ml/kg of the non- 
diffusible iodinated compound sodium iothalamate- (70% weight/volume, 420 mg iodine/ml, 
Conray 420, Mallinckrodt Medical Ltd, Northampton, England, UK). Post-contrast slices 
were taken at the same levels as the initial study starting -20 seconds after finishing delivering 
the contrast agent.
Images were reviewed using different windows (bone window) to highlight particular 
structures and contrast uptake. Sagittal and dorsal views were also examined to assess 
location of a lesion and its extent.
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CT images were evaluated qualitatively for the presence of: a) areas of abnormal attenuation 
of soft tissue and bone, b) mass effect (e.g. displaced falx cerebri and / or distorted ventricular 
system) and c) abnormal contrast enhancement (Table 14, page 49). Changes in density were 
also assessed quantitatively (Tidwell 1999). The current literature describes general criteria 
that aid in identifying the nature of a space-occupying lesion and specifically describes the 
attributes of some common tumours (Kraft & Gavin 1999). The CT appearance of the most 
common intracranial tumour types are summarised in Table 15 (page 51). The CT findings for 
the cases presented in this dissertation are summarised in Table 19 (page 123).
Table 14. Imaging features used to characterise intracranial space-occupying lesions
Number Singular or multiple
Axial origin Extra-axial or Intra-axial
Anatomic site Specific anatomic location 
(sella, nasal passages, dura, ventricular system, cerebrum)
Shape Ovoid to spherical, lenticular, broad-based, lobular, 
plaque-likp, amorphous or infiltrative
Margins Smooth or irregular; well-defined or poorly defined
Pattern of growth Growth displacing, or replacing adjacent structures, 
and growth extension (mass effect)
Density Hypodense, isodense, hyperintense
Contrast enhancement Intensity (none, mild, moderate, strong) and 
pattern (uniform, non-uniform, or ring)
Other pathological features Evidence for hydrocephalus, oedema, haemorrhage, 
necrosis, mineralisation, hyperostosis, osteolysis, cysts
CSF analysis
CSF samples were collected, if thought to be of potential diagnostic value, from patients 
where any perceived risk was felt justified. Although, CSF parameters are often altered by the 
presence of brain tumours, in most instances the abnormalities are non-specific and often only 
of value in supporting other findings (Bailey & Higgins 1986; Dewey et al 2000; Webb & 
Muir 2000). CSF analysis is of particular value in identifying evidence of inflammation and 
possible tumour identification, following cytology (Christopher et al 1988; Grevel & Machus
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1990; Kraus & McDonnell 1996). The potentially low diagnostic yield and the risk of 
herniation associated with taps in patients with raised ICP means that at UGVS CSF analysis 
follows intracranial imaging. The presence of an intracranial mass and /or clinical evidence of 
increased ICP usually precluded a tap. The anaesthetic protocol followed was designed to 
minimise risks associated with raised ICP (see Anaesthetic protocols page 50). If a tap was 
undertaken in a case with suspected raised ICP the patient was hyperventilated prior to 
sampling and mannitol (Mannitol intravenous infusion BP 20% w/v, Galen Research 
Laboratories Ltd) administered.
CSF was collected from the cerebellomedullary cistern (Rusbridge 1997) using a 3 inch 20 or 
22 gauge spinal needle selected according to patient size (Yale® Spinal, BD, Spain). The 
collection site was clipped and aseptically prepared and the operator wore gloves. Samples 
were inspected immediately for colour, consistency and turbidity.
The cell count was performed using a haemocytometer. A differential cell count was 
determined following cytocentrifugation (cytospin). Cytospins were performed by 
centrifuging 0.5-0.75ml of CSF for 5 minutes at 750 rpm with a Cytospin3 R ;^ the supernatant 
was pipetted off and the pellet resuspended in a drop of serum. A smear of this was stained 
with Diff-Quick and examined.
Total protein concentration was determined colourmetrically by diluting the CSF sample in a 
ratio of 1:3 with 3% sulphosalicylic acid; after 5 minutes the absorption at 660nm was 
compared to that of the acid alone.
Anaesthetic protocols
Radiographic, CT examinations and CSF sampling were performed under general anaesthesia. 
Below is an anaesthetic technique that is currently in use at UGVS to anaesthetise dogs with 
suspected intracranial disease. Slightly variable anaesthetic regimens were used depending 
upon an individual patient's requirements. In patients with deteriorating cranial neurological 
status, the ideal anaesthetic agent should provide general anaesthesia while reducing cerebral 
metabolic rate, maintain cerebral perfusion and arterial oxygenation, and should not promote 
either cerebral vasodilation or seizures.
’ Shandon Scientific Limited, Astmoor, Runcorn, Cheshire, WAT IPR, England
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Patients were premedicated with pethidine (2 mg/kg IM) (Pethidine, Martindale); no 
premedicant was administered if the patient was obtunded and / or easy to handle. Prior to 
induction the animals were pre-oxygenated by facemask with 100% oxygen for 5 minutes and 
administered 1 mg/kg IV of lignocaine (Lignavet, C-Vet Veterinary Product). Lignocaine 
administration was followed by induction with diazepam (0.2-0.5 mg/kg IV) (Diazemuls, 
DumexPO’^ ) and thiopentone (Intraval sodium, Merial) or propofol (Rapinovet, Schering- 
Plough Animal Health) to effect. Maintenance was with low concentration of isoflurane 
(IsoFlo® vet, Schering-Plough Animal Health) in 100% oxygen. Patients were ventilated from 
immediately after induction until procedure completed. During the whole procedure, patients 
were carefully manipulated and positioned to avoid jugular compression, as this increases ICP.
Cerebral blood flow (CBF) is largely influenced by cerebral perfusion pressure (CPP), which 
is the difference between arterial blood pressure and ICP, and arterial blood gas tensions. 
Characteristic of cerebral blood vessels is the ability to alter their resistance in response to 
change in CPP. Via this mechanism of “autoregulation” CBF is maintained relatively constant 
within a wide range of arterial blood pressure values. Disease states and volatile anaesthetics 
affect cerebral autoregulation (Bedford 1991; Bagley 1996a).
In patients with progressively increasing ICP the most important sequel is the reduction in 
CPP that may lead to cerebral ischaemia. ICP may be manipulated by changing CBF and / or 
brain hydration (mannitol, frusemide). Mannitol (1.0 g/kg IV over 20 minutes) was 
administered prior to anaesthesia only in cases with strong evidence of increased ICP and / or 
deteriorating neurological status thought to be related to increasing ICP. Vomiting can 
increase ICP and drugs that are emetic are avoided. Pethidine was chosen as premedication 
agent because it does not induce vomit, does not depress respiratory function and is short- 
acting. Coughing and hypertension at intubation also increase ICP thus lignocaine 
administration was used to deepen anaesthesia and reduce these effects (Hamill et al 1981).
Diazepam was administered prior to thiopentone and propofol to reduce the dose of these two 
anaesthetic agents, as well as for its anti-epileptic properties. Thiopenthone and propofol 
(especially thiopentone) may in fact decrease arterial blood pressure by a larger extent than 
ICP thus increasing the risk of cerebral ischaemia. Benzodiazepines also decrease the 
incidence of propofol induced myoclonus (Colder 1999).
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Thiopentone and propofol are chosen as induction agents in patients with increased ICP 
because they induce a marked reduction in cerebral metabolic rate while maintaining cerebral 
vascular responsiveness to changes in mean arterial blood pressure and PaC02. Conversely, 
inhalation agents depress vascular autoregulation and this may result in a deleterious 
additional increase in ICP. This effect is much greater with halothane than isoflurane. 
Controlled ventilation of the patient from after induction, through the entire procedure reduces 
the effect of the inhalant agent on CBF (Nakaichi et al 1996). CBF, in fact, varies directly 
with PaC02 and indirectly with Pa02; ICP falls within minutes of the onset of ventilation. 
However, PaC02 does not have to be reduced below 25mmHg; at this point the 
vasoconstrictor effect of hypocarbia itself will cause hypoxia, and ischaemic cell damage 
(Colder 1999).
Close monitoring of the patient is required during and after contrast medium administration as 
haemodynamic changes occur and anaphylactoid reaction is possible. Reported 
haemodynamic effects include an initial increase followed by a decrease in arterial blood 
pressure, increased central venous pressure, increased cardiac output, and decreased systemic 
vascular resistance (Robertson 1999). A secondary effect of the increased plasma osmolarity 
is diuresis, leading to further alterations in fluid balance. During the whole procedure animals 
are administered intravenous fluids at maintenance rate. Lactated ringers may be used as a 
maintenance fluid, however it is hyponatrémie relative to normal canine plasma, so isotonic 
saline is usually employed.
Management
From the history, clinical findings and results of further investigations, a diagnosis was made, 
a prognosis developed and treatment instigated as appropriate. The details are given for each 
case in the chapter Case Reports (page 55) and summarised in Table 17, page 119.
Therapeutic protocols
In all cases that were treated, therapy was instigated after discussion with the owner and 
modified if necessary in respect of their specific ambitions. At UGVS palliative therapy for 
intracranial neoplasia consists of anti-inflammatory doses of oral corticosteroids, with 
anticonvulsants as required.
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The anti-inflammatory regimen used consists of oral prednisolone (Prednidale 5-Amolds®, 
Arnolds Veterinary Products, Ltd) at a dose of 1 mg/kg/day for the first two weeks; the total 
daily dose divided in two doses separated by 12 hours. After this period, the dose was tapered 
to 0.5 mg/kg/day, administered once a day. However, this protocol was modified depending 
on patient response.
Anticonvulsant therapy consisted of phenobarbitone (Phenobarbitone tablets BP 15 or 60mg, 
Approved Prescription Services, Ltd) at initial dose of 4-6mg/kg/day, divided in two doses 
separated by 12 hours. Serum levels were measured as appropriate.
Post mortem
In five cases euthanasia was performed followed by post mortem examination. Gross post 
mortem examination was performed and the brain removed within 30 minutes of death. 
Brains were stored in a minimum of -lOx their volume of 4% buffered neutral formalin. 
Histological evaluation was initially made on routine haematoxylin and eosin preparations. 
Other special stains and immunostaining were undertaken as indicated to pursue definitive 
identification of tumour type.
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Index of cases
The clinical, ancillary and in some cases, pathological findings of sixteen selected canine 
clinical cases are detailed. Relevant information is reported in the description of each case; 
diagnostic investigation, management and outcome are summarised in Table 18 (page 122) 
and in more detail in Table 17 (page 119). In cases where precise indication of the medication 
the animal was on prior to referral is not reported is because this information was not 
available.
Table 16. Summary of patients’ details
Case Breed Age Presenting sign(s) Diagnosis
1
(138470)
Border collie 14 yrs Isolated, generalised, tonic-clonic 
seizures
Space-occupying lesion forebrain with 
nasal cavity involvement [C]*
2
(139044)
Collie-X 6 yrs Clustered generalised, tonic-clonic 
seizures, behavioural changes
Space-occupying lesion forebrain with 
nasal cavity involvement[C]
3
(140763)
Lurcher 9.5 yrs Clustered, generalised, tonic-clonic 
seizures
Space-occupying lesion forebrain [C]
4
(139076)
Collie-X 11 yrs Seizure activity?
unsteadiness, behavioural changes
Multiple space-occupying lesions: 
forebrain and rostral caudal fossa[C]
5
(140363)
Golden
retriever
7 yrs Clustered, generalised, tonic-cionic 
seizures, behavioural changes
Space-occupying lesion forebrain 
[C/P*]
6
(140354)
Boxer 6.5 yrs Isolated, generalised, tonic-cionic 
seizures, behavioural changes
Space-occupying lesion forebrain with 
midbrain involvement [C/P)
7
(139916)
Labrador
retriever
3.5 yrs Clustered, generalised, tonic-cionic 
seizures, behavioural changes; 
mild ataxia
Space-occupying lesion hindbrain with 
forebrain metastasis [C/P]
8
(139452)
Golden
retriever
11 yrs Isolated, generalised, tonic-cionic 
seizures, behavioural changes
Hydrocephalus and intracranial 
arachnoid cyst [C]
9
(138951)
Border collie 3.5 yrs Isolated, generalised, tonic-cionic 
seizures, behavioural changes
Idiopathic epilepsy [C]
10
(140277)
X-breed 7 yrs Isolated, generalised, tonic-clonic 
seizures
Idiopathic epilepsy [C]
11
(139250)
Labrador
retriever
5.5 yrs Behavioural changes, ataxia, blindness? Space-occupying lesion forebrain [C]
12
(139254)
Cairn terrier 9.5 yrs Behavioural changes, ataxia, ‘absence ‘ 
periods and absent pupillary light reflexes
Space-occupying lesion forebrain with 
midbrain involvement [C]
13
(139848)
Rough collie 8 yrs Collapse, profound obtundation Space-occupying lesion forebrain with 
midbrain involvement [C/P]
14
(138568)
Bullmastiff 2.5 yrs Dysphagia, ataxia, vestibular signs Hindbrain neoplasia and 
megaesophagus [C/P]
15
(139359)
Weimaraner 11 yrs Ataxia, intermittent head tilt Space-occupying lesion hindbrain [C]
16
(138763)
Boxer 7 yrs Behavioural changes, weight loss, 
increased appetite, polydipsia/polyuria and 
enlarged extremities
Pituitary macroadenoma and 
acromegaly [C]
*[C] indicates clinical diagnosis; [P] indicates pathological diagnosis
56
Case reports
Case 1: No. 138470
Signalment: Border collie, male entire, aged approximately 14 years, weight 27.5 kg
Diagnosis: mass lesion rostral forebrain, involving the right frontal lobe of the cerebrum and 
the right olfactory bulb, extending through the cribriform plate into the caudal aspect of the 
nasal cavity.
History
The dog was presented with a history of isolated, generalised, tonic-clonic seizures of 
approximately five months duration, occurring with a frequency of approximately one a 
month. The frequency of seizures had increased in the two weeks preceding referral. The case 
history did not give precise indication of the increased frequency of seizures. According to the 
owner the dog was otherwise normal between seizures. At the time of presentation the dog 
was on no anticonvulsant medication.
Physical examination
On physical examination the dog was bright and alert, with no significant clinical findings 
other than a bilaterally stiff hindlimb gait due to established and NSAIDs-responsive 
osteoarthritis (carprofen, RimadyF^Pfizer, Animal Health, Ltd). A full neurological 
examination failed to demonstrate any abnormalities. Based on the history, forebrain 
dysfunction was identified. Primary or secondary brain neoplasia, degenerative or 
inflammatory brain diseases were considered the most likely diagnoses.
Investigations and provisional diagnosis
The standard protocol for investigation of seizure disorders was performed.
The pre-contrast CT images of the skull and brain demonstrated the presence of a solitary, 
hypodense mass located in the right rostral cranial cavity, at the level of the frontal cortex, 
extending to the olfactory bulb and involving the cribriform plate (Figure 5a, b). The mass, 
grossly ovoid shaped, produced a midline shift with left displacement of the falx cerebri, and 
appeared to be eroding through the lamina temporalis laterally, and into the frontal sinus 
dorsally (Figure 5c). On the post-contrast images a thin, irregular, poorly defined rim of 
enhancement was seen (Figure 5d).
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A diagnosis of an intracranial space-occupying lesion was made. Neoplasia was considered to 
be the most likely diagnosis because of the age of the patient and the evidence from the CT 
scan of bone lysis, suggesting an aggressive behaviour. Despite the apparent invasion of the 
nasal cavity, at the time of presentation, the dog did show neither nasal signs nor facial pain. 
The CT appearance was consistent with a meningioma or a primary nasal neoplasia extending 
caudally into the cranial vault. Oligodendroglioma and astrocytoma were also considered in 
the differential diagnosis.
Management and outcome
The size and erosive nature of the mass excluded the possibility of surgical excision. The 
position was such that radiation therapy carried the risk of significant acute ocular side 
effects®, and the owner elected to manage the dog palliatively. The dog was discharged on 
anti-inflammatory doses of prednisolone (1 mg/kg/day), which resulted in control of seizure 
activity. No anticonvulsant therapy was initiated because the owner requested that they not be 
used.
The dog was seizure-free until the time of its death, which occurred suddenly 10 weeks after 
assessment at UGVS. The dog was found dead by the owner; neither seizure activity nor 
clinical signs of nasal cavity involvement had developed in the intervening period. No post 
mortem examination was performed.
® Dr J.M. Dobson, Department o f  Clinical Veterinary Medicine, The Queen’s Veterinary Hospital, University o f  
Cambridge Veterinary School
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Figure 5. Case 1, 138470. a) sagittal post-contrast image - note rostrally located 
hypodense mass with poorly defined enhancing peripheral rim and extension through the 
cribiform plate; b) transverse pre-contrast image at the level of the frontal sinuses - note 
soft tissue infiltration of the cribriform plate and displacement of the left olfactory bulb;
59
C ase repo rts
j l l o Y I  I
'  I t M  1 7 0 / k / H K n i  
10#,'# I I -  l!t 
J J I i .  II litIH
1. 1 OS I.I IW  U |  I S I  I I I I I I I I I X# I N I  J  1 0 0  , |  i I •• 
I # ,  N i i w  '#'# I # , :  I I I  O J  
I J O k U .  i O O m ft - ;  
S C  J  lOlNM 
S U  Omni 
S I  J . O s :  
/  J .  0 0
% /
c)
Cl :#,i wi jonii'
" 4 ,  ,  - I  # 1 •  t 1 I
: _it| II .11
C
d)
Figure 5 (cont). Case 1, 138470. c) transverse post-contrast image at the level of the 
frontal sinuses - note osteolysis of the lamina temporalis laterally, the frontal sinuses 
dorsally and the displacement of the perpendicular lamina of the ethmoid; d) transverse 
post-contrast image at the level of the frontal lobe - a large, hypodense, non-enhancing 
mass lesion is present within the right frontal lobe; there is a poorly defined rim of 
enhancement and the presence of contrast in the falx cerebri emphasises the midline shift 
to the left.
60
Case reports
Case 2: No. 139044
Signalment: Collie X, male entire, aged approximately 6 years, weight 17.5 kg
Diagnosis: mass lesion right frontal lobe and olfactory bulb extending through the cribriform 
plate into the caudal aspect of the right nasal cavity.
History
The dog was presented with a two-month history of generalised, tonic-clonic seizures, and 
behavioural changes consisting of lethargy, aggressiveness, and occasionally pacing, head 
pressing and circling. Initially the seizures were isolated in character and occurred with a 
frequency of once a week. Over the two weeks preceding referral, seizure activity had 
changed to cluster seizures occurring with a frequency of two to three episodes a week. In 
addition, the dog had a history of chronic sneezing and of apparent lumbar / caudal abdominal 
discomfort. The sneezing had lasted for approximately three months and had been 
unresponsive to antibacterial therapy. Ten weeks before presentation the dog had also been 
treated with delmadinone acetate (Tardak, Pfizpr Ltd) for suspected prostatic hypertrophy.
Investigations prior to referral had concentrated on assessing potential extracranial causes of 
seizures. These investigations included routine haematology and biochemistry, bile acid 
stimulation test, plasma ammonia, serum phenobarbitone, plasma thyroxine, urinalysis, 
bacterial culture of the urine, radiology of the thorax, abdomen and spine, and abdominal 
ultrasound, all of which were unremarkable.
Treatment with phenobarbitone had been initiated about six weeks before referral to UGVS 
(3.5 mg/kg/day). Referral was precipitated by the increased frequency of seizures and the 
development of clusters, despite the increase of phenobarbitone to 8 mg/kg/day three weeks 
before presentation. Neurological assessment performed by the referring veterinary surgeon 
demonstrated multifocal central nervous system signs consisting of depressed mental status, 
pacing, circling to the right, absent consensual pupillary light reflex and decreased menace 
response on the right eye, reduced gag reflex and bilateral loss of nostril, ear and facial 
sensation.
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Physical examination
At the time of presentation to UGVS there were no overt neurological deficits. The 
neurological impairment reported by the referring veterinary surgeon was most likely the 
manifestation of transient postictal effects. There was apparent lumbar / caudal abdominal 
pain and despite the dog sneezing several times in the consulting room, there was no evidence 
of nasal discharge, facial pain or swelling. Based on both history and physical examination 
findings a right-sided forebrain lesion was suspected. Primary and metastatic intracranial 
neoplasia were considered the most likely diagnoses.
Further investigation
On the basis of the history of suspected prostatic hypertrophy and the lumbar / caudal 
abdominal pain detected on examination, a rectal examination was performed and urine was 
taken for routine biochemistry and cytology, all of which were unremarkable. Lateral survey 
radiographs of the abdomen and of the spine were also unremarkable, as well as the CT of the 
lumbo-sacral joint. These results ruled out both secondary neoplastic CNS / lumbosacral area 
involvement and disease of the lumbosacral joint as the cause of the dog’s abdominal and 
spinal hyperpathia.
On the basis of the history of chronic sneezing a ventral 20° rostral-dorsocaudal oblique open 
mouth (V20° Ro-DCd) view of the nasal cavity was taken. A subtle loss of ethmoid turbinate 
pattern and outline of the cribriform plate, next to a small area of soft tissue opacity in the 
caudolateral aspect of the right nasal cavity was detected (Figure 6e).
The pre-contrast CT images of the skull and brain demonstrated the presence of a singular, 
eccentric, isodense to hyperdense mass in the right olfactory bulb and frontal lobe and 
evidence of bony destruction involving the cribriform plate (Figure 6c). The mass was 
associated with displacement of the falx cerebri to the left and appeared to extend through the 
midline to the left frontal lobe. The mass was grossly ovoid in shape and the margins varied 
from well to poorly defined (Figure 6a). Brain tissue displacement to the left was detectable 
from the level of the olfactory bulbs to the pituitary region. A better appreciation of the 
extension of the mass was obtained by sagittal reconstruction (Figure 6d).
In the post-contrast study the mass enhanced intensely and relatively uniformly (Figure 6b) 
and a predominantly right-sided contrast enhancing mass became visible in the caudal aspect
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of the ethmoid turbinates. A diagnosis of a forebrain space-occupying lesion extending into 
the caudal portion of the right nasal cavity was made. Neoplasia was considered the most 
likely diagnosis. An attempt to obtain a biopsy specimen via the right nasal cavity was 
unsuccessful because of the position of the mass. Thus, it was not possible to establish if this 
was a primary brain tumour, which had secondarily involved the nasal passages or vice versa.
Management and outcome
The position of the mass was such that surgical excision was not possible and radiation 
therapy would have been likely to produce significant acute ocular side effects (Harris et al 
1997). The owner elected to manage the dog palliatively. The dog was discharged on anti­
inflammatory doses of prednisolone (1 mg/kg/day) in addition to the phenobarbitone (8 
mg/kg/day).
On steroid medication the demeanour of the dog progressively improved over the following 
month, to the point where the dog was as active as before the seizures started and no longer 
aggressive, head pressing or pacing; the intensity and frequency of the sneezing had also 
decreased. The dog was seizure-free for eight weeks. Seizure activity recurred two weeks 
after the dose of corticosteroids had been tapered to 0.5 mg/kg/day. Despite increasing the 
prednisolone dose to the previous regimen (1 mg/kg/day) seizure activity increased and other 
clinical signs such as lethargy, pacing and intense sneezing recurred suggesting that the 
palliative effects of the corticosteroids were waning, and that the mass was reaching a critical 
size.
The dog was euthanased approximately two weeks later (10 weeks after first assessment at 
UGVS) because of the development of status epilepticus; no post mortem examination was 
performed.
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Figure 6. Case 2, 139044. a) Transverse pre-contrast image at the level of the frontal cortex, 
an iso- to mildly hyperdense broad-based eccentric mass may be seen within the right 
olfactory and frontal lobe with displacement to the left of the falx cerebri; b) Transverse post­
contrast image at similar level to a) uptake of contrast is intensive and uniform and 
emphasises the abnormalities present on the pre-contrast image;
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Figure 6 (cont). Case 2, 139044. c) Transverse pre-contrast image at the level of the cribriform plate, abnormal 
soft tissue infiltrates through the right side of the cribriform plate destroying the turbinate pattern and partially 
the horizontal wing of the vomer; d) contrast enhanced sagittal image confirms involvement of caudal nasal and 
rostral cerebral structures; e) V20° Ro-DCd radiograph showing soft tissue opacity in the caudolateral aspect of 
the right nasal cavity, in addition to a subtle loss of ethmoid turbinate pattern and outline of the cribriform plate.
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Case 3: No. 140736
Signalment: Lurcher, female entire, aged 9 years and 5 months, weight 18.0 kg 
Diagnosis: mass lesion, right forebrain involving the frontal and olfactory cortex.
History
The dog was presented with approximately a two-month history of isolated, generalised, tonic- 
clonic seizures, the frequency of which had increased in the week preceding referral. The first 
two seizure episodes had been separated by an interictal period of seven weeks; a third seizure 
had occurred two weeks after the second. Refen'al was precipitated by the development of 
cluster seizures. Postictal signs consisting of disorientation and attention seeking 
characterised all seizure events, and lasted 10 to 15 minutes; the dog was otherwise normal 
between seizures. Routine biochemistry performed by the referring veterinary surgeon was 
unremarkable. At the time of presentation the dog was on no anticonvulsant therapy.
Physical examination
On physical examination the dog was bright and alert with no significant clinical findings. 
Based on the history a forebrain lesion was suspected. The most likely diagnoses were 
considered primary and secondary intracranial neoplasia; inflammatory or degenerative brain 
diseases.
Investigations and diagnosis
The standard protocol for investigation of intracranial disease and seizure disorders was 
performed.
The pre-contrast CT images of the brain and skull identified a deeply located area of 
hypodensity within the right frontal and olfactory lobes. This area was ovoid in shape, had 
poorly defined margins and appeared to extend cranially into the olfactory bulb. Mild 
displacement to the left of the falx cerebri was also detected (Figure 7a). On the post-contrast 
images a thin, poorly defined rim of enhancement was seen; contrast enhancement of the falx 
cerebri emphasised the midline shift to the left (Figure 7b).
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A diagnosis of an intracranial space-occupying lesion was made. This mass was thought to be 
most likely neoplastic in nature; oligodendroglioma and astrocytoma were considered the main 
differential diagnoses.
Management and outcome
Surgical excision was not possible because of the deep location of the mass. The owner did 
not consider radiation therapy a viable option. The dog was discharged on anti-inflammatory 
doses of prednisolone (1 mg/kg/day) and phenobarbitone (7 mg/kg/day). The dog was seizure- 
free for seven weeks, except for one seizure episode, which had occurred 10 days after 
reducing the dose of corticosteroids to 0.5 mg/kg/day. On that occasion, increasing the 
prednisolone dose to the previous regimen (1 mg/kg/day), regained the control of seizures 
activity. The dog was euthanased approximately three weeks later because of the development 
of severe clusters of seizures. No post mortem examination was performed.
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b)
Figure 7. Case 3, 140736. a) Transverse pre-contrast image at the level of the frontal lobe showing a deeply 
located area of hypodensity with poorly defined margins to the right of midline; b) Transverse post-contrast 
image at the same level as a), the area of hypodensity identified in the pre-contrast studies is surrounded by a 
thin, irregular rim of enhancement and the midline shift to the left is emphasised by enhancement of the falx 
cerebri.
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Case 4: No. 139076
Signalment: Collie X, male neutered, aged approximately 10 years and 9 months, weight 21 kg
Diagnosis: multiple mass lesions forebrain and rostral aspect of caudal fossa, and mass effect 
not associated with visible mass / masses in the right hemisphere at the level of the midbrain. 
1) space-occupying lesion involving the right frontal lobe and olfactory bulb, and eroding 
through the cribriform plate; 2) midline mass lesion ventral to the tentorium cerebelli.
History
The dog was presented with a one-month history of ataxia, which had deteriorated over the 
week preceding referral. The history was also suggestive of recent, subtle but progressive 
mental status / behavioural changes, mainly consisting of lethargy, and occasionally vacant 
staring, and possible seizure activity.
Physical examination
At the time of examination the dog appeared “vacant” and obtunded, though there were no 
overt neurological deficits. Based on the history and clinical examination findings a forebrain 
lesion was suspected. Primary and secondary brain neoplasia was thought to be the most 
likely diagnosis. Degenerative and inflammatory brain diseases were also considered a 
possibility.
Investigations and provisional diagnosis
The standard protocol for investigation of intracranial diseases and seizure disorders was 
performed.
Plain radiographs of the thorax and abdomen were unremarkable.
On the pre-contrast CT images of the brain and skull morphological abnormalities were 
detected on the ventral aspect of the brain, extending from the cribriform plate to the midbrain. 
A midline shift to the left of the falx cerebri (imaged due to partial mineralisation) and both 
lateral ventricles was evident. Both lateral ventricles appeared misshapen with the right 
smaller than the left; the temporal horn of the left lateral ventricle also appeared enlarged 
(Figure 8a, b). These findings were suggestive of the presence of a right-sided mass lesion 
causing CSF flow obstruction at the level of interventricular foramina. Areas of hypodensity
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surrounding an eccentric, hypo- to isodense mass lesion were seen at the level of the ventral 
right frontal lobe (Figure 8b). These areas of hypodensity were suggestive of cerebral oedema 
and appeared to follow the so-called corona radiata pattern. Invasion through the cribriform 
plate was apparent.
On the post-contrast CT images a non-homogeneously enhancing mass was seen in the rostral 
portion of the brain, with the most intense enhancement in the right olfactory bulb and frontal 
lobe regions. Contrast enhancement of the falx cerebri indicated a marked midline shift to the 
left at the level of the frontal lobe (Figure 8c).
Midline shift to the left was also present at the level of the midbrain, not caused by a visible 
mass in both pre- and post-contrast studies. Post-contrast transverse CT images detected a 
second contrast enhancing smaller mass, located along the midline, ventrally to the rostral 
aspect of the tentorium cerebelli at approximately the level of the tectum. A mass in this 
location is likely to interfere with CSF flow through the mesencephalic aqueduct. CT findings 
indicating the presence of CSF flow obstruction and cerebral oedema, in addition to the size of 
the mass suggest that ICP was likely to be elevated (North & Reilly 1990). Increased ICP 
might have accounted for the depressed mental status of the animal upon examination.
A diagnosis of multiple intracranial space-occupying lesions, most likely neoplastic in 
character, was made. However, multiple primary brain tumours, including meningioma, have 
been rarely reported in dogs (LeCouteur et al 1981; LeCouteur 1990).
For the mass involving the right frontal lobe of the cerebrum and olfactory bulb, meningioma 
and a primary nasal neoplasia, which had extended caudally into the cranial vault, were 
considered the main differential diagnoses. The second, more caudal lesion was considered 
most likely to be a pathologic process independent from the cranial one. However, the 
possibility this second mass represented a single metastasis and / or the focal extension of the 
forebrain mass lesion could not be excluded. The second mass could also have represented a 
single intracranial metastasis of an extracranial neoplasia, despite no abnormalities being 
detected on physical examination and on survey radiographs of chest and abdomen.
The midbrain midline shift was probably a secondary consequence of the severe cerebral 
oedema associated with the frontal lobe mass. Moore et al (1991) describes the CT and MRI 
features of a case of primary nasal adenocarcinoma involving the left frontal lobe and
70
Case reports
olfactory bulb in which the intense peritumoural oedema extended caudal to the tumour mass 
as far as the midbrain producing at this level, displacement of the brain to the right.
Management and outcome
Patients with multiple and deeply located lesions are poor candidates for surgery. Radiation 
therapy was likely to result in severe acute ocular side effects, and was not considered a viable 
option by the owner. In addition, the nature of the lesion causing the major displacement of 
the brain in the right hemisphere was uncertain. Thus, it was elected to manage the dog 
palliatively. The dog was discharged on anti-inflammatory doses of prednisolone (1 
mg/kg/day).
After starting corticosteroid medication the dog showed a temporary improvement, being more 
alert and less unsteady. Cluster seizures were observed after twenty days; at that point the 
owner elected euthanasia. No post mortem examination was performed.
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a)
b)
Figure 8. Case 4. 139076. a) Transverse pre-contrast image at the level of the cranial aspect of the 
tympanic bulla - note the asymmetrical distorted lateral ventricles, enlarged left ventricle, and shift to the left of 
both falx cerebri and ventricular system suggesting the presence of a right sided mass; b) transverse pre-contrast 
image at the level of the frontal lobe. An iso- to hypodense mass is present in the ventrolateral aspect of the right 
frontal lobe surrounded by an extensive area of hypodensity. A shift to the left of a partially mineralised falx 
cerebri is also evident;
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c)
Figure 8 (cont). Case 4, 139076. c) Transverse post-contrast image at a similar level to b) -  note the strong 
peripheral rim of enhancement and the contrast enhancement of the falx cerebri.
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Case 5: No. 140363
Signalment: Golden retriever, female entire, aged 7 years, weight 32.3 kg
Diagnosis: mass lesion forebrain located on the lateral convexity of the left cerebral 
hemisphere at the level of the ftonto-parietal eortex junction; meningioma.
History
The dog was presented with a history of two episodes of clustered, generalised, tonic-clonic 
seizures occurring approximately three months apart. Phenobarbitone medication had been 
initiated after the second episode (4 mg/kg/day), which had occurred a week before 
examination at UGVS. The history was also indicative of recent development of behavioural 
changes consisting of aggression and attention seeking.
Physical examination
At the time of presentation no abnormalities were detected. The history was suggestive of 
forebrain dysfunction. Primary or secondary brain neoplasia, degenerative or inflammatory 
brain diseases, as well as idiopathic epilepsy were considered possible differential diagnoses.
Investigations and diagnosis
The standard protocol for investigation of intracranial disease and seizure disorders was 
performed.
The pre-contrast CT images of the brain and skull identified a focal area of thickening on the 
left dorsolateral calvarium, extending from the level of the choanae to the rostral end of the 
tympanic bullae, caused by hyperostosis of the frontal / parietal bones (Figure 9a). An 
irregular, thin, hypodense rim of brain tissue suggestive of white matter oedema was seen 
within the left cerebral hemisphere at the junction of the parietal / frontal lobes. Mild 
enlargement of the left lateral ventricle was also detected (Figure 9b).
On post-contrast CT images a single extra-axial intensely and uniformly enhancing mass 
lesion could be detected on the lateral convexity of the left cerebral hemisphere at the level of 
the parietal cortex. The mass was broad-based and plaque-like with well-defined margins and 
a pedunculated portion extending medially (Figure 9c). A diagnosis of a forebrain space-
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occupying lesion was made. Neoplasia was considered the most likely diagnosis, with the CT 
appearance being consistent with meningioma.
Management and outcome
Although the mass would have been amenable to surgical excision, because of its superficial 
location, the owner decided to have the dog euthanased.
Post mortem examination
Gross post mortem examination confirmed the presence of a slightly brownish plaque shaped 
mass lesion in the region of the parietal / frontal lobe junction (Figure 9d). The mass was 
strictly adherent to the dura mater. Histopathology confirmed the nature of the mass as a 
meningioma and loeal infiltration into the brain parenchyma.
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Figure 9. Case 5, 140363. a) Transverse pre-contrast -image at the level of the temporomandibular joint (bone 
window) where a focal area of hyperdensity is seen in the left dorsolateral calvarium at the junction of the 
parietal / frontal bones indicating hyperostosis; b) Transverse pre-contrast image at the same level as a) (brain 
window) in which the increased density of the parietal / frontal bones cannot be seen;
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d)
Figure 9 (Cont). Case 5, 140363. c) Transverse post-contrast image at a similar level to a) and b). showing an 
extra-axial, intensively enhancing mass lesion involving the frontal / parietal lobes, which is plaque shaped and 
has a broad base of contact with the bone; d) post mortem appearance of the mass (arrow).
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Case 6: No. 140354
Signalment: Boxer, male entire, aged ~ 6 years and 6 months, weight 25 kg
Diagnosis: mass lesion right forebrain affecting the frontal, temporal and parietal lobes of the 
cerebrum, and the thalamic area, and extending caudally to involve the midbrain; anaplastic 
oligodendroglioma.
History
The dog was presented with a history of a single generalised, tonic-clonic seizure, which had 
occurred two weeks previous to referral. The seizure episode had been followed by the 
development of blindness in the left eye and ataxia. The ataxia had progressively deteriorated, 
with the dog stumbling, staggering to the left and occasionally falling to the side. The history 
was also indicative of changes in mentation and behaviour, consisting of lethargy, bumping 
into objects, getting stuck into comers and occasional head pressing. Five days prior to 
referral, steroid medication had been initiated, which had resulted in improvement of the 
clinical signs.
Physical examination
On examination the dog was found to be severely obtunded and staggering to the left; it had 
severe left-sided proprioceptive deficits and decreased menace response in the left eye. In 
addition the dog occasionally exhibited head pressing behaviour. Based on these findings a 
right-sided forebrain lesion was suspected. Primary and secondary brain neoplasia was 
considered the most likely diagnoses. Vascular accidents, inflammatory brain diseases, or 
degenerative CNS diseases were also considered a possibility.
Investigations and diagnosis
The standard protocol for investigation of intracranial disease and seizure disorders was 
performed.
CT of the brain and skull detected morphological abnormalities extending from the level of the 
fi-onto-parietal junction, to approximately the level of the tentorium cerebelli.
On the pre-contrast CT images a shift to the left of the falx cerebri and a markedly 
compressed, distorted right lateral ventricle with a dilated left lateral ventricle were seen. The
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temporal horn of both lateral ventricles also appeared enlarged (Figure 10a). Distortion of the 
ventricular system was detected from the level of the frontal cortex to the region of the 
midbrain. Poorly marginated areas of hypodensity suggestive of cerebral oedema were seen 
within the right cerebral hemisphere and followed the typical telencephalic white matter 
pattern (corona radiata pattern) (Figure 10a). These areas were particularly evident within the 
parietal lobe and extended caudally to involve the occipital cortex. These findings were 
suggestive of the presence of a right-sided mass lesion.
On the post-contrast CT images a single, irregularly shaped mass lesion was detected in the 
right cerebral hemisphere at the level of the frontal lobe. The mass appeared to involve the 
ventral portion of the corona radiata, the internal capsule, the caudate nucleus area, and 
extended dorsally into the parieto-temporal region. It also appeared to impinge on the 
thalamus and third ventricle, causing obstructive hydrocephalus. The mass enhanced with a 
ring-like pattern and had a wide central hypodense area, suggestive of a necrotic core (Figure 
10b).
On a post-contrast sagittal image (slightly to, the right of midline) the markedly hypodense, 
deeply located mass, appeared to extend from approximately the level of the optic chiasm to 
the rostral aspect of the tentorium cerebelli. The ring-like enhancement and the hypodense 
areas detected on the transverse images were extensive and obvious on the sagittal 
reconstruction. Sagittal reconstruction emphasised the rostral extension of the mass to involve 
the frontal area of the cerebrum (Figure 10c).
A diagnosis of an intracranial space-occupying lesion was made. Neoplasia was considered 
the most likely diagnosis with oligodendroglioma and astrocytoma being the main differential 
diagnoses. Rapidly growing, malignant variants, such as glioblastoma multiforme were 
considered a possibility on the basis of history, clinical (acute onset and rapid deterioration of 
neurological deficits) and CT findings (widespread cerebral oedema and necrotic core).
Management and outcome
The size and location of the mass excluded the possibility of surgical excision and/or radiation 
therapy. The prognosis was considered grave and the dog was started on anti-inflammatory 
doses of prednisolone (1 mg/kg/day). During the first twelve hours following recovery from
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anaesthesia, the neurological status of the dog dramatically deteriorated, and the owner elected 
euthanasia.
Post mortem examination
Gross post mortem examination (Figure lOd) confirmed the presence of a fairly well 
circumscribed, unencapsulated mass involving the cerebral hemispheres (predominately on the 
right) at the level of the thalamus. Histopathology confirmed the nature of the mass as an 
anaplastic oligodendroglioma. Infiltration into the adjacent lateral ventricles was apparent.
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Figure 10. Case 6, 140354. a) Transverse pre-contrast image at the level of the midbrain showing changes in 
the lateral ventricles with distortion of the right and enlargement of the left and evidence of white matter oedema 
(arrow); b) Transverse post-contrast image at the same level as a) revealing a hypodense mass with an irregular 
rim of enhancement involving the right temporal and parietal lobes, as well as the corona radiata, caudate 
nucleus, internal capsule and thalamus;
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Figure 10 (Cont). Case 6, 140354. c) sagittal post-contrast image confirming the deep location of the mass and 
extensive associated oedema d) post mortem preparation at similar level to images a) and b).
82
Case reports
Case 7: No. 139916
Signalment: Labrador retriever, male neutered, aged 3 years and 7 months, weight 36 kg
Diagnosis: mass lesion, right hindbrain next to the fourth ventriele, with a broad base of 
attachment to the peti'ous bone; choroid plexus papilloma.
History
The dog was presented with a one-month history of severe generalised, tonic-clonic seizures. 
The seizures had the tendency to occur as clusters.
The referring veterinary surgeon had diagnosed idiopathic epilepsy given the dog’s breed and 
age, the absence of interictal neurological deficits and abnormalities on routine haematology 
and biochemistry panels. Treatment with phenobarbitone (2.5 mg/kg/day) had been initiated, 
initially resulting in a degree of improvement. Referral was precipitated by the increased 
frequency of seizures despite the increased dosage of medication (3.3 mg/kg/day). Over the 
two weeks preceding referral, the dog developed changes in mentation consisting mainly of 
decreased awareness and slight ataxia.
Physical examination
At the time of presentation no significant clinical and neurological abnormalities were 
detected. Based on the historical picture forebrain dysfunction was identified. Idiopathic 
epilepsy was thought to be the most likely diagnosis, although inflammatory, degenerative and 
neoplastic brain diseases were also considered a possibility.
Investigations and diagnosis
The standard protocol for investigation of seizure disorders was performed.
Computed tomographic study of the brain and skull revealed the presence of a mass lesion 
within the caudal fossa, extending from the petrosal crest to the occipital bone.
On the pre-contrast CT images a right-sided singular, large, hyperdense, eccentric mass was 
seen located near the fourth ventricle. The mass was ovoid in shape, had distinct, smooth 
margins, and an iso- to hyperdense centre. It had a broad base of attachment to the right 
petrous bone and involved the cerebellopontine angle area (Figure 11a, c). Displacement of 
the brainstem and cerebellum, as well as compression of the fourth ventricle was evident. On
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the post-contrast CT images the mass enhanced intensely and uniformly and was surrounded 
by a hypodense rim, suggestive of cerebral oedema (Figure lib ). A ring-like pattern of 
hypodensity was seen within the caudal portion of the mass, suggestive of a necrotic centre. 
On the post-contrast study a second smaller enhancing area could be seen just left of midline at 
approximately the level of the fourth ventricle. CT images resolution was not sufficient to 
establish whether or not this mass was connected to the first one.
A diagnosis of caudal fossa space-occupying lesions was made. These masses were thought to 
be most likely neoplastic in nature; meningioma and choroid plexus papilloma were 
considered the main differential diagnosis. Ependymoma was also considered a possibility.
Management and outcome
The size and location of the masses excluded the possibility to elect for surgical excision. The 
owner did not consider radiation therapy a viable management option. However, in this case 
radiation therapy would have carried the risk of severe otitis externa (Spugnini et al 1995). In 
addition, radiation therapy is poorly effective with highly vascularised tumours, and in this 
case ehoroid plexus papilloma was one of the main differential diagnosis. The owner was 
given a poor prognosis and the dog was euthanased.
Post mortem examination
Post mortem examination revealed an off-white / yellow erosive hriable mass in the region of 
the right hindbrain. Several smaller lesions of similar colour were seen over the ventral 
surface of the cerebrum and in the region of the optie ehiasm (Figure lid ). Histopathology 
confirmed the nature of the mass as a choroid plexus papilloma.
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a)
b)
Figure 11. Case 7, 139916. a) Transverse pre-contrast image at the level of the caudal fossa 
showing an extra-axial, ovoid-shaped, hyperdense mass in the ventrolateral aspect of the right 
hindbrain and involving the cerebellopontine angle -  note the broad-base of attachment to the 
petrous bone; b) Transverse post-contrast image at the same level as a) showing the mass to 
enhanee intensively and uniformly, with the strongest enhancement occurring at its periphery;
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d)
Figure 11. Case 7, 139916 (Cont). c) Transverse post-contrast image at the same level as a) and b) viewed 
with a bone window showing no apparent bony involvement; d) post mortem appearance of the brain.
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Case 8: No. 139452
Signalment: Golden retriever, female neutered, aged ~ 11 years, weight 36.5 kg 
Diagnosis: hydrocephalus and intracranial arachnoid cyst (IAC).
History
The dog was presented with a three-month history of generalised, tonic-clonic seizures, with 
an inter-ictal period of fourteen to seventeen days. Seizures were isolated in character with the 
exception of one incident of cluster seizures. Interictal abnormalities were limited to increased 
vocalisation for no apparent reason and a poorly defined change in behaviour. The latest 
seizure occurred the evening before examination at UGVS.
Physical examination
Physical and neurological examination was unremarkable. Based on the history a forebrain 
lesion was suspected. Primary or secondary brain neoplasia was thought to be the most likely 
diagnosis; degenerative or inflammatory brain diseases, as well as idiopathic epilepsy, were 
considered in the differential diagnosis.
Investigations and diagnosis
The standard protocol for investigation of intracranial disease and seizure disorders was 
performed.
Pre-contrast CT images of the brain and skull revealed an extreme hydrocephalus extending 
thorough the entire telencephalon (Figure 12a, b, c, d). The lateral and third ventrieles were 
remarkably dilated; a fluid filled cyst-like structure with sharply defined margins was evident 
in the region of the quadrigeminal cistern (Figure 12b). On post-contrast study no other 
morphological abnormalities were detected and the cyst-like structure did not enhance.
The otherwise relatively normal features of the cranium, and the mild clinical signs despite the 
dramatic distension of the ventricular system, suggested that the hydrocephalus was acquired. 
A diagnosis of hydrocephalus and possible intracranial arachnoid cyst (lAC) was made.
Management and outcome
Both hydrocephalus and intracranial arachnoid cysts are reported in association with seizures 
and behavioural changes in dogs (Harrington et al 1996; Vemau et al 1997; Thomas 1999).
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Whether in this case seizure activity related to the hydrocephalus and / or the lAC is not 
established. However, for both conditions the literature suggests that shunting may improve 
the clinical status of the patient (Thomas 1998; Anderson et al 2000). In human patients 
fenestration is also used for the surgical treatment of lAC and this has also been reported in the 
dog (Vemau et al 1997). The most appropriate surgical approach (fenestration vj' shunting) 
has not been established. In this case, a ventriculoperitoneal shunt was considered a viable 
method of achieving long-term drainage of the ventricular system and thus ameliorating the 
neurological abnormalities.
Whilst the owner considered this option the patient was managed with 4 mg/kg/day of 
phenobarbitone and prednisolone (1 mg/kg/day). During the three weeks preceding surgery 
the patient did not seizure. A medium pressure (opening pressure 5-9 cm H^O) 
ventriculoperitoneal shunt (Shunt kit, contour-flex valve. Radionics) with reservoir was 
placed, with the ventricular catheter in the right lateral ventricle. The patient was discharged 
on an unchanged phenobarbitone dosage regime. The steroids were withdrawn.
During the three weeks following surgery the dog remained seizure-free and its demeanour 
improved remarkably. At 7 weeks following surgery there was a sustained improvement in 
demeanour, in particular the reappearance of behavioural traits that had been lost prior to 
surgery. A CT scan at this point showed that there had been some relaxation of the cortex and 
an unsuspected collapse of the right hemisphere. Only one seizure occurred during the first 
twelve weeks following surgery. Telephone follow up at ten months following surgery 
confirmed a normal demeanour and behaviour of the dog, as well as a good control of seizure 
activity, with episodes of isolated, generalised tonic-clonic seizures occurring with a frequency 
of one every six to ten weeks. The phenobarbitone dosage regime has not been modified (4 
mg/kg/day). Monitoring of the anticonvulsants therapy has been performed by the referring 
veterinary surgeon.
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a)
Figure 12. Case 8, 139452. Transverse post-contrast images showing abnormal dilation of the ventricular 
system, which was present in the entire telencephalon: a) Transverse post-contrast image at the level of the 
caudal telencephalon, showing the caudal extension of the hydrocephalus; b) Transverse post-contrast image at 
the level of the rostral colliculi in the midbrain region - note the presence in addition to the abnormal dilated 
lateral ventricles of a non-enhancing fluid filled cyst like structure in the region of the quadrigeminal cistern;
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d)
Figure 12 (Cont). Case 8, 139452. c) Transverse post-contrast image at the level of the thalamus; d) transverse 
post-contrast image at the level of the frontal lobe, showing the rostral extension of the hydrocephalus.
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Case 9; No. 138951
Signalment: Border collie, female neutered, aged 3 years and 6 months, weight 14.7 kg 
Diagnosis: idiopathic epilepsy.
History
The dog was presented with a thirteen-month history of isolated, generalised, tonic-clonic 
seizures lasting two to three minutes and occurring approximately every three to four weeks. 
According to the owner, the dog was showing no other signs of illness, was eating well, and 
appeared to be perfectly normal between seizures. No pre- and postictal neurological 
abnormalities were reported. The history was not indicative of the dog having been involved 
in any trauma or exposure to toxins. Treatment with phenobarbitone (2 mg/kg/day) had been 
initiated two months prior to referral; this had not resulted in control of seizure activity.
Physical examination
On examination the dog was bright and alert, with no significant clinical findings. A full 
neurological examination failed to demonstrate any abnormalities. Based on the history, 
forebrain dysfunction was identified. Idiopathic epilepsy was thought to be the most likely 
diagnosis. Inflammatory, neoplastic and degenerative diseases were also considered in the 
differential diagnosis.
Investigations and provisional diagnosis
The standard protocol for investigation of seizure disorders was performed. Routine 
haematology and biochemistry panels were within normal limits, as well as toxoplasma titres 
and neospora neutralisation dilutions. On both pre- and post-contrast CT images of the brain 
and skull, no structural abnormalities were detected. The CSF tap and fluid analysis were 
unremarkable. Based on elimination of metabolic causes of seizures, normal appearance of the 
brain on CT, and unremarkable CSF analysis, a diagnosis of idiopathic epilepsy was made.
Management and outcome
The dog was discharged on phenobarbitone at a dosage regime of 4 mg/kg/day; a blood 
sample taken after two weeks showed the serum phenobarbitone level (15.2 mg/1) being in the 
therapeutic range (15-45 mg/1), although close to the lowest limit. Clinical biochemistry and
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serum phenobarbitone level were re-evaluated six months after first assessment at UGVS. The 
results indicated adequate phenobarbitone serum concentration (21.6 mg/1 peak; 18.6 mg/1 
trough); there were no evidence of phenobarbitone-induced bone marrow toxicity, but the SAP 
was raised (850 U/1). However, the transaminases, bilirubin, and serum bile acids, the latter 
evaluated at the referring veterinary practice, were within normal limits, suggesting that this 
represented enzyme induction rather than hepatic pathology. During the following five 
months routine biochemistry and serum bile acids evaluation performed in two occasions by 
the referring veterinary surgeon did not suggest the development of liver disease.
Telephone follow up at twelve months after first assessment at UGVS confirmed that 
phenobarbitone medication at the dose of 4 mg/kg/day has resulted in acceptable control of 
seizure activity with only four seizures during this period.
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Case 10: No. 140277
Signalment: X breed, male entire, aged approximately 7 years, weight 29 kg
Diagnosis: idiopathic epilepsy
History
The dog was presented with an approximately four-month history of isolated, generalised, 
tonic-clonic seizures, occurring with a frequency of once a week. Jaw snapping and rhythmic 
turning of the head toward the right shoulder were described to precede the tonic-clonic phase 
in each seizure event. Duration of the ictus was two to three minutes; postictal disorientation 
usually lasted five to ten minutes. No interictal abnormalities were reported. The history was 
not indicative of the dog having been involved in any trauma or exposure to toxins. In 
addition the dog had a history of chronic sneezing; more recently a clear nasal discharge had 
appeared. Three months prior to referral, phenobarbitone medication had been initiated (4 
mg/kg/day). This had not resulted in control of seizure activity. The dose of phenobarbitone 
had been increased from 4 to 5 mg/kg/day, four days before presentation. Referral was 
precipitated by the increased frequency of seizures over the previous two weeks (two and three 
episodes per week, respectively).
Physical examination
At the time of presentation no significant clinical and neurological abnormalities were 
detected, with the only remarkable abnormality consisting of corneal opacity, secondary to 
oedema, in the left eye. Based on the history, forebrain dysfunction was identified. Seizure 
activity was thought to be most likely the result of a structural brain disease. Primary or 
secondary brain neoplasia was considered the most likely diagnosis. Inflammatory or 
degenerative brain diseases, as well as idiopathic epilepsy were included in the differential 
diagnosis.
Investigations and diagnosis
The standard protocol for investigation of seizure disorders was performed.
Routine haematology showed a mildly inflammatory leukogram with neutrophilia, most likely 
related to the recently developed rhinitis. (WBC 18.300 x lO^^/l; neutrophils 12.810 x 10^
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^/l). Routine biochemistry panels revealed increased SAP (307 U/1); Toxoplasma titres and 
Neospora neutralisation dilutions were within normal limits. On both pre- and post-contrast 
CT images of the brain and skull no structural abnormalities were detected. The CSF analysis 
was unremarkable. Based on elimination of metabolic causes of seizures, normal appearance 
of the brain on CT, and unremarkable CSF analysis, a presumptive diagnosis of idiopathic 
epilepsy was made.
Management and outcome
The patient was discharged on an unchanged phenobarbitone dosage regimen; a blood sample 
taken two weeks after showed the phenobarbitone level to be within therapeutic range (18.58 
mg/1). During the following month, seizure frequency decreased approximately to one episode 
every four weeks; at that point the referring veterinary surgeon initiated potassium bromide 
medication (25 mg/kg/day). Telephone follow up at seven months after assessment at UGVS 
confirmed improvement in seizure activity control, with seizures occurring every 6 to 7 weeks, 
and being less severe than when the dog was first presented.
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Case 11; No. 139250
Signalment: Labrador retriever, male entire, aged ~ 5 years and 6 months, weight 37 kg
Diagnosis: mass lesion in the forebrain involving the mid-parietal lobe of the dorsal cerebrum, 
at the level of the midbrain.
History
The dog was presented with an approximately one-month history of behavioural change, 
mainly consisting of aggression, intermittent ataxia and visual dysfunction. The ataxia had 
suddenly deteriorated two weeks preceding referral, with the dog staggering and falling over; 
in addition it had become anorexic, extremely anxious and occasionally had been seen 
bumping into objects. Subsequent progress had been variable, with the dog having "good" 
days and “bad" days.
Physical examination
On examination the dog was found to be mildly obtunded and withdrawn, with proprioceptive 
deficits in all four limbs and occasional hypermetria in the hindlimbs. Based on these findings 
a forebrain and / or a multifocal lesion involving also the brainstem / cerebellum was 
suspected. Primary and secondary brain neoplasia, inflammatory or degenerative brain 
diseases were considered the most likely diagnostic possibilities.
Investigations and diagnosis
The standard protocol for investigation of intracranial disease was performed.
The pre-contrast CT images of the skull and brain demonstrated the presence of a large, 
singular, midline located, mildly hyperdense mass, in the midparietal lobe of the dorsal 
cerebrum (Figure 13a). The mass extended from just rostral to the thalamus caudally as far as 
the midbrain. The mass was ovoid in shape and had poorly defined margins. It was associated 
with a mass effect consisting of mild enlargement of both lateral ventricles (with the left larger 
then the right) and right displacement of the falx cerebri. On the post-contrast images the 
mass enhanced intensely and relatively uniformly. A hypodense ring-like area surrounded the 
mass, suggestive of perilesional oedema; (Figure 13b). Post-contrast sagittal CT images
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emphasised that the mass extended cranially to involve the caudal portion of the dorsal frontal 
lobe (Figure 13c).
A diagnosis of a forebrain space-occupying lesion was made. This mass was thought to be 
most likely neoplastic in nature; meningioma, astrocytoma and oligodendroglioma were 
considered the main differential diagnoses.
Management and outcome
The size and location of the mass excluded the possibility of surgical excision and / or 
radiation therapy. The owner elected to manage the dog palliatively. The dog was discharged 
on anti-inflammatory doses of prednisolone (1 mg/kg/day).
After starting steroid medication the demeanour of the dog improved, it became more active, 
was no longer anorexic or aggressive and no longer bumped into objects. The staggering and 
falling episodes stopped, although the dog remained mildly ataxic. Nine weeks after discharge 
clinical signs of aggressiveness and falling recurred, suggesting that the palliative effects of 
the corticosteroids were waning, and that the mass was reaching a critical size. These signs 
worsened over the following week and the dog was euthanased. No post mortem was 
performed.
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Figure 13. Case 11,139250“, a) Transverse pre-contrast image at the level of the midbrain showing a 
hyperdense, ovoid-shaped mass in the dorsal cerebrum surrounded by an irregular area of hypodensity, 
suggestive of cerebral oedema; b) Transverse post-contrast image at the same level as a) - the mass 
enhances intensely and uniformly and the margins vary from well to poorly defined; the 
displacement of the focally enhanced falx cerebri suggests a midline shift to the right;
CT images are marked 139246 due to a technical error.
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Figure 13. Case 11, 139250 (Cont). c) In the post-contrast sagittal image the mass extends rostrally and appears 
to also involve the frontal lobe.
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Case 12: No. 139254
Signalment: Caim terrier, female neutered, aged 9 years and 6 months, weight 9.5 kg
Diagnosis: mass lesion forebrain in the left cerebral hemisphere involving the ventricular 
system and extending through the olfactory, frontal, and temporal lobes, the thalamic area and 
the midbrain.
History
The dog was presented with an approximately two-week history of sudden onset of ataxia, 
behavioural changes, consisting mainly of aggression, ‘absence’ periods and absent pupillary 
light reflexes. Occasionally, the dog had also been seen to fall to either side. Three days prior 
to referral fteatment with carprofen (Rimadyl, Pfizer Animal Health Ltd) (4.2 mg/kg/day) had 
been initiated, with no improvement.
Physical examination
On neurological examination the dog was found to be mildly obtunded, ataxic on all four 
limbs, with bilaterally absent pupillary light reflexes and absent menace response in both eyes, 
despite having no obvious visual deficits. In the consulting room the dog spent most of the 
time lying in sternal recumbency. When walking, it was ataxic with a crouched forelimb gait 
and fell on two occasions. The dog also showed discomfort on manipulation of the neck. 
Based on these findings a forebrain and / o r a  multifocal lesion involving also the brainstem 
was suspected. Intracranial neoplasia and inflammatory brain disease were considered the 
most likely diagnoses.
Investigations and provisional diagnosis
The standard protocol for investigation of intracranial diseases was performed.
On the pre-contrast CT images of the brain and skull a poorly marginated, predominately 
ovoid, hyperdense mass was seen to the left of the midline and ventral to the left lateral 
ventricle, extending from the level of the frontal / olfactory cortex to the level of the midbrain. 
The mass produced compression and distortion of the left lateral ventricle, as well as 
enlargement of the right lateral and third ventricles and appeared to impinge on the thalamic
99
Case reports
and caudate nucleus regions. After contrast injection the mass enhanced intensely and 
uniformly, with fairly distinct margins (Figure 14a, b).
A diagnosis of intracranial space-occupying lesion was made. This mass was thought to be 
most likely neoplastic in nature. On the basis of CT appearance and location, choroid plexus 
papilloma and ependymoma were considered the main differential diagnoses. However, 
oligodendroglioma can also be associated with a similar CT pattern. In addition, focal GME 
was also considered in the differential diagnosis, on the basis of signalment, history and CT 
findings (Braund 1985; Munana & Luttgen 1998). Focal GME is characterised by hyperdense 
appearance on pre-contrast images and by a strong, in most cases uniform and well marginated 
enhancement on post-contrast studies (Sorjonen 1990; Spéciale et al 1992; Gibbons et al 
1999).
Management and outcome
The owner declined any treatment. Over the three days following discharge the dog 
deteriorated very quickly. The ataxia and falling worsened and severe mental status / 
behavioural changes developed, to the point where the dog was restless, unable to sleep and 
eat, and continuously vocalising. At that point the dog was euthanased; no post mortem 
examination was performed.
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Figure 14. Case 12, 139254. a) Transverse pre-contrast image at the level of the frontal sinuses showing a 
discrete region of hyperdensity near the midline, ventral to the left lateral ventricle, resulting in distortion and 
enlargement of both lateral ventricles; b) Transverse post-contrast image at a similar level to a) - the mass 
enhances intensely and uniformly and has fairly distinct margins; distension of the third ventricle is evident.
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Case 13: No. 139848
Signalment: Rough collie, male entire, aged 8 years, weight 27 kg
Diagnosis: mass lesion forebrain located on the floor of the calvarium at the level of the 
thalamus and extending caudally into the midbrain region; meningioma.
History
The dog was presented with a twenty-four hour history of collapse and profound obtundation. 
Investigations prior to referral included routine haematology, routine biochemistry, and plain 
radiographs of the thorax, all of which were unremarkable. The dog had been treated with 
intravenous fluid-therapy and diazepam, in addition to antibiotic (amoxycillin-clavulanic acid) 
and corticosteroid (dexamethasone) injections, with no improvement.
Physical examination
On clinical and neurological examination the dog was severely obtunded, had proprioceptive 
deficits in all four limbs and mild papilloedema in both eyes. Based on these findings a 
forebrain and / or brainstem lesion was suspected. Intracranial neoplasia, vascular accidents, 
and inflammatory brain diseases were considered the most likely diagnoses.
Investigations and diagnosis
The standard protocol for investigation of intracranial diseases was performed. Prior to 
anaesthesia the patient was administered mannitol at the dose of I g/kg with the aim of 
reducing ICP.
The pre-contrast CT images of the brain and skull demonstrated the presence of an isodense to 
mildly hyperdense large mass on the floor of the calvarium in the region of the thalamus, 
which extended caudally as far as the midbrain. The mass was relatively broad-based and 
attached to the meninges. Mass effects consisting of enlarged left lateral ventricle, distorted 
and slightly enlarged right lateral ventricle, and enlarged and distorted third and fourth 
ventricles were detected on the plain scans (Figure 15a). Distortion of the ventricular system 
was detected from the level of the frontal cortex to the midbrain region in both transverse and 
sagittal images. An irregular pattern of enhancement occurred after injection of contrast agent 
(Figure 15b,c). A diagnosis of an intracranial space-occupying lesion was made. This mass
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was thought to be most likely neoplastic in nature; meningioma was the main differential 
diagnosis.
Management and outcome
Because of its location and size, the mass was considered unsuited to surgical excision and / or 
radiation therapy. As they were given a poor prognosis the owners eleeted for euthanasia.
Post mortem examination
Gross post mortem confirmed the presence of a mass on the ventral aspect of the brainstem at 
the level of the hippocampus. Histology identified the nature of the mass as a meningioma.
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Figure 15. Case 13, 139848. a) Transverse pre-contrast image at the level of the thalamus 
showing enlarged left lateral ventricle, distorted right lateral ventricle and enlarged and 
distorted third ventricle. A mildly hyperdense mass may be seen on the floor of the 
calvarium; b) Transverse post-contrast image at a similar level to a) - note the intense 
enhancement at the periphery of the mass;
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Figure 15 (Cont). Case 13, 139848. c) Transverse post-contrast image approximately at the 
level of the rostral aspect of the tentorium cerebelli - note the different pattern of 
enhancement from figure b).
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Case 14: No. 138568
Signalment: Bullmastiff, male entire, aged 2 years and 6 months, weight 37 kg 
Diagnosis: brainstem neoplasia; histopathology remains unclassified.
History
The dog was presented with a ten-day history of dysphagia, ataxia, vestibular signs and 
occasional head pressing. Prior to referral the dog had been diagnosed with bilateral otitis 
media / externa and started on systemic corticosteroids and antibiotic medication in 
conjunction with topical application of ears drops, with no improvement.
Physical examination
On physical and neurological examination the dog was found to be severely obtunded (Figure 
16a), weak and ataxic on all four limbs, with a left head tilt, intermittent positional nystagmus, 
ventrolateral strabismus of the left eye, absent gag reflex and depressed tongue movements. In 
addition, the dog occasionally circled to the left. There were increased chest sounds in the 
ventral lung fields and a mucopurulent nasal discharge. No evidence of otitis was detected.
The multiple cranial nerve deficits (VIII, IX, X and XII) along with the severe depression were 
consistent with a hindbrain lesion involving the pons and medulla oblongata; mental dullness 
may be observed as a consequence of disruption of the ascending reticular activating system. 
Inflammatory brain diseases, neoplasia and hypothyroidism were considered the main 
differential diagnosis.
Mental dullness, otitis externa, circling and vestibular signs are possible clinical manifestation 
of hypothyroidism in dogs. Certain primary brain tumours, such as medulloblastoma, choroid 
plexus papilloma and epidermoid cyst, as well as some inflammatory diseases, including 
distemper encephalitis and the disseminated form of GME, have a predilection for the 
pontomedullary area of the brain (Braund 1999). All the above, mentioned tumour types have 
been reported to occur in dogs younger than 5 years of age (LeCouteur 1999; Moore et al 
1996).
Investigations and provisional diagnosis
The standard protocol for investigation of intracranial diseases was performed.
106
Case reports
No abnormalities were detected on routine haematology and biochemistry except for increased 
hepatic enzymes considered secondary to the administration of prednisolone prior to referral 
(SAP 847 U/1, AST 51 U/1, ALT 161 U/1). T4 and TSH serum concentration was within 
normal limits.
A megaoesophagus was identified on plain radiographs of the chest along with a diffuse 
increased opacity of the lungfields consistent with aspiration pneumonia. No discrete masses 
were identified.
In both pre- and post-contrast CT images of the brain a mild, bilateral enlargement of the 
lateral ventricles was detected. CSF analysis was within normal limits, as well as Toxoplasma 
titres, Neospora and Distemper neutralisation dilutions. Myasthenia gravis might have 
accounted for clinical signs of weakness, megaoesophagus and cranial nerves IX, X and XII 
dysfunction. However, myasthenic animals are not ataxic and / or obtunded, and the condition 
was not further investigated. Thymoma, a possible cause of myasthenia gravis, was ruled out 
with the plain radiographs of the chest (Taylor 2000).
Management and outcome
During the period of hospitalisation the dog received parenteral fluid therapy (Compound 
sodium lactate intravenous infusion BP (Vet), Ivex Pharmaceuticals), intravenous antibiosis 
(40mg/kg/day amoxycillin/clavulanate; Augmentin Intravenous, Smith Kline Beecham) and 
was started on immuno-suppressive doses of corticosteroids (prednisolone 4 mg/kg/day) with 
no improvement.
The prognosis for recovery was considered grave and the owner elected for euthanasia.
Post mortem examination
Gross post mortem (Figure 16b) of the brain revealed a diffuse swelling affecting the medulla 
and the presence of a pale homogenous mass disrupting the normal brain architecture. 
Sectioning of the brain at the level of the optic chiasma confirmed the presence of 
hydrocephalus. Histopathological analysis has not, so far, definitively identified the tumour 
type, although, the cytological appearance was suggestive of a glial origin.
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Figure 16. Case 14, 138568. a) Photograph of the patient to show profound obtundation and 
weakness; b) gross post mortem appearance of the dorsal surface of the brain -  note the 
generalised swelling of the brain stem and the distortion of the fourth ventricle.
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Case 15: No. 139359
Signalment: Weimaraner, male entire, aged 10 years and 8 months, weight 40.5 kg
Diagnosis: mass lesion left hindbrain involving the caudal pole of the cerebellum and the 
brainstem.
History
The dog was presented with a four-month history of ataxia that had deteriorated over the 
previous few days. Two weeks before presentation to the Neurology Service the dog had been 
diagnosed with laryngeal paralysis by the UGVS Soft Tissue Surgery service. This was 
corrected with an arytenoid latéralisation procedure and the dog was recovering well. At that 
time plain radiographs of the chest revealed, in addition to aortic calcification and moderate 
bronchial mineralisation, the presence of a cavitating lesion in the periphery of the right 
middle lung lobe. The nature of this lesion was not established. Over the two weeks 
preceding referral the dog developed an intermittent right head tilt and occasionally was seen 
leaning to the right.
Physical examination
On examination the dog was found to have a mild, but persistent right head tilt, ataxia, mild 
proprioceptive deficits in all four limbs and an occasional ventral strabismus in both eyes. The 
reflexes in all four limbs and the function of the cranial nerves were within normal limits. 
These findings of vestibular disease with upper motor neuron signs in all four limbs were 
consistent with a lesion in either the caudal fossa or two lesions, one in the spinal cord (most 
probably C1-C5 segments) and a separate lesion in either the hindbrain or in the middle ear. 
For an intracranial localisation, primary and secondary neoplasia was considered the main 
differential diagnosis.
Investigations and diagnosis
The standard protocol for investigation of intracranial diseases was performed.
No abnormalities were detected on the pre-contrast study of the brain and skull (Figure 17a). 
On the post-contrast CT images a large, ovoid, intensely enhancing paraxial mass, was seen 
between the caudal pole of the cerebellum and the brainstem. The mass had well defined
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margins, extended predominantly left to the midline, and appeared to involve the 
cerebellopontine angle area (Figure 17b). Post-contrast dorsal images confirmed the location 
and extent of the mass (Figure 17c).
A diagnosis of an intracranial space-occupying lesion of the caudal fossa was made. The mass 
was thought to be most likely neoplastic in nature, and the main differential diagnoses 
included meningioma and choroid plexus papilloma; oligodendroglioma and astrocytoma were 
also considered in the differential diagnoses.
Management and outcome
The location and size of the mass excluded the possibility of surgical excision. The owner 
elected for palliative management and the dog was discharged on anti-inflammatory doses of 
prednisolone (1 mg/kg/day).
After starting steroid medication the dog improved markedly, becoming significantly less 
ataxic; the head tilt also improved. Three weeks after the dog had been diagnosed with 
intracranial neoplasia, two skin masses appeared, one located on the plantar surface of the left 
stifle and one on the right side of the prepuce. Fine needle-aspirate and smear examination 
showed these masses to be mast cell tumours. These masses had most likely arisen 
independently of the brain tumour; mast cell tumours do not commonly metastasise to the 
nervous system (Paterson 1998).
No further treatment was instigated as the dog was already on prednisolone, the use of which 
alone or in combination with other chemotherapeutic agents (Thamm et al 1999) is 
recommended for disseminated mast cell tumours. In addition the owner did not consider a 
viable option to start the dog on chemotherapy. The dog at the time of the diagnosis of the 
mast cell tumour was on 1 mg/kg/day of prednisolone, which almost equates to the 
chemotherapeutic dose for mast cell tumours (Thamm et al 1999)
During the following seven weeks the patient remained stable although the mast cell tumours 
became progressively larger. At this point the dog deteriorated acutely, was unable to stand 
and / or to walk, and developed haematuria with uncontrollable bleeding from the skin 
tumours. These symptoms were thought to relate to the mast cell tumours and not to 
intracranial neoplasia. At that point the dog was euthanased; no post mortem examination was 
performed.
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Figure 17. Case 15, 139359. a) Transverse pre-contrast image at the level of the rostral aspect of the tentorium 
cerebelli- note the absence of morphological abnormalities suggesting a mass; b) Post-contrast study at the level 
of the caudal fossa, showing the presence of a para-axial, mainly left sided, intensely enhancing mass involving 
both brainstem and cerebellum - note the involvement of the cerebellopontine angle;
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Figure 17 (Cont). Case 15,139359. c) Post-contrast dorsal and sagittal images highlighting the caudal fossa 
location of the mass.
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Case 16: No. 138763
Signalment: Boxer, female neutered, aged approximately 7 years, weight 23 kg 
Diagnosis: pituitary macroadenoma and acromegaly.
History
The dog was presented with a five to six month history of progressive weight loss in addition 
to vague endocrine and neurological abnormalities. The owner reported that progressive 
enlargement of the distal part of all four limbs had occurred in addition to the development of 
behaviour abnormalities consisting of lethargy, wandering, occasionally pacing, head pressing, 
and circling, the latter often compulsive in character. The history was also suggestive of mild 
polyuria / polydipsia (PUPD) and increased appetite.
Investigation prior to referral included routine haematology and biochemistry, thyroid function 
evaluation, urinalysis, radiology of the chest and abdomen, and abdomenal ultrasound, all of 
which were unremarkable except for mild increase in SAP, ALT and cholesterol.
Physical examination
On examination the dog was found to be thin, obtunded, and to have a strong tendency to 
circle to the right. The distal part of all four limbs was noticeably enlarged, although neither 
painful nor oedematous. This enlargement was more pronounced on the forelimbs and on 
palpation was thought to represent soft tissue enlargement (Figure 18a). Mild hypertrichosis 
was noted, especially on the hindquarters. The dog also had a broad face with prominent 
jowls, a protruding mandible, and increased interdental spacing (Figure 18a). Though these 
features were characteristic of the breed, in this case they were remarkable and the owner, 
when questioned, reported that they had become more evident over the last few months.
Based on these findings a tumour in the region of the pituitary gland was suspected. 
Hypertrichosis, enlargement of the head and extremities, increased soft tissue in the 
oropharyngeal area and PUPD are clinical signs reported in dogs with acromegaly (Feldman & 
Nelson 1996).
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Investigations and provisional diagnosis
Routine biochemistry analysis confirmed the mild abnormalities in SAP (243 U/1), ALT 
(121.00 U/1) and cholesterol (11.59) reported by the referring veterinary surgeon. These 
abnormalities are common findings in both hyperadrenocorticism and acromegaly, due to 
increased secretion of growth hormone. Thus an ACTH stimulation test was performed along 
with the measurement of basal IGF-I levels. The results of the ACTH stimulation test were 
unremarkable, whereas the increased levels of IGF-I substantiated a diagnosis of acromegaly 
(IGF-I> 1,000 nmol/1).
Plain radiographs of the skull identified a slightly thickened calvarium; however, the degree of 
thickening was considered unremarkable in a dog of this breed. Survey radiographs of the 
distal part of the forelimbs identified that the enlargement was due to development of the soft 
tissues.
The pre-contrast CT images of the brain and skull demonstrated the presence of a singular, 
large, ovoid, hyperdense mass at the level of the pituitary fossa. The mass was located on the 
midline and extended dorsally beyond the sella turcica into the thalamic / hypothalamic area. 
The mass had distinct and smooth margins and was associated with enlargement of both lateral 
ventricles (Figure 18b). On the post-contrast study the mass enhanced intensely and uniformly 
(Figure 18c).
A diagnosis of intracranial neoplasia was made. In conjunction with clinical signs of 
acromegaly and diencephalic syndrome it was thought the mass was likely to represent an 
endocrinologically active pituitary macroadenoma, arising from the somatotropic cells. 
Acromegaly as the result of a pituitary tumour has not previously been reported in the dog 
(Heritage 1998a,b). As meningioma in the hypophyseal fossa mimicking the clinical and CT 
features of pituitary macroadenomas has been described, meningioma was considered in the 
differential diagnosis, though this would not give an increase in IGF-I.
Management and outcome
The owner elected for palliative management, and the dog was discharged on anti­
inflammatory doses of prednisolone (1 mg/kg/day).
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After starting steroid medication the demeanour of the dog and the neurological signs 
improved; the referring veterinary surgeon reported that the behavioural abnormalities were 
still present but less severe than when the dog was first presented to UGVS. The dog 
remained stable for the nine months following assessment at UGVS, except for a transient 
deterioration of behaviour, which occurred approximately 30 weeks after assessment. Nine 
months after assessment at UGVS a mild recrudescence of neurological abnormalities 
occurred, with the dog becoming lethargic and occasionally pacing and head pressing. The 
dog was euthanased approximately nine weeks later because of further deterioration of 
neurological status in addition to the development of severe dermatitis, which was 
unresponsive to antibacterial therapy. During the 11 months following assessment at UGVS, 
the dog had been kept on an unchanged prednisolone dosage regimen. No post mortem 
examination was performed.
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Figure 18. Case 16, 138763. a) Note the broad face and enlargement of the forelimbs; b) Transverse pre­
contrast image at the level of the pituitary gland showing the presence of a hyperdense large, ovoid-shaped, 
midline located mass at the level of the pituitary fossa - note dorsal extension into the thalamic / hypothalamic 
area and dilation of both lateral ventricles;
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Figure 18 (Cont). Case 16, 138763. c) Transverse post-contrast image at the same level as c) showing the 
intense and uniform enhancement.
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Summary of case reports
The aim of this dissertation is to emphasise the need for a systematic diagnostic approach to 
intracranial disease, with particular regard to the investigation of seizure disorders, which may 
occur in association with intracranial neoplasia.
The cases presented here highlight the wide variety of clinical presentations associated with 
brain tumours and illustrate the features of signalment, history and physical examination that 
are useful in making the clinician suspicious that a brain tumour may be present.
Cases useful in highlighting exceptions from the general guidelines have also been included 
(cases 7, 8, and 10). Cases have been grouped according to the presenting complaint into four 
categories: a) animals in which seizure activity was part of the presenting complaint (cases 1 
to 10); b) dogs in which seizures were not part of the admitting complaint but whose history 
and physical examination findings localised the lesion to the forebrain and / or were suggestive 
of a multifocal / diffuse lesion with forebrain involvement (cases 11, 12 and 13); c) dogs with 
brainstem signs (cases 14 and 15); and d) dogs with hypothalamic syndrome (case 16).
The investigative protocol in all cases concentrated, initially on assessing potential extracranial 
causes for the signs of intracranial dysfunction observed. Additional investigations were 
undertaken as thought appropriate. These included canine distemper virus, Toxoplasma and 
Neospora caninum status, serum lead and phenobarbitone levels, endocrinological function 
tests, urinalysis and plain radiographs. In some cases, economical restrictions had to be taken 
into consideration in planning the diagnostic work-up.
All cases involved underwent a CT evaluation of the brain and skull. CSF analysis was only 
performed if felt to be essential for diagnosis in cases with CT evidence of a mass lesion or 
overt clinical signs of raised ICP.
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Discussion
Seizures are the reflection of a state of increased neuronal excitability and / or synchronisation 
(Heinemann & Eder 1997; March 1998). Increased neuronal excitability and / or 
synchronisation may occur in association with a wide spectrum of conditions capable of 
disrupting, temporarily and / or permanently, normal cerebrocortical function. A detailed 
history and a carefully conducted physical and neurological examination are fundamental to 
rationally elaborate a list of differential diagnoses, and hence planning the diagnostic work-up 
accordingly.
Lesion localisation 
Signs of forebrain disease
Though not indicative of a specific aetiology seizures, by definition, always localise the lesion 
to the forebrain if toxic and metabolic causes can be ruled out (Kraus & McDonnell 1996). 
Animals with forebrain lesions, which have the potential to promote seizures activity, can also 
manifest other neurological deficits indicative of forebrain dysfunction (Bagley et al 1999a). 
Close observation and evaluation of consciousness, behaviour, posture of head, trunk and 
limbs, as well as gait, are necessary (Schwartz-Porsche 1999). This is the reason why all cases 
presented for evaluation of seizure disorders, undergo a neurological examination as detailed 
as that reported in Figure 3 (page 44) and Figure 4 (page 45).
Seizures in animals that exhibit interictal neurological deficits are indicative of an underlying, 
structural brain disease (symptomatic epilepsy) (March 1998). However, in two (cases 1 and 
3) of the eight cases (cases 1-8) reviewed here for which a structural brain abnormality was 
identified (seven space-occupying lesion and one case of hydrocephalus-IAC) the history and 
physical examination findings did not suggest / detect interictal neurological abnormalities 
(Tab 21, page 133). This observation suggests that whereas animals with interictal 
abnormalities always have a structural brain disease, a normal interictal period does not rule 
out that a structural brain disease is the cause of the observed seizure activity.
Primary idiopathic epilepsy is thought to be the result of multifocal or diffuse unrecognised 
morphological and / or functional abnormalities of the cerebral cortex (March 1998;
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Discussion
Westbrook 2000). Diagnosis of idiopathic epilepsy is reached via exclusion of other possible 
extracranial and intracranial causes of seizures. Lack of interictal abnormalities and typical 
age at onset are the two clinical features most useful in making the clinician consider IE as a 
possible diagnosis (Knowles 1998). In the two cases of idiopathic epilepsy included in this 
series (cases 9 and 10) neither showed interictal neurological abnormalities (Tab 21, page 
133). As I have described above the lack of interictal abnormalities does not rule out 
symptomatic epilepsy and such findings must be put in the context of other features of the 
case.
Although seizures are one of the most common clinical signs in animals with forebrain disease 
(Braund 1999), all pathologic processes capable of resulting in seizure activity may also occur 
without being accompanied by seizures. Thus, neurological deficits indicative of forebrain 
dysfunction other than seizures may be the only clinical signs detectable in patients with 
intracranial disease (e.g., case 12).
Deranged mental status and behavioural changes as a indicator o f forebrain disease
Animals with forebrain disease frequently manifest mental status and / or behavioural changes 
such as: apathy, disorientation, obtundation, stupor, failure to recognise the owner and familiar 
people, lack of recognition of environment, loss of trained habits and, occasionally 
hyperexcitability or aggression. Abnormal propulsive movements such as pacing, circling 
(usually toward the side of the lesion) and head pressing are also common (Braund 1999; de 
Lahunta 2000a).
Changes in mental status and / or behaviour are likely to be in the history. Conversely, these 
abnormalities are often not recognised / detected by the veterinary surgeon during 
examination. In six (cases 4, 6, 11-13 and 16) of the nine cases (2, 4-6, 8, 11-13, and 16) 
exhibiting derangement of mental status / behavioural changes as part of the presenting 
complaint, which had a diagnosis of a structural lesion affecting the forebrain, such changes 
could be detected at the time of examination. In three other cases with structural brain disease 
(cases 2, 5 and 8) neurological examination was unremarkable. This emphases the need in all 
cases of suspected intracranial disease, for careful questioning the client regarding behaviour 
and personality (see History and physical examination, page 40). This is particularly true for 
brain tumour patients, which often suffer a slow progression (over months) of early, non-
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specific signs such as dulling of personality. These signs are commonly initially attributed to 
“old age” and may not be recognised by both owners and veterinary surgeons (Dewey et al
2000). Between the six cases above mentioned with forebrain disease and detectable mental 
status / behavioural change at the time of presentation, a more severe obtundation was 
observed in patients with extensive involvement of the thalamic and midbrain regions (cases 6, 
12 and 13). The thalamus and midbrain contribute to the reticular activating system (RAS). 
The function of the RAS is to diffusely alert the entire cerebral cortex; lesions of each of its 
components may result in stupor and coma (Chrisman 1990).
Proprioceptive deficits and gait abnormalities
Proprioception depends on the successful integration and performance of many components of 
the CNS and PNS. Postural reactions are frequently abnormal in animals with brain disease. 
They may occur in combination with cranial nerve deficits, especially with brainstem lesions 
caudal to the midbrain, or may be the only sign of intracranial disease. The finding of postural 
reaction deficits in combination with cranial nerve dysfunction is especially significant, since 
it provides evidence that a lesion lies within the CNS, rather than the PNS (Jeffery 2001).
Abnormalities in the gait are often apparent in animals that have lesions in the spinal cord or 
parts of the brain caudal to the midbrain; the induced deficit is ipsilateral to the lesion (Jeffery
2001). Gait abnormalities, if present, consist of sensory (general proprioceptive) ataxia 
accompanied by UMN hemi/ or tetraparesis depending upon location and extension of the 
lesion; patients adduct / abduct the limbs while walking and occasionally “knuckle”. A 
delayed onset (long stride) and prolonged protraction of limbs movements is noticed (de 
Lahunta 2000a). Conversely, forebrain lesions will often cause no deficits in the gait 
(although there may be abnormalities in control of the direction that the dog walks), but there 
are frequently deficits in postural reactions controlateral to the lesion (Braund 1999; Dewey at 
al 2000; Jeffery 2001). Animals with unilateral thalamic or cerebral cortical disease usually 
exhibit contralateral postural deficits, whereas in animals with multifocal or diffuse thalamic 
and cerebral cortex lesions postural reaction deficits may be present in all four limbs 
(Chrisman 1990; de Lahunta 2000a).
Careful evaluation of the postural reactions and spinal reflexes in patients with depressed 
postural reactions is important in differentiating between intracranial and spinal cord disease
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(Braund 1999; de Lahunta 2000a). Results of muscle tone and muscle bulk evaluation 
contribute to further substantiate a postural deficit that is UMN in origin. The neurological 
deficits in limb coordination associated with disease in the rostral spinal cord (C1-C5) may be 
very similar to those found in association with intracranial disease affecting structures caudal 
to the midbrain (e.g., case 15). This emphasises the need for carefully examining of cranial 
structures whenever disease in the rostral spinal cord is suspected (Braund 1999; Dewey 2000; 
Jeffery 2001).
Cranial nerve deficits arising from forebrain dysfunction
Impairment of vision (e.g., bumping into objects, depressed menace response) on the 
contralateral side may be seen with lesions of the occipital cortex (cortical blindness); in this 
circumstance pupil size and pupillary light reflexes are normal (Braund 1999; de Lahunta 
2000a). Vision is frequently impaired if the lesion extends to involve the optic chiasma, optic 
tract and the lateral geniculate nuclei. Whereas in case 16 only visual deficits were observed, 
with lesions involving the optic chiasma pupils may be dilated and weakly or not responsive to 
light stimulation (Braund 1999). Ocular and optic nerve lesions may also results in PLR 
deficits, but the lesion has to be extremely severe (de Lahunta 2000a). Acute vision loss may 
be the only or the predominant neurological deficit with tumours affecting the optic chiasma 
region (Davidson et al 1991). Lesions of the somatosensory cortex and / or thalamus may also 
result in contralateral facial hypoalgesia (Braund 1999; de Lahunta 2000a; Jeffery 2001). 
Anosmia / hyposmia may occur with forebrain lesions affecting the second or higher order 
neurons of the olfactory system (King 1987; Myers at al 1988). Cranial nerves deficits other 
than those above reported are not a feature of forebrain disease. Evaluation of cranial nerves 
reflex function is therefore essential in lesion localisation.
Signs offorebrain dysfunction and pituitary tumours
Signs of forebrain dysfunction, primarily consisting of behaviour and / or mental status 
changes may be associated with a pituitary tumour. In most cases patients with pituitary 
neoplasia develop clinical signs of endocrine dysfunction (most commonly 
hyperadrenocorticism and / or diabetes insipidus) prior to the onset of signs of CNS 
dysfunction (Sarfaty et al 1988; Nafe 1990). However, as many canine pituitary tumours are 
non-functional, neurological abnormalities may be the only clinical signs manifested by the
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patients (Davidson et al 1991; Kipperman et al 1992). In case 16, progression of signs of 
adversive syndrome (deLahunta 2000b) in a patient with a relatively long-term (five to six 
months) history of vague endocrine and neurological abnormalities was suggestive that a 
pituitary macroadenoma might have been causative. In this case serum IGF-I concentrations 
were only marginally elevated and the time elapsed might not have been sufficient for the 
development of more severe clinical abnormalities secondary to the endocrine dysfunction 
(Feldman & Nelson 1996).
Pituitary tumours in dogs tend to expand dorsally causing compression of and encroaching on 
the diencephalic structures (Nafe 1990). The extent and severity of the diencephalic 
involvement correlate to the severity of the behavioural / mental status changes (Bertoy et al 
1996; Sarfaty et al 1988). Visual impairment is rare; however, deficits in the optic nerve at the 
level of the optic chiasma including dilated, poorly responsive pupils and visual impairment 
may occur (Braund 1999). Seizures have been reported in association with pituitary tumours, 
but are rare (Sarfaty et al 1988; Bagley & Gavin 1998).
Signs of brainstem disease
Although seizures are a specific sign of forebrain dysfunction, seizure activity and / or other 
neurological abnormalities localising the lesion to the rostrotentorial structures may occur as 
result of multifocal and / or diffuse intracranial disease. In these circumstances, neurological 
deficits suggestive of brainstem, less commonly cerebellar involvement, may be seen. In cases 
11 and 13 the historical picture and physical examination findings were consistent with a 
forebrain lesion but also exhibited abnormalities consistent with disease of the caudal fossa.
In addition, neurological deficits arising from brainstem / cerebellar impairment may be the 
only clinical signs detectable in patients with multifocal / diffuse intracranial disease also 
involving the forebrain. Not all forebrain lesions result in detectable neurological 
abnormalities (Foster et al 1988) (see Silent areas of the cerebral cortex, page 145).
Dysfunction of one or more cranial nerves (other than cranial nerves I and II) in an animal 
with obvious gait and proprioceptive abnormalities and / or altered mental status (often 
severely), localise the lesion to the brainstem and, sometimes, to specific areas within the 
brainstem (case 14). Signs of vestibulocochlear nerve dysfunction localise the lesion to the 
brainstem only if neurological examination findings rule out a peripheral lesion (Braund 1999;
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Kraus & McDonnell 1996). Clinical signs related to cranial nerve nuclei include jaw paralysis, 
masticatory muscle atrophy, facial paralysis, depressed comeal / palpebral reflex and menace 
response, strabismus, altered pupillary light reflexes, pharyngeal paralysis resulting in 
dysphagia and diminished gag reflex, dysphonia and inspiratory distress from laryngeal 
paralysis, tongue paralysis and signs of central vestibular disease (Braund 1999). Cranial 
nerve deficits may be mono- or bilateral depending upon extension of the lesion. Detection of 
multiple cranial nerve deficits in an animal with postural reactions deficits ipsilateral to cranial 
nerve involvement, and intact spinal reflex function, suggests a brainstem lesion (Kraus & 
McDonnell 1996).
Dogs with brainstem tumours frequently are presented with vestibular signs, such as ataxia and 
head tilt, but signs commonly useful in differentiating central from peripheral vestibular 
disease (positional / vertical and / or variable nystagmus and conscious proprioceptive deficits 
in the limbs) are not consistently detected. Nevertheless, peripheral disease should never 
cause changes in animal’s state of consciousness. It would seem justified that dogs older than 
5 years of age with vestibular signs of unknown cause be evaluated with advanced imaging 
techniques to exclude intracranial space-occupying lesions (Harrington et al 1995; Kraus & 
McDonnell 1996; Bagley 1999; Bagley et al 1999a).
Signs of cerebellar disease
Whereas both forebrain and brainstem lesions may result in disturbances of the sensorium of 
the animal and cranial nerves dysfunction, in general, this is not tme for cerebellar disease 
(Jeffery 2001). Signs of cerebellar dysfunction include dysmetria (usually hypermetria), head 
or body intention tremors, a broad-based stance at rest, and truncal ataxia. There may be a 
delay in initiation of movements that are often accompanied by tremors. There may be 
menace deficits with normal vision (Braund 1999). However, pure cerebellar signs are rarely 
encountered (e.g., cerebellar malformation, white hair shaking syndrome).
Paradoxical vestibular disease and neurological signs associated with cerebellopontine angle 
lesions
Cerebellar lesions that affect the vestibular pathway in the flocculonodular lobes and / or the 
caudal cerebellar peduncles may cause paradoxical vestibular syndrome. In this syndrome the 
head and body tilt are toward the side opposite the lesion. Usually the general proprioceptive
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system afferent to the cerebellum is involved as well. This produces a mild ipsilateral ataxia 
and a postural reaction deficit, on the same side as the lesion. There is an associated 
nystagmus with the fast phase toward the lesion (Adamo & Clinkscales 1991; Braund 1999). 
Mass lesions are the most common cause of paradoxical vestibular diseases. Neoplasia, 
especially choroid plexus tumours and meningiomas, and the focal form of GME are the main 
differential diagnoses for lesions at this site (Adamo & Clinkscales 1991; Braund 1999).
When the cerebellopontine angle is involved, the clinical signs observed include ipsilateral 
head tilt, asymmetrical tetraparesis, positional nystagmus, and facial and trigeminal nerve 
palsies. Lesions of the cerebellopontine angle may also result in the above, mentioned 
paradoxical vestibular syndrome (Nafe 1990). For space-occupying lesions affecting the 
cerebellopontine angle, neoplasia is the most likely diagnosis. The differential diagnoses for 
tumours arising in this location include choroid plexus tumours, neurofibromas (most 
commonly affecting the VIIT^ cranial nerve), meningiomas and occasionally ependymomas or 
glial tumours as well as GME. Vestibular disease and facial paresis have been reported with 
meningioma of the cerebellopontine angle (Fischer 1994). In case 7, in which CT study 
revealed a hindbrain space-occupying lesion that involved the right cerebellopontine angle, 
post mortem examination demonstrated this lesion to be a choroid plexus papilloma.
Diagnostic approach to seizure disorders
The ultimate goal of the diagnostic evaluation of seizure disorders is to identify the cause of 
the seizure activity. Only then a reliable prognosis may be given and a rational treatment plan 
instituted (Schwartz-Porsche 1999). Reactive seizures carry the possibility of being eliminated 
if the underlying cause is detected and corrected (Cuddon 1996; O’Brien 1998). Idiopathic 
epilepsy generally carries a better prognosis than symptomatic epilepsy due to progressive and 
active brain disease; however in large-breeds of dogs seizures are usually more severe and 
difficult to control with anticonvulsants than in small-breeds of dogs (Shell 1993b).
The first step in the diagnostic approach to seizure disorders is to ascertain that seizure activity 
has occurred.
Seizure-like paroxysmal events associated with a transient alteration in neurological function 
may represent a diagnostic problem. The only diagnostic test, which distinguishes definitively 
between seizures and seizure-like paroxysmal disorders, is the EEG recording at the time of
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the episode. The practical difficulties in achieving this means that such tests are not 
undertaken in veterinary clinical work. Additionally, difficulties related to both the recording 
and interpretation of interictal EEGs in dogs has resulted in a low take up of this technique in 
the veterinary world (Srenk & Jaggy 1996; Holliday & Williams 1998; Jaggy & Bemardini 
1998)
Therefore careful history taking remains the comer stone in the identification of seizures in 
most dogs. In practically all instances, dogs with seizure-like paroxysmal events do not 
exhibit post-ictal effects. Possible exceptions are dogs that exhibit autonomic release 
phenomena after a syncopal episode and dogs with vestibular disease that continue to appear 
disorientated from their vertigo. Tab 22 (page 142) summarises the major historical and 
physical examinations findings used to distinguish seizures from seizure-like paroxysmal 
events.
History
The history is the cornerstone of the diagnostic approach to seizure disorders.
Signalment
The breed and age are of aetiological significance. Developmental and congenital brain 
diseases may present with seizures -  e.g., the congenital hydrocephalus of certain miniature 
breeds such as Maltese, Chihuahuas and Yorkshire terrier (Harrington et al 1996; Podell 1996; 
Thomas 1999)^ This is also true for dogs of brachycephalic breeds which, with increasing 
age, show a disposition for brain tumours and, therefore, for epileptic seizures (Podell 1996). 
Miniature schnauzers can suffer from a massive, genetically caused hyperlipidaemia, which 
can cause seizures (Schwartz-Porsche 1999). Age-dependence can signify both extracerebral 
and cerebral causes of seizures. For example, in puppies and young animals, especially from 
miniature and toy breeds, hypoglycaemia is caused by anorexia and gastrointestinal 
disturbances, but rarely by storage diseases (Schwartz-Porsche 1999). In dogs older than five 
years the cause is often an insulinoma (Podell 1996).
Age-dependence is evident in idiopathic epilepsy in that it generally manifests itself between 
the ages of six months and five years. Related dogs with epilepsy, an increasing number of
A causative relation between hydrocephalus and seizures has not been definitely proved.
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epileptics in the breeding-line or in the breed itself confirm or suggest a hereditary origin. 
(Knowles 1998).
Seizure history
Clients’ observations are fundamental in defining seizure type and pattern. Historical details 
that we found to be useful in patients with seizures have been reported in the section case 
assessment protocols -  History and physical examination (page 40).
However, many dogs are unobserved for long period of time and many owners do not 
accurately know the number of unobserved seizures, or they genuinely may never have 
observed their dog to seizure. In this case the suspicion of seizure activity may arise from the 
clients’ observations regarding changes in behaviour and / or attitude, and or patterns of 
elimination in previously housetrained individuals. For example in case 4 the recent 
development of lethargy and attention seeking in a dog, which in one occasion had been found 
lying in lateral recumbency and completely disorientated in the garage, were the historical 
details which suggested the possibility of seizure activity.
Historical findings and idiopathic epilepsy
Idiopathic epilepsy usually begins with a single generalised tonic-clonic seizure and the initial 
interictal periods can extend for weeks or months (Podell 1996). In most cases the frequency 
of seizures gradually increases, although this can vary widely between individuals (Schwartz- 
Porsche 1999). However, although generalised tonic-clonic seizures are the most common 
seizure type in dogs with idiopathic epilepsy, simple or complex partial seizures or partial 
seizure with secondary generalisation also occur, and some individuals have more than one 
type of seizure (Heynold et al 1997; Jaggy et al 1998; Knowles 1998; Thomas 2000). In case 
9, seizure type (isolated, generalised, tonic-clonic), seizure frequency (one episode every 3-4 
weeks), and the absence of interictal neurological abnormalities (see forward) were highly 
suggestive of idiopathic epilepsy in an individual with a supportive signalment.
Historical findings and symptomatic epilepsy
Symptomatic epilepsy should be suspected when: a) seizures start before 1 or after 5 years of 
age (see forward); b) the patient suffers partial seizures or partial seizures with secondary 
generalisation, or when the first seizure had been a focal seizure; c) there is a sudden onset of
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multiple seizures; and / or d) interictal abnormalities are detected on history, examination, or 
laboratory tests (Podell et al 1995; Podell 1996; March 1998; Thomas 2000).
Table 22. Clinical features of the most common seizure-like paroxysmal disorders in dogs
Syncope Often associated with exercise or excitement 
(may be induced by changes in posture)
Partial or complete loss of consciousness 
Lack of violent motor activity 
Short duration and rapid recovery 
Lack of postictal signs
Presence of underlying cardiac (cardiac arrhythmias) or respiratory disease
Narcolepsy / Cataplexy Attacks often induced by excitement or feeding 
attacks reversed by external stimulation 
Flaccid paralysis and loss of consciousness 
Lack of postictal and autonomic signs
Myasthenia gravis Precipitated by exercise; often gradual onset and gradual recovery 
stiffness, tremors, weakness 
No impairment of consciousness 
Lack of postictal signs
Vestibular dysfunction Nystagmus, head tilt, ataxia with prolonged duration of signs (days) 
Usually no impairment of consciousness 
Lack of postictal signs
Sleep disorder Occurs only during sleep 
attacks can be interrupted by awakening 
Abnormal movements during sleep (twitching, vocalisation, paddling) 
Lack of postictal and autonomic signs
Obsessive compulsive behaviour Stereotypic pattern of abnormal behaviour 
prolonged duration of signs (hours, days) 
Event can usually be interrupted 
Normal consciousness 
Lack of postictal signs
Scotty cramp Breed specific 
Exercise or stress-induced 
Lack of postictal signs
Canine distemper myoclonus Continuous abnormal movements
No impairment of consciousness (if disease inactive)
Lack of postictal or autonomic signs
Tremor disorders
Parker 1990; Spéciale & Dayrell-Hart 1
Often exacerbated by exercise or excitement 
prolonged duration of signs 
Usually no impairment of consciousness 
Lack of postictal signs
396; Knowles 1998; Thomas 2000
Clinically it is essential to distinguish between progressive and non-progressive brain disease 
because this influences both treatment options and prognosis (Schwartz-Porsche 1999). The 
presence of active structural brain disease is suggested by a short first interictal period (Podell 
et al 1995), a rapid increase in seizure frequency (LeCouteur 1995) and changes in seizure type 
and duration of the events (Schwartz-Porsche 1999). Conversely, the longer the duration of 
the period during which the patient has had seizures without any other abnormalities, the less 
likely an underlying progressive brain disease is present (Thomas 1998).
In cases of progressive brain disease the seizures frequently manifest themselves as cluster 
seizures or as status epilepticus (Schwartz-Porsche 1999). In cases 2 and 3 the dramatic
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increase of seizure frequency over a short period of time (approximately two weeks) and the 
development of cluster seizures were highly suggestive of a progressive brain disease. In case 
5, a progressive structural brain disease was considered likely to be the cause of the seizure 
activity, despite an interictal period of three months, because of the development of cluster 
seizures in an elderly patient and the appearance, shortly prior to referral, of behavioural 
changes. A progressive morphological brain disease was thought to be most likely the cause 
of the seizures also in case 10, but in this case all diagnostic testing was unremarkable leading 
to a diagnosis of idiopathic epilepsy. Despite the age at onset for idiopathic epilepsy clusters 
between six months and 5 years, reports in the veterinary literature suggests that it may 
develop in dogs younger than six months as well as older than ten years of age (Knowles 
1998). However, the intrinsic limits of the neurodiagnostic investigative techniques currently 
available may not allow in some cases a confident diagnosis of idiopathic epilepsy. In case 10, 
signalment and history were highly suggestive of a progressive structural brain disease. In 
such a case, despite the results of all the diagnostic investigations performed being 
unremarkable, the clinician may still suspect that an underlying undetected morphological 
brain disease is present and he / she might consider a diagnosis of cryptogenic epilepsy more 
appropriate than a diagnosis of idiopathic epilepsy (Berendt & Gram 1999; Thomas 2000).
Inflammatory, degenerative and neoplastic brain diseases are typical examples of progressive 
brain disease. Inflammatory brain disease should be strongly suspected in any patient with 
neurological deficits referable to multifocal lesions, and with persistent neurological deficits in 
addition to seizures, or evidence of systemic illness (Koblik 1995; Thomas 1998). Moreover, 
inflammatory disorders should be considered in any dog with a very short duration (less than 
several weeks) of seizures even in the absence of other abnormalities, because seizures may be 
the preliminary sign of a progressive inflammatory disease (Tipold 1995; Thomas 1998) (e.g., 
case 3). However, inflammatory brain diseases may not result in seizures and thus they should 
be suspected whenever progressive deterioration of neurological deficits is observed (e.g., 
cases 11,12 and 14).
Historical findings and reactive seizures
Although in seizure disorders of extracerebral aetiology the seizure event can vary greatly, 
there are some features that tend to be consistent. As extracranial causes of seizures affect the 
brain symmetrically, most reactive seizures are generalised, tonic-clonic in character. Toxicity
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is usually characterised by sudden onset of cluster seizures or status epilepticus in previously 
healthy animals, whereas, in most cases by the time metabolic diseases produces seizures, 
historical, physical, and laboratory findings are highly suggestive of the underlying disease 
(O’Brien 1998). However, even dogs with idiopathic epilepsy may be presented to a 
veterinarian for their first seizure in status epilepticus whilst dogs with intracranial neoplasia 
may only present after a mild, complex, partial seizure (Podell 1996).
Other historical details
Association of the seizures with specific activity (e.g., feeding, exercise) and / or time of the 
day are of diagnostic importance. In idiopathic epilepsy many seizures occur while the animal 
is sleeping or resting, and usually when it is at home. This association is less frequent in 
symptomatic epilepsy, and it is usually absent with seizures resulting from progressive brain 
disease (Shell 1993b). Pre- and post-prandial seizures may be an indication of metabolic 
disorder, especially hepatic encephalopathy and hypoglycaemia resulting from insulinoma. 
Seizures that occur on excitement or physical exertion may also be hypoglycaemic in origin, 
but they can also point to cardiac causes (Podell 1996; Schwartz-Porsche 1999). In none of 
the clinical cases presented in this dissertation did seizure activity appeare to be correlated to 
specific circumstances.
Interictal neurological abnormalities
While many dogs have seizures where a morphologic or metabolic cause is not found 
(idiopathic epilepsy) in patients with structural brain disease seizures are an expression of this 
and thus, such patients are more likely to develop interictal neurological abnormalities (Bagley 
& Gavin 1998). Whereas the presence of interictal neurological abnormalities is always 
indicative of an underlying structural brain disease, a normal interictal neurological 
examination does not exclude the possibility that a structural brain abnormality is the cause of 
the observed seizure activity. Idiopathic epilepsy, reactive seizures as well as structural 
lesions affecting the so-called “quite” areas of the cerebral cortex (see Silent areas of the 
cerebral cortex, page 145) are often characterised by a normal interictal neurological 
examination (de Lahunta 2000a).
Particular care must be taken when examining dogs during the immediate postictal period as 
neurological impairment may simply be a manifestation of transient ictal or postictal
144
Discussion
disturbances and thus not the result of a permanent structural damage. Repeated neurological 
examinations of postictal animals in 24 to 48 hours are needed to determine whether the 
deficits remain consistent (Nafe 1990; Knowles 1998). Case 2 at the time of presentation to 
UGVS did not have any overt neurological deficits; the profound neurological abnormalities 
observed by the referring veterinary surgeon probably reflected transient postictal disturbances 
in cerebrocortical function.
Silent areas of the cerebral cortex
Seizure activity is a frequent clinical manifestation of intracranial neoplasia in the canine 
species. Although, in many cases by the time owners seek the attention of a veterinary 
surgeon overt motor and / or sensory neurological deficits are detectable, seizures may be the 
only clinical manifestation of an intracranial neoplasm. This is especially true for lesions 
affecting the rostral cerebrum (Foster et al 1988; Nafe 1990). The presence in the rostral 
cerebrum of the “silent / quiet” areas of the brain is likely to contribute to this trend (Munana 
& Luttgen 1998).
“Silent / quiet areas” of the cerebral cortex represent regions which can be stimulated 
mechanically, chemically, or electrically without producing an obvious motor or sensory 
response. These areas are also referred to as the association cortex. They are not involved in 
processing sensory and motor information per se but the integration of more than one sensory 
modality may take place (Hogg 1987; Chrisman 1990). The frontal and prefrontal areas of the 
human cerebral cortex are specifically involved with cognitive behaviour, motor planning, 
thought, and perception. The frontal lobes may allow humans to weigh the consequences of 
future actions and plan accordingly. Disease within these areas frequently produces vague 
symptoms of transient personality disturbances, temperament changes, memory loss, or 
convulsions. As disease progresses additional symptoms consistent with motor or sensory 
dysfunction, or both, develop. This observation has been attributed to spread of involvement 
to “non-silent” areas of the brain (Saper et al 2000).
Although the association area is much smaller in dogs than in man, and dysfunction in such 
areas is difficult to evaluate in dogs, a parallel between neoplasia in man and animals may be 
reasonably made. In domestic animals, the association cortex consists of the cognitive 
association area of the parietal and occipital lobes, the interpretative association area of the
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temporal lobe, and the premotor association area of the frontal lobe (Hogg 1987; Chrisman 
1990).
In the dog, experimentally produced lesions of the frontal lobes have been reported to cause no 
signs, seizures alone, or behavioural changes such as uncontrolled rage or apathy. Frontal 
lobotomy may result in reduced proficiency in tests requiring memory. In this study, 
integrative frontoparietal function (vision, intellect, proprioception, movement initiation, and 
sensation) was initially unimpaired in most dogs. Seizures or behavioural abnormalities, or 
both, preceded detectable abnormalities in the neurological examination. This is consistent 
with the natural progression of disease in dogs: rapid deterioration of neurological status 
follows development of persistent neurological deficits (Foster et al 1988; Bagley & Gavin 
1998; Bagley 1999).
Lesions of the olfactory lobe and rostral portion of the frontal lobe are more commonly 
associated with seizure activity and normal interictal neurological function (Patnaik et al 1986; 
Foster et al 1988; Patnaik 1989; Smith et al 1989; Moore et al 1991; Voges & Ackerman
1995). Nasal / paranasal tumours that invade the brain causing CNS dysfunction with minimal 
or no signs of nasal cavity involvement (e.g., swelling at the site of origin of the neoplasm, 
epistaxis, etc) can represent a diagnostic challenge (e.g., case 2) (Sackman et al 1989; Thrall et 
al 1989; Park et al 1992).
Epidemiological issues
In the canine species symptomatic epilepsy is said to be less common than idiopathic epilepsy 
but objective data is not available. Idiopathic epilepsy is a clinical diagnosis based on the 
typical age at onset, lack of interictal abnormalities and exclusion of other causes (Knowles 
1998; Thomas 2000). Idiopathic epilepsy is statistically more probable when the dog 
experiences its first seizure between 1 and 5 years of age. Conversely, symptomatic epilepsy 
is more likely in dogs that have their first seizure at less than 1 or greater than 5 years of age, 
have an initial interictal period less than 4 weeks, or have a partial seizure as the first observed 
seizure (Podell et al 1995). Overall, dogs older than 7 years have the highest prevalence of 
symptomatic epilepsy, with primary intracranial neoplasia as the most common diagnosis 
(Podell et al 1995). However, more recent reports suggest that despite brain tumours being the
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most frequent cause of late-onset seizures in the geriatric dog, they should be considered in the 
differential diagnosis for dogs that start seizuring from 5 years of age (Bagley et al 1999a).
In dogs younger than 1 year of age, congenital / development brain diseases (e.g., 
lissencephaly, hydrocephalus), inflammatory and degenerative diseases (e.g., storage diseases) 
are the most common cause of seizures. However, a significant proportion of dogs between 1 
and 5 years of age can also suffer from a congenital brain disorder that may be progressive in 
nature, such as storage disease and hydrocephalus (Podell 1996).
All the above considerations indicate that in dogs presented for the evaluation of seizure 
disorders, signalment, history and initial physical and neurological examination findings 
provide essential information for the rational planning of the diagnostic approach.
Diagnostic evaluation
A  minimum database should be collected for all dogs including a complete blood count, serum 
chemistry profile, and urinalysis though these tests have in themselves a low yield of a 
positive diagnosis for seizures (Podell 1996). However, in conjunction with a thorough 
physical examination the results of these tests allow the clinician to confidently rule out, or 
conversely diagnose, most causes of extracerebral seizure disorders (Podell 1996). Additional 
metabolic and / or endocrinological diagnostic testing, plasma lead concentration, and specific 
serum antibody titres for infectious diseases may be performed according to the history and 
clinical suspicion for each case. At UGVS dogs presented for evaluation of seizure disorders 
are routinely tested for serum Toxoplasma titres and Neospora neutralisation dilution titres, 
unless other causes of symptomatic epilepsy are considered more likely and / or economic 
restriction are a consideration.
In animals that at the time of presentation are on anticonvulsant therapy, evaluation of serum 
anticonvulsant agent(s) concentration is also recommended as this may underlie perceived 
problems with seizures control. Serum anticonvulsant levels are routinely measured at UGVS 
unless: a) anticonvulsant therapy has been initiated or the dosage regimen has been modified at 
a time prior to referral such that immediate assessment is inappropriate (e.g., cases 5 and 7); b) 
this evaluation had been performed at the referring veterinary practices (e.g., cases 2, 8 and 9); 
c) the development of interictal neurological abnormalities suggests that failure in control of
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seizure activity is unlikely to be due to inappropriate serum anticonvulsant concentrations 
(case 7).
Advanced diagnostic imaging study of the brain should be performed in all dogs less than 1 or 
greater than 5 years of age because they have the highest probability for symptomatic epilepsy. 
Advanced neuroimaging techniques offer the best opportunity to detect morphological 
abnormalities resulting from an intracranial anomaly or neoplasia, the most prevalent causes of 
seizures in dogs less than 1 and greater than 7 years old, respectively (Podell et al 1995; Podell
1996). In addition, as general rule, advanced imaging techniques studies should be performed 
in all animals with persistent interictal neurological abnormalities, determined via either 
history or examination, regardless of the age of the patient: permanent interictal neurological 
abnormalities always indicate the presence of structural brain abnormalities. In the light of an 
unremarkable scan a CSF tap is justified.
Seizures and brain tumours
Epidemiological issues
While seizures are often reported to be a clinical manifestation of brain tumours in dogs, the 
actual incidence of seizures associated with intracranial tumours is not well established. In a 
series of 21 dogs with brain tumour, 8 had seizures (Palmer et al 1974). Foster et al (1988) 
described the clinical features of 43 dogs with forebrain tumours, 51% of which had seizures. 
In a more recent series of 95 dogs with brain tumours, 46 had seizures as admitting complaint 
(Bagley 1999; Bagley et al 1999a). As seizures were more often a presenting complaint in 
dogs older than 9 years of age, the possibility that the recent development of seizure activity in 
dogs of this group of age is due to a brain tumour should strongly be considered, and advanced 
imaging testing would be mandatory for diagnosis. In the brain tumour case series presented 
by Bagley (1999) 95% of the dogs were 5 years or older at the time of the diagnosis. The 
cases reviewed here are in accordance with this observation: in all but two (cases 7 and 14) of 
the fourteen cases which were diagnosed with intracranial neoplasia (six known -  cases 5, 6, 7, 
13,14 and 16 - and seven suspected - cases 1 ,2 ,3 ,4 ,1 1 ,1 2  and 15), the patient was 5 years or 
older at the time of diagnosis.
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The relationship between brain tumours and seizure activity
The historical and clinical findings in patients with intracranial neoplasia are variable and 
reflect the location, size and associated pathologic effects of the tumour (LeCouteur 1999; 
Dewey et al 2000).
Location
Tumour location appears to be the most important factor associated with the development of 
seizures. The literature suggests that the majority of brain tumours associated with seizures 
affect the rostrotentorial structures, especially the frontal, olfactory and parietal lobes (Foster 
et al 1988; Bagley 1999; Bagley et al 1999a). The cases reviewed here are in accordance with 
this observation: of the nine cases of forebrain neoplasia (three known -  cases 5, 6 and 13 -  
and six suspected -  cases 1-4, 11 and 12), six had seizures as admitting complaint (cases 1-6). 
Only one dog with seizure activity and interictal signs, which localised the lesion to the 
forebrain, was diagnosed with a caudal fossa tumour following computed tomographic study 
(case 7). The mild gait / balance abnormalities reported by the owner might have made the 
clinician suspicious of brainstem / hindbrain involvement, but no apparent neurological 
deficits were found at the time of examination. Bagley and Gavin (1998) also report a case of 
brainstem neoplasia associated with seizure activity; on post mortem examination the 
diagnosis was choroid plexus papilloma and no apparent metastasis were found in the 
rostrotentorial structures. In case 7 the histopathological diagnosis was also choroid plexus 
papilloma but multiple métastasés were found in the diencephalon and cerebral hemispheres.
Mass lesions may not be identified on CT study if isodense to normal brain parenchymal tissue 
in the pre-contrast study, non-enhancing on the post-contrast one, not associated with other 
noticeable pathology(ies) and / or because of small size (Kraft & Gavin 1999). In addition, 
small metastatic foci may also go undetected on post mortem evaluation.
Thus, a direct causative relation between seizure activity and brainstem tumours can neither be 
claimed nor excluded. Interestingly, seizures can be experimentally produced from brainstem 
stimulation. However, the seizure activity observed in human patients with brainstem tumours 
is thought to originate from cortical tissue that is distant from the tumour (Pilcher et al 1993). 
Currently seizures in animals with brainstem tumours are thought most likely to result from
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secondary pathophysiological alterations (e.g., vasogenic oedema, hydrocephalus, alterations 
in blood flow) affecting forebrain structures (Bagley & Gavin 1998).
Tumours of the frontal, olfactory and parietal lobes are reported to be more often associated 
with seizures (Smith et al 1989; Bagley & Gavin 1998; Bagley 1999; Bagley et al 1999a). In 
four of the six dogs with forebrain tumours and seizure activity, the lesion involved the frontal 
and / or olfactory lobes (cases 1 to 4); in cases 5 and 6 involvement of the parietal lobe was 
apparent.
Tumours of the diencephalon are also reported as frequently associated with seizure activity 
(Bagley & Gavin 1998). Thalamocortical circuits are in fact essential in generalisation of 
seizures activity within the cerebral cortex (Coulter 1997). In the experience here presented, 
three dogs (cases 6, 12 and 13) had had findings suggestive of involvement of the thalamic 
area but only one had seizures as part of the presenting complaint (case 6). In this dog the 
simultaneous presence of cortical and thalamic lesions, might have enhanced both antidromic 
and orthodromic activity in the thalamocortical axons. Antidromic and orthodromic are 
proved to lead to a “reverberating circuit” of,excitation, thus facilitating spread of electrical 
activity and the development of seizure activity (Coulter 1997; March 1998). Development of 
seizure activity might have also been facilitated by the midbrain involvement. A role for the 
midbrain reticular formation in generalisation of electrical activity has in fact also been 
proposed, because of its diffuse projection to the cortex. As seizures frequently occur while 
the animal is asleep, it is thought that changes in the reticular formation during sleeping affect 
the spread of the seizure activity (Shell 1993a; Proctor & Gale 1997).
One dog (case 12) with involvement of the thalamic area exhibited “absence periods”. In 
human patients dysfunction of specific thalamic nuclei has been proved to be responsible for 
the appearance of generalised, absence seizure (MacDonald 1997; Stefan & Carter Snead III
1997). In case 12 the absence periods apparently experienced by the dog might have 
represented true absence seizures.
Other features potentially related to whether a tumour is related to seizures
Other features have been identified that are associated with increased incidence of seizures in 
humans with brain tumours. These include a young age, slow growth rate, and a benign nature 
(Recht & Glantz 1997). The latter two features may also be relevant in dogs. In the studies of
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Foster et al (1988) and Bagley (1999) the majority of dogs exhibiting seizures had 
meningioma, which tends to grow slowly and to be histologically benign (Moore et al 1996).
Other tumour types affecting the rostrotentorial structures, which had been reported in dogs 
with seizures include: astrocytomas, oligodendrogliomas, choroid plexus papillomas, pituitary 
tumours, and nasal adenocarcinoma extending caudally into the olfactory areas, as well as 
unclassified types of tumours (Bagley & Gavin 1998; Bagley 1999).
Interestingly, the incidence of seizures in humans with cerebral métastasés is lower compared 
with those patients with primary brain tumour (Recht & Glantz 1997). No data is available in 
the veterinary literature to state if a similar trend occurs in animals as well.
Pathophysiological mechanisms o f seizure generation in brain tumour patients
As previously stated in this dissertation, the pathophysiological mechanisms of seizure 
generation are still not completely understood. Brain tumours probably result in seizures 
either because of direct alteration in neuronal function and inter-neuronal connectivity or 
because of secondary changes induced by the tumour such as changes in blood flow, cerebral 
oedema, haemorrhages and hydrocephalus (Bagley 1996a; Bagley 1996b; Bagley & Gavin
1998).
Normal CNS function relies on the initiation and transmission of excitatory impulses between 
neurons and groups of neurons. The morphological and functional organisation of the cerebral 
cortex is such that excitatory activity is prevalent (Martin 1991; Connors 1997). Under normal 
circumstances local and regional inhibitory circuits modulate the electrical activity within the 
cerebral cortex and prevent abnormal spread of excitatory activity to both cortical and 
subcortical areas (Prince 1997; March 1998). During a seizure the normal balance of 
excitation and inhibition is altered, favouring excitation. Seizure activity may develop because 
of increased inherent neuronal excitability, increased recurrent excitation and / or decreased 
recurrent inhibition (March 1998). Any of these factors, alone or in combination, may result 
in a paroxysmal hypersynchronous discharge of neurons within a seizure focus (Connors 1984; 
Selcer & Selcer 1990). However, a clinical seizure occurs only if the number of neurons in the 
seizure focus reaches a “critical mass” (Lane & Bunch 1990). Unsuccessful local and regional 
inhibition has also to occur, to allow the electrical activity to be carried to other parts of the 
brain. If unsuccessful inhibition occurs, then other neuronal aggregates are excited; successful
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recruitment of a critical number of areas with synchronised depolarisation, ultimately, leads to 
a seizure (Podell 1996; Westbrook 2000).
Brain tumours may increase inherent neuronal excitability by inducing morphological and / or 
functional changes such as changes in dendritic structures, receptor density and / or receptor 
sensitivity as well as dysfunction of cellular ion pumps (During et al 1995; Connors 1997; 
Heinemann & Eder 1997; March 1998). Similar changes may also occur in inhibitory 
intemeurons, leading to a decreased efficacy of inhibitory mechanisms (Kandel & Schwartz 
1991; Connors 1997; Shumate & Jin 1998). Compression, distortion and shift of brain 
parenchyma may physically disrupt inhibitory circuits resulting in decreased recurrent 
inhibition (feed-forward and feedback inhibition) and increased recurrent excitation (Bagley 
1996b; March 1998). True loss of brain parenchyma occurs only with slow growing tumours 
as a compensatory mechanism to a progressively increasing ICP (North & Reilly 1990; Bagley 
1996a).
Tumour-associated inflammation of surrounding normal brain tissue, in conjunction with 
immune-mediated events, contributes significantly to regional tissue damage and creates a 
condition of neuronal hyperirritability, which in turn may enhance seizure activity (Bagley 
1996b). Focal or multifocal / diffuse cerebral ischaemia secondary to decreased cerebral 
pressure perfusion results in ischaemic necrosis (Bedford 1991). Areas of ischaemic necrosis 
also contribute to brain inflammation, thus facilitating generation and spread of abnormal 
electrical activity. In turn, vasogenic and inflammatory oedema increase ICP further. 
Increased ICP results in further deterioration of cerebral blood flow; thus a vicious cycle can 
develop, in which oedema and brain ischaemia become progressive (North & Reilly 1990). 
Haemorrhages are likely to facilitate seizure generation via ischaemic necrosis secondary to 
increased ICP, and via the inflammatory reaction of surrounding brain tissue (Bagley 1996b). 
However, despite the evidence that brain tumour associated pathologies might play a role in 
the generation of seizures in brain tumour patients, no correlation has been proved between 
their severity or extension and the presence and severity of seizures.
In brain tumour patients, neuronal death occurs through a wide variety of mechanisms ranging 
from direct disruption of cerebral blood circulation to ischaemic necrosis secondary to 
increased ICP. Neuronal death results in loss of inhibitory circuits and increased recurrent
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excitation. The axons of deranged excitatory neurons that have lost their target connections 
undergo sprouting and make aberrant connections with other excitatory neurons. The net 
result is a hyperexcitable neuronal network (Au Louis et al 1997; McNamara & Wada 1997; 
McKinney et al 1997; Prince 1997).
Neuronal swelling, hyperirritability, and increased neuronal discharge may facilitate 
generation and maintenance of synchronised neuronal firing also via potentiation of non- 
synaptic mechanisms of synchronisation such as ephaptic transmission and electrotonic 
coupling (McNamara 1994; Gibson et al 1999; Velazquez & Carlen 2000).
Kindling and mirror focus (Lane & Bunch 1990; Shell 1993a; March 1998) may contribute to 
the progressive increase in seizure frequency observed in brain tumour patients, as well as to 
explain why seizure activity, in humans, usually does not originate in tumour-involved brain 
tissue, and why in some instances seizure activity may originate in cortical tissue relatively 
distant from the tumour itself (Pilcher et al 1993). Cerebral ischaemia and associated oedema 
are likely to play an important role in creating a condition of neuronal hyperirritability in areas 
of the brain distant from the tumour.
Axonal sprouting, kindling, mirror focus and most of the cellular changes described are 
chronic in character; this may account for the apparent higher incidence of seizures in patients 
with slow growing tumours (e.g., meningiomas). However, to date, in both human and 
veterinary medicine the information available regarding the pathophysiological mechanisms of 
seizure generation, the biological behaviour of brain tumours and the mechanisms by which 
brain tumours interfere with normal brain function, are not sufficient to elucidate the 
pathogenesis of seizure activity in brain tumour patients. This also means that further work is 
necessary to be able to identify the properties of brain tumours that correlate with the potential 
for seizure generation, as well as the severity of seizure activity.
Conclusions
Seizures are one of the most common clinical signs in dogs with intracranial neoplasia, 
together with signs of vestibular dysfunction and ataxia. With the advent of advanced imaging 
modalities the ability to diagnose brain tumours in-vivo has increased. However, as these 
diagnostic modalities are costly and access to them is not universal, it is important to
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determine, on the basis of historical and physical examination findings, which patients are 
likely to benefit from advanced imaging as part of their diagnostic evaluation.
At the time of presentation, seizures may be the only clinical manifestation of an intracranial 
tumour, although they are frequently accompanied by changes in mental status and / or 
behavioural derangement. In domestic animals, the bulk of neuronal integration occurs in the 
brainstem and spinal cord. Thus, even relatively large tumours in some areas of the cerebrum 
may not result in detectable deficits in either motor or sensory function. Rapid deterioration of 
neurological status usually occurs following development of persistent abnormalities 
detectable upon neurological examination. Poor seizure control is the reason why most canine 
brain tumour patients are euthanased, making this clinical problem an important determinant 
of morbidity and mortality.
The case material presented here, in conjunction with a broad review of the literature, indicates 
that brain tumours are likely to be the cause of the neurological dysfunction more often, and in 
younger dogs, than was believed in the past. Advanced imaging modalities are a relatively 
new acquisition in veterinary medicine and their utilisation in the diagnostic evaluation of 
seizure patients has provided clinicians with information regarding intracranial disease which 
was not available in the past. The consequent changes in our understanding of the 
epidemiology of brain tumours, has driven and represents a major impetus to their further 
investigation.
In such a dynamic scenario the ultimate goal of clinicians everywhere is to identify those 
clinical features which will enable us to recognise patients with suspect intracranial neoplasia 
at earlier stages of the disease. Currently, it is still fair to regard the treatment of canine brain 
tumours as palliative. Earlier identification is likely to be one of the factors contributing to an 
improvement in outcome in the future.
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A albumin
ACTH adrenocorticotropic hormone
ALT alanine aminotransferase
AP alkaline phosphatase
AST aspartate aminotransferase
BBB blood-brain barrier
BCNU carmustine
Ca calcium
CBF cerebral blood flow
CPP cerebral perfusion pressure
Cl chloride
CSF cerebrospinal fluid
CNS central nervous system
CP complex partial
CT computed tomography / tomographic
B.C. epithelial cells
BEG electroencephalographic / electroencephalogram/s
e.g. for example
EMA epithelial membrane antigen
et al and others
FL frontal lobe
g gram
G globulin
GFAP glial fibrillary acidic protein
GH growth hormone
GME granulomatous meningoencephalitis / -encephalomyelitis
HB haemoglobin
H&E haematoxylin and eosin
HT haematocrit
lAC intracranial arachnoid cyst
ICP intracranial pressure
IE idiopathic epilepsy
IFAT indirect fluorescent antibody test
IGF-I insulin-like growth hormone
III/IIFd third
IM intramuscular
IV intravenous / fourth
IVth fourth
K potassium
KBr potassium bromide
1 litre
L left
LV/s lateral ventricle/s
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M midbrain
MAG myelin-associated glycoprotein
MBP myelin basic protein
MCH mean corpuscular haemoglobin
MCHC mean corpuscular haemoglobin concentration
MCV mean corpuscular volume
mmol millimole/s
MPV mean platelet volume
MRI magnetic resonance imaging
Na sodium
n nanogram/s
NE not evaluated
nmol nanomole/s
NP not performed
NSAID nonsteroidal anti-inflammatory drug
OB olfactory bulb
OL olfactory lobe
PaC02 arterial carbon dioxide tension
Pa02 arterial oxygen tension
PB phenobarbitone
PDH pituitary dependent hyperadrenocorticism
PE primary epilepsies
PET platelet count
PME post mortem examination
PNS peripheral nervous system
PUPD polyuria / polydipsia
qnalit. Qualitative
R right
RAS reticular activating system
RBC red blood cells
RDW red cell size distribution width
RS reactive seizures
SAP serum alkaline posphatase
SE symptomatic epilepsies
SG specific gravity
SP simple partial
T4 thyroxin
TL temporal lobe
TSH thyroid-stimulating hormone
U unit/s
UGVS University of Glasgow Veterinary School
UMN upper motor neuron
V20° Ro-DCd ventral 20° rostral-dorsocaudal oblique open mouth
v.s. ventricular system
WBC white blood cell
WHO World Health Organisation
XPT X-ray phototherapy
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o degree > greater than
a alpha < less than
P beta > greater than or
g gram equal to
micro < less than or equal
n nano to
% percentage
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